<SEC-DOCUMENT>0001493152-23-021998.txt : 20230621
<SEC-HEADER>0001493152-23-021998.hdr.sgml : 20230621
<ACCEPTANCE-DATETIME>20230621160520
ACCESSION NUMBER:		0001493152-23-021998
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20230615
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230621
DATE AS OF CHANGE:		20230621

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Azitra Inc
		CENTRAL INDEX KEY:			0001701478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464478536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41705
		FILM NUMBER:		231029827

	BUSINESS ADDRESS:	
		STREET 1:		21 BUSINESS PARK DRIVE, SUITE 6
		CITY:			BRANFORD
		STATE:			CT
		ZIP:			06405
		BUSINESS PHONE:		(203) 489-0183

	MAIL ADDRESS:	
		STREET 1:		21 BUSINESS PARK DRIVE, SUITE 6
		CITY:			BRANFORD
		STATE:			CT
		ZIP:			06405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:AZTR="http://azitrainc.com/20230615">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_AZTR_azitrainc.com_20230615 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230615_20230615 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001701478 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityCentralIndexKey">0001701478</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aztr-20230615.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-15to2023-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001701478</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-15</xbrli:startDate>
        <xbrli:endDate>2023-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20230615__20230615_zfWGp4FRR7jb"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <span id="xdx_90B_edei--DocumentPeriodEndDate_c20230615__20230615_zHFKAS2P4KKj"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 15, 2023</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20230615__20230615_zGSBJCmLzGIk"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityRegistrantName">AZITRA,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20230615__20230615_zgxd0i118GM9"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20230615__20230615_zBw4IEKS0Yia"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityFileNumber">001-41705</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20230615__20230615_zLAsGWo51Shb"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityTaxIdentificationNumber">46-4478536</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span>(Commission</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 0.7pt; padding-left: 0.7pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20230615__20230615_zqbnOOf9ESu1"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressAddressLine1">21
    Business Park Drive</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20230615__20230615_z1j0MlWhnOUk"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressCityOrTown">Branford</ix:nonNumeric></span>,
    <span id="xdx_908_edei--EntityAddressStateOrProvince_c20230615__20230615_zzdnCPpC5q72"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressStateOrProvince">CT</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20230615__20230615_zkhn06NPsmbg"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressPostalZipCode">06405</ix:nonNumeric></span></b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--CityAreaCode_c20230615__20230615_zEaAjOAAO6Xd"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:CityAreaCode">(203)</ix:nonNumeric></span>
    <span id="xdx_908_edei--LocalPhoneNumber_c20230615__20230615_zHo43okyYTP3"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:LocalPhoneNumber">646-6446</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
    telephone number, including area code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
    name or former address, if changed since last report.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20230615__20230615_zfK8FHS8dB0i"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SolicitingMaterial_c20230615__20230615_zEW8EWd5ZvRe"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementTenderOffer_c20230615__20230615_zWzdUfd6JZfg"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20230615__20230615_zR2HD6c3N7E8"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20230615__20230615_zqcaoQK8rzzi"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:Security12bTitle">Common
    Stock: Par value $0.0001</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20230615__20230615_zo94BuAtQQta"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:TradingSymbol">AZTR</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SecurityExchangeName_c20230615__20230615_zozU4sVD6CA7"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE
    American</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20230615__20230615_z79OfpyLyFp7"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90B_edei--EntityExTransitionPeriod_c20230615__20230615_zDQSE8iJn2y2"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2023, Azitra, Inc., a Delaware corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting
Agreement&#8221;) with ThinkEquity LLC, as representative (the &#8220;Representative&#8221;) of the several underwriters identified therein,
relating to the Company&#8217;s initial public offering (the &#8220;Offering&#8221;) of 1,500,000 shares of the Company&#8217;s common
stock, par value $0.0001 (the &#8220;Shares&#8221;). The Company previously filed the form of underwriting agreement as an exhibit to
its Registration Statement on Form S-1, as amended from time to time (File No. 333-269876) (the &#8220;Registration Statement&#8221;).
The price per Share to the public was $5.00. The Company also granted the Representative a 45-day option to purchase up to 225,000 additional
Shares on the same terms and conditions for the purpose of covering any over-allotments in connection with the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2023, the Company consummated the Offering and issued the Shares for aggregate net proceeds of approximately $6.5 million, after
deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the net proceeds from the
Offering for clinical trials and product development, research and development, clinical manufacturing as well as for working capital
and other general corporate purposes. Concurrently with the closing of the Offering, the Company also issued warrants to purchase an
aggregate of up to 60,000 shares of its common stock to the Representative or their designees, at an exercise price of $6.25 per share
(the &#8220;Representative&#8217;s Warrants&#8221;). The Representative&#8217;s Warrants are exercisable beginning on December 12, 2023,
and expire on June 15, 2028, pursuant to the terms and conditions of the Representative&#8217;s Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares were offered, issued and sold to the public pursuant to the Registration Statement, which was declared effective by the Securities
and Exchange Commission (&#8220;SEC&#8221;) on June 15, 2023, and the prospectus forming a part thereof. A final prospectus dated June
15, 2023, describing the terms of the Offering was filed with the SEC on June 20, 2023 and is available on the SEC&#8217;s website located
at <span style="text-decoration: underline">http://www.sec.gov</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions. The representations, warranties and
covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely
for the benefit of the parties to such agreement and were subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K contains forward-looking statements that involve risks and uncertainties, such as statements related to the
use of proceeds from the Offering, as well as other risks detailed from time to time in the Company&#8217;s filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Underwriting Agreement is qualified in its entirety by reference to the Underwriting Agreement attached as Exhibit
1.1 hereto and is incorporated herein by reference. The foregoing description of the Representative&#8217;s Warrants issuable thereunder
are qualified in their entirety by reference to the form of Representative&#8217;s Warrant attached hereto as Exhibit 4.1 and incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>In
connection with the closing of the Offering, the Company amended and restated its Amended and Restated Certificate of Incorporation (the
&#8220;Amended and Restated Certificate of Incorporation&#8221;) and amended and restated its Bylaws (the &#8220;Amended and Restated
Bylaws&#8221;). The Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware
on June 21, 2023 and became effective on that date. The Amended and Restated Bylaws became effective immediately upon the consummation
of the Offering. A description of the material terms of the Amended and Restated Certificate of Incorporation and the Amended and Restated
Bylaws can be found in the section of the Registration Statement, entitled &#8220;Description of Securities,&#8221; and is incorporated
herein by reference.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 47.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions are qualified in their entirety by reference to the complete text of the Amended and Restated Certificate of Incorporation
and the Amended and Restated Bylaws, which are attached hereto as Exhibits 3.1 and 3.2, respectively, and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 47.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2023, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is attached as
Exhibit 99.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 47.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2023, the Company issued a press release announcing the closing of the Offering. A copy of the press release is attached as
Exhibit 99.2 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 47.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 7.01 (including the exhibits) shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section,
and is not incorporated by reference into any filing under the Securities Act or the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Underwriting Agreement by and between the Company and the Representative dated June 15, 2023.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Certificate of Incorporation of Azitra, Inc.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex3-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of Azitra, Inc.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Representative&#8217;s Warrant (included in Exhibit 1.1).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release dated June 15, 2023.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-2.htm">Press release dated June 21, 2023.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">104</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Cover
Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AZITRA,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    June 21, 2023</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Francisco D. Salva</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francisco
    D. Salva</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LW6rKLJLh4o4ZQwRb6uLUtyakdafPZJvabchhkASzvlyhBiJNa10hQynRZHBAeumUg6hwCsymgt6R7rZJuBngTdtHSvj+vMHpuQZ9Mx0HM/PXuitT22xTCCahTIK5cQviZSQ70TQ6SmZqy7ROK0qUKaEnKlhjU5xO3w4qDcZqts+6ohsNZkE4nE0yB+QUSxhT0/1Ir5byLJUBKO+ArFmejRdzMM6qmFZYe2z7ID+O/gCGrNJTQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTION
VERSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>between</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AZITRA,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THINKEQUITY
LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>as
Representative of the Several Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AZITRA,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>UNDERWRITING
AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
15, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on Schedule 1 attached hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 41<SUP>st</SUP> Fl</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Azitra, Inc., a corporation formed under the laws of the State of Delaware (the &ldquo;Company&rdquo;), hereby confirms
its agreement (this &ldquo;Agreement&rdquo;) with ThinkEquity LLC (hereinafter referred to as &ldquo;you&rdquo; (including its correlatives)
or the &ldquo;Representative&rdquo;) and with the other underwriters named on <U>Schedule 1</U> hereto for which the Representative is
acting as representative (the Representative and such other underwriters being collectively called the &ldquo;Underwriters&rdquo; or,
individually, an &ldquo;Underwriter&rdquo;) as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.
<U>Purchase and Sale of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.1
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Firm Shares</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.1.1.
<U>Nature and Purchase of Firm Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)
On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company
agrees to issue and sell to the several Underwriters, an aggregate of 1,500,000 shares (&ldquo;Firm Shares&rdquo;) of the Company&rsquo;s
common stock, par value $0.0001 per share (the &ldquo;Common Stock&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)
The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares set forth opposite their respective
names on <U>Schedule 1</U> attached hereto and made a part hereof at a purchase price of $4.625 per share (92.50% of the per Firm Share
offering price). The Firm Shares are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus
(as defined in Section 2.1.1 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.1.2.
<U>Shares Payment and Delivery</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)
Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on the second (2<SUP>nd</SUP>) Business Day following
the effective date (the &ldquo;Effective Date&rdquo;) of the Registration Statement (as defined in Section 2.1.1 below) (or the third
(3<SUP>rd</SUP>) Business Day following the Effective Date if the Registration Statement is declared effective after 4:01 p.m., Eastern
time) or at such earlier time as shall be agreed upon by the Representative and the Company, at the offices of Venable LLP, 151 W. 42<SUP>nd
</SUP>Street, 49<SUP>th</SUP> Floor, New York, NY 10036 (&ldquo;Representative Counsel&rdquo;), or at such other place (or remotely by
facsimile or other electronic transmission) as shall be agreed upon by the Representative and the Company. The hour and date of delivery
and payment for the Firm Shares is called the &ldquo;Closing Date.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)
Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the
Company upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the Firm Shares (or through
the facilities of the Depository Trust Company (&ldquo;DTC&rdquo;)) for the account of the Underwriters. The Firm Shares shall be registered
in such name or names and in such authorized denominations as the Representative may request in writing at least two (2) full Business
Days prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Shares except upon tender of payment by
the Representative for all of the Firm Shares. The term &ldquo;Business Day&rdquo; means any day other than a Saturday, a Sunday or a
legal holiday or a day on which banking institutions are authorized or obligated by law to close in New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.2
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Over-allotment Option</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.2.1.
<U>Option Shares</U>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Shares,
the Company hereby grants to the Underwriters an option to purchase up to 225,000 additional shares of Common Stock, representing fifteen
percent (15%) of the Firm Shares sold in the offering, from the Company (the &ldquo;Over-allotment Option&rdquo;). Such 225,000 additional
shares of Common Stock, the net proceeds of which will be deposited with the Company&rsquo;s account, are hereinafter referred to as
&ldquo;Option Shares.&rdquo; The purchase price to be paid per Option Share shall be equal to the price per Firm Share set forth in Section
1.1.1 hereof. The Firm Shares and the Option Shares are hereinafter referred to together as the &ldquo;Public Securities.&rdquo; The
offering and sale of the Public Securities is hereinafter referred to as the &ldquo;Offering.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.2.2.
<U>Exercise of Option</U>. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative
as to all (at any time) or any part (from time to time) of the Option Shares within 45 days after the Effective Date. The Underwriters
shall not be under any obligation to purchase any Option Shares prior to the exercise of the Over-allotment Option. The Over-allotment
Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in
writing by overnight mail, e-mail or facsimile or other electronic transmission setting forth the number of Option Shares to be purchased
and the date and time for delivery of and payment for the Option Shares (the &ldquo;Option Closing Date&rdquo;), which shall not be later
than one (1) full Business Day after the date of the notice or such other time as shall be agreed upon by the Company and the Representative,
at the offices of Representative Counsel or at such other place (including remotely by facsimile or other electronic transmission) as
shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Shares does not occur on the
Closing Date, the Option Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment Option with respect to
all or any portion of the Option Shares, subject to the terms and conditions set forth herein, (i) the Company shall become obligated
to sell to the Underwriters the number of Option Shares specified in such notice and (ii) each of the Underwriters, acting severally
and not jointly, shall purchase that portion of the total number of Option Shares then being purchased as set forth in <U>Schedule 1
</U>opposite the name of such Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.2.3.
<U>Payment and Delivery</U>. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same
day) funds, payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Underwriters)
representing the Option Shares (or through the facilities of DTC) for the account of the Underwriters. The Option Shares shall be registered
in such name or names and in such authorized denominations as the Representative may request in writing at least one (1) full Business
Day prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Option Shares except upon tender of payment
by the Representative for applicable Option Shares. The Option Closing Date may be simultaneous with, but not earlier than, the Closing
Date, and in the event that such time and date are simultaneous with the Closing Date, the term &ldquo;Closing Date&rdquo; share refer
to the time and date of delivery of the Firm Shares and the Option Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.3
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Representative&rsquo;s Warrants</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.3.1.
<U>Purchase Warrants</U>. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date
and Option Closing Date, as applicable, an option (&ldquo;Representative&rsquo;s Warrant&rdquo;) for the purchase of an aggregate number
of shares of Common Stock representing 4% of the Public Securities, for an aggregate purchase price of $100.00. The Representative&rsquo;s
Warrant agreement, in the form attached hereto as <U>Exhibit A</U> (the &ldquo;Representative&rsquo;s Warrant Agreement&rdquo;), shall
be exercisable, in whole or in part, commencing on a date which is one hundred eighty (180) days after the Effective Date and expiring
on the five-year anniversary of the Effective Date at an initial exercise price per share of Common Stock of $6.25, which is equal to
125% of the initial public offering price of the Firm Shares. The Representative&rsquo;s Warrant Agreement and the shares of Common Stock
issuable upon exercise thereof are hereinafter referred to together as the &ldquo;Representative&rsquo;s Securities.&rdquo; The Representative
understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative&rsquo;s
Warrant Agreement and the underlying shares of Common Stock during the one hundred eighty (180) days after the Effective Date and by
its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representative&rsquo;s Warrant
Agreement, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result
in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to
anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of
the Representative or of any such Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.3.2.
<U>Delivery</U>. Delivery of the Representative&rsquo;s Warrant Agreement shall be made on the Closing Date and shall be issued in the
name or names and in such authorized denominations as the Representative may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as of the Applicable Time
(as defined below), as of the Closing Date and as of the Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.1
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Filing of Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.1.1.
<U>Pursuant to the Securities Act</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
a registration statement, and an amendment or amendments thereto, on Form S-1 (File No. 333-269876), including any related prospectus
or prospectuses, for the registration of the Public Securities and the Representative&rsquo;s Securities under the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), which registration statement and amendment or amendments have been prepared by the
Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission
under the Securities Act (the &ldquo;Securities Act Regulations&rdquo;) and will contain all material statements that are required to
be stated therein in accordance with the Securities Act and the Securities Act Regulations. Except as the context may otherwise require,
such registration statement, as amended, on file with the Commission at the time the registration statement became effective (including
the Preliminary Prospectus included in the registration statement, financial statements, schedules, exhibits and all other documents
filed as a part thereof or incorporated therein and all information deemed to be a part thereof as of the Effective Date pursuant to
paragraph (b) of Rule 430A of the Securities Act Regulations (the &ldquo;Rule 430A Information&rdquo;)), is referred to herein as the
&ldquo;Registration Statement.&rdquo; If the Company files any registration statement pursuant to Rule 462(b) of the Securities Act Regulations,
then after such filing, the term &ldquo;Registration Statement&rdquo; shall include such registration statement filed pursuant to Rule
462(b). The Registration Statement has been declared effective by the Commission on the date hereof. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Each
prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information
that was used after such effectiveness and prior to the execution and delivery of this Agreement, is herein called a &ldquo;Preliminary
Prospectus.&rdquo; The Preliminary Prospectus, subject to completion, dated May 9, 2023, that was included in the Registration Statement
immediately prior to the Applicable Time is hereinafter called the &ldquo;Pricing Prospectus.&rdquo; The final prospectus in the form
first furnished to the Underwriters for use in the Offering is hereinafter called the &ldquo;Prospectus.&rdquo; Any reference to the
&ldquo;most recent Preliminary Prospectus&rdquo; shall be deemed to refer to the latest Preliminary Prospectus included in the Registration
Statement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Applicable
Time&rdquo; means 5:15 p.m, Eastern time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Issuer
Free Writing Prospectus&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities Act Regulations
(&ldquo;Rule 433&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Securities
Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission by the Company, (ii) a &ldquo;road
show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission,
or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Public Securities
or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission
or, if not required to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule 433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Issuer
General Use Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective
investors (other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433 (the &ldquo;Bona Fide Electronic
Road Show&rdquo;)), as evidenced by its being specified in <U>Schedule 2-B</U> hereto. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Issuer
Limited Use Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Pricing
Disclosure Package&rdquo; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Pricing
Prospectus and the information included on <U>Schedule 2-A</U> hereto, all considered together. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.1.2.
<U>Pursuant to the Exchange Act</U>. The Company has filed with the Commission a Form 8-A (File Number 001-41705) providing for the registration
pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), of the shares of Common
Stock. The registration of the shares of Common Stock under the Exchange Act has been declared effective by the Commission on or prior
to the date hereof. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the
shares of Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating terminating
such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.2
<U>Stock Exchange Listing</U>. The shares of Common Stock have been approved for listing on the NYSE American LLC (the &ldquo;Exchange&rdquo;),
and the Company has taken no action designed to, or likely to have the effect of, delisting the shares of Common Stock from the Exchange,
nor has the Company received any notification that the Exchange is contemplating terminating such listing except as described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.3
<U>No Stop Orders, etc</U>. Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued any
order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied
with each request (if any) from the Commission for additional information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.4
<U>Disclosures in Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.1.
<U>Compliance with Securities Act and 10b-5 Representation</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material
respects with the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus, including the prospectus
filed as part of the Registration Statement as originally filed or as part of any amendment or supplement thereto, and the Prospectus,
at the time each was filed with the Commission, complied in all material respects with the requirements of the Securities Act and the
Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection with this Offering and the
Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except
to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)
Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or
at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits or
will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; provided,
however, that this representation and warranty shall not apply to the Underwriters&rsquo; Information (as defined below). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(iii)
The Pricing Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does
not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus
hereto does not conflict with the information contained in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus
or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Pricing Prospectus
as of the Applicable Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with written
information furnished to the Company with respect to the Underwriters by the Representative expressly for use in the Registration Statement,
the Pricing Prospectus or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such
information provided by or on behalf of any Underwriter consists solely of the following disclosure contained in the &ldquo;Underwriting&rdquo;
section of the Prospectus: the information under the subsections &ldquo;Discretionary Accounts,&rdquo; &ldquo;Electronic Offer, Sale
and Distribution of Shares,&rdquo; &ldquo;Stabilization,&rdquo; and &ldquo;Passive Market Making&rdquo; (the &ldquo;Underwriters&rsquo;
Information&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(iv)
Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time
of any filing with the Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will
include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this representation
and warranty shall not apply to the Underwriters&rsquo; Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.2.
<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements or other
documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been
so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by
which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, or (ii) is material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is
in full force and effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other
parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution provision may
be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms
of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor
may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the Company&rsquo;s
knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge, no event has occurred that, with the lapse
of time or the giving of notice, or both, would constitute a default thereunder. To the best of the Company&rsquo;s knowledge, performance
by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable
law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the
Company or any of its assets or businesses (each, a &ldquo;Governmental Entity&rdquo;), including, without limitation, those relating
to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.3.
<U>Prior Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
Statement, the Pricing Disclosure Package and the Preliminary Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.4.
<U>Regulations</U>. The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning the effects
of federal, state, local and all foreign regulation on the Offering and the Company&rsquo;s business as currently contemplated are correct
in all material respects and no other such regulations are required to be disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus which are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.5
<U>Changes After Dates in Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.5.1.
<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change
in the financial position or results of operations of the Company, nor any change or development that, singularly or in the aggregate,
would result in a material adverse change, in or affecting the condition (financial or otherwise), results of operations, business, assets
or prospects of the Company (a &ldquo;Material Adverse Change&rdquo;); (ii) there have been no material transactions entered into by
the Company, other than as contemplated pursuant to this Agreement; and (iii) no officer or director of the Company has resigned from
any position with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.5.2.
<U>Recent Securities Transactions, etc</U>. Subsequent to the respective dates as of which information is given in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i) issued any securities or incurred
any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution
on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.6
<U>Independent Accountants</U>. To the knowledge of the Company, Grassi &amp; Co., CPAs, P.C. (the &ldquo;Auditor&rdquo;), whose report
is filed with the Commission as part of the Registration Statement, the Pricing Disclosure Package and the Prospectus, is an independent
registered public accounting firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting
Oversight Board. The Auditor has not, during the periods covered by the financial statements included in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g)
of the Exchange Act.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.7
<U>Financial Statements, etc</U>. The financial statements, including the notes thereto and supporting schedules included in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, fairly present in all material respects the financial position and the
results of operations of the Company at the dates and for the periods to which they apply; and such financial statements have been prepared
in conformity with U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;), consistently applied throughout the periods involved
(provided that unaudited interim financial statements are subject to year-end audit adjustments that are not expected to be material
in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules included in the Registration Statement
present fairly in all material respects the information required to be stated therein. Except as included therein, no historical or pro
forma financial statements are required to be included in the Registration Statement, the Pricing Disclosure Package or the Prospectus
under the Securities Act or the Securities Act Regulations. The pro forma and pro forma as adjusted financial information and the related
notes, if any, included in the Registration Statement, the Pricing Disclosure Package and the Prospectus have been properly compiled
and prepared in accordance with the applicable requirements of the Securities Act and the Securities Act Regulations and present fairly
in all material respects the information shown therein, and the assumptions used in the preparation thereof are reasonable and the adjustments
used therein are appropriate to give effect to the transactions and circumstances referred to therein. All disclosures contained in the
Registration Statement, the Pricing Disclosure Package or the Prospectus regarding &ldquo;non-GAAP financial measures&rdquo; (as such
term is defined by the rules and regulations of the Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of
Regulation S-K of the Securities Act, to the extent applicable. Each of the Registration Statement, the Pricing Disclosure Package and
the Prospectus discloses all material off-balance sheet transactions, arrangements, obligations (including contingent obligations), and
other relationships of the Company with unconsolidated entities or other persons that may have a material current or future effect on
the Company&rsquo;s financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital
resources, or significant components of revenues or expenses. Except as disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, (a) neither the Company nor any of its direct and indirect subsidiaries, including each entity disclosed
or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus as being a subsidiary of the Company (each,
a &ldquo;Subsidiary&rdquo; and, collectively, the &ldquo;Subsidiaries&rdquo;), has incurred any material liabilities or obligations,
direct or contingent, or entered into any material transactions other than in the ordinary course of business, (b) the Company has not
declared or paid any dividends or made any distribution of any kind with respect to its capital stock, (c) there has not been any change
in the capital stock of the Company or any of its Subsidiaries, or, other than in the course of business, any grants under any stock
compensation plan, and (d) there has not been any material adverse change in the Company&rsquo;s long-term or short-term debt.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.8
<U>Authorized Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
stated in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will have on the Closing Date the
adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Pricing
Disclosure Package and the Prospectus, on the Effective Date, as of the Applicable Time and on the Closing Date and any Option Closing
Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares
of Common Stock of the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts
or commitments to issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.9
<U>Valid Issuance of Securities, etc.</U></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.9.1.
<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by
this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights
of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities
were issued in violation of the preemptive rights of any holders of any security of the Company or similar contractual rights granted
by the Company. The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in
the Registration Statement, the Pricing Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common
Stock were at all relevant times either registered under the Securities Act and the applicable state securities or &ldquo;blue sky&rdquo;
laws or, based in part on the representations and warranties of the purchasers of such Shares, exempt from such registration requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.9.2.
<U>Securities Sold Pursuant to this Agreement</U>. The Public Securities have been duly authorized for issuance and sale and, when issued
and paid for pursuant to the terms of this Agreement, will be validly issued, fully paid and non-assessable; the holders thereof are
not and will not be subject to personal liability by reason of being such holders; the Public Securities are not and will not be subject
to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all
corporate action required to be taken for the authorization, issuance and sale of the Public Securities has been duly and validly taken.
The Representative&rsquo;s Securities have been duly authorized for issuance and sale and, when issued and paid for pursuant to the terms
of this Agreement and the Representative&rsquo;s Warrant Agreement will be validly issued, fully paid and non-assessable; the holders
thereof are not and will not be subject to personal liability by reason of being such holders and all corporate action required to be
taken for the authorization, issuance and sale of the Representative&rsquo;s Warrant Agreement has been duly and validly taken; the shares
of Common Stock issuable upon exercise of the Representative&rsquo;s Warrant have been duly authorized and reserved for issuance by all
necessary corporate action on the part of the Company and when paid for and issued in accordance with the Representative&rsquo;s Warrant
and the Representative&rsquo;s Warrant Agreement, such shares of Common Stock will be validly issued, fully paid and non-assessable;
the holders of the Representative&rsquo;s Securities are not and will not be subject to personal liability by reason of being such holders;
and such shares of Common Stock are not and will not be subject to the preemptive rights of any holders of any security of the Company
or similar contractual rights granted by the Company. The Public Securities and Representative&rsquo;s Securities conform in all material
respects to all statements with respect thereto contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.10
<U>Registration Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities
of the Company have the right to require the Company to register any such securities of the Company under the Securities Act or to include
any such securities in a registration statement to be filed by the Company.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.11
<U>Validity and Binding Effect of Agreements</U>. This Agreement and the Representative&rsquo;s Warrant Agreement have been duly and
validly authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreements of the Company,
enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may be limited by bankruptcy,
insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii) as enforceability of any indemnification
or contribution provision may be limited under the federal and state securities laws; and (iii) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.12
<U>No Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement, the Representative&rsquo;s Warrant
Agreement and all ancillary documents, the consummation by the Company of the transactions herein and therein contemplated and the compliance
by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both:
(i) result in a material breach of, or conflict with any of the terms and provisions of, or constitute a material default under, or result
in the creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company
pursuant to the terms of any agreement or instrument to which the Company is a party; (ii) result in any violation of the provisions
of the Company&rsquo;s Certificate of Incorporation (as the same have been amended or restated from time to time, the &ldquo;Charter&rdquo;)
or the by-laws of the Company; or (iii) violate any existing applicable law, rule, regulation, judgment, order or decree of any Governmental
Entity as of the date hereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.13
<U>No Defaults; Violations</U>. No material default exists in the due performance and observance of any term, covenant or condition of
any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other material agreement or
instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party
or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is (i) not in
violation of any term or provision of its Charter or by-laws, or (ii) in violation of any franchise, license, permit, applicable law,
rule, regulation, judgment or decree of any Governmental Entity, except in the case of this clause (ii) for such violation that would
not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.14
<U>Corporate Power; Licenses; Consents</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.14.1.
<U>Conduct of Business</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the
Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates
and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business
purpose as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where failure to have such
consents, authorizations, approvals, registrations, orders, licenses, certifications, and permits would not reasonably be expected to
result in a Material Adverse Change. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.14.2.
<U>Transactions Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement and to carry
out the provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith have
been obtained. No consent, authorization or order of, and no filing with, any court, government agency or other body is required for
the valid issuance, sale and delivery of the Public Securities and the consummation of the transactions and agreements contemplated by
this Agreement and the Representative&rsquo;s Warrant Agreement and as contemplated by the Registration Statement, the Pricing Disclosure
Package and the Prospectus, except with respect to applicable federal and state securities laws and the rules and regulations of the
Financial Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.15
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires (the &ldquo;Questionnaires&rdquo;)
completed by each of the Company&rsquo;s directors and officers immediately prior to the Offering (the &ldquo;Insiders&rdquo;) as supplemented
by all information concerning the Company&rsquo;s directors, officers and principal shareholders as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, as well as in the Lock-Up Agreement (as defined in Section 2.24 below), provided to
the Underwriters, is true and correct in all material respects and the Company has not become aware of any information which would cause
the information disclosed in the Questionnaires to become materially inaccurate and incorrect.</FONT></P>




<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.16
<U>Litigation; Governmental Proceedings</U>. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation
or governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company or, to the Company&rsquo;s
knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, and which if resolved adversely to the Company would result in a Material Adverse Change or otherwise affect the
Company&rsquo;s ability to consummate the Offering. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.17
<U>Good Standing</U>. The Company has been duly organized and is validly existing as a corporation and is in good standing under the
laws of the State of Delaware as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction
in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify,
singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.18
<U>Insurance</U>. The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering
such risks which the Company believes are adequate, including, but not limited to, directors and officers insurance coverage at least
equal to $5,000,000 and all such insurance is in full force and effect. As of the date hereof, the Company has no reason to believe that
it will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage
from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result
in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.19
<U>Transactions Affecting Disclosure to FINRA</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.1.
<U>Finder&rsquo;s Fees</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there
are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting or origination
fee by the Company or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements, agreements or
understandings of the Company or, to the Company&rsquo;s knowledge, any of its shareholders that may affect the Underwriters&rsquo; compensation,
as determined by FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.2.
<U>Payments Within Twelve (12) Months</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s
fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons
who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation
or association with any FINRA member, within the twelve (12) months prior to the Effective Date, other than the payment to the Underwriters
as provided hereunder in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.3.
<U>Use of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.4.
<U>FINRA Affiliation</U>. To the Company&rsquo;s knowledge, there is no (i) officer or director of the Company, (ii) beneficial owner
of 5% or more of any class of the Company&rsquo;s securities or (iii) beneficial owner of the Company&rsquo;s unregistered equity securities
which were acquired during the 180-day period immediately preceding the filing of the Registration Statement that is an affiliate or
associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.5.
<U>Information</U>. All information provided by the Company and to the Company&rsquo;s knowledge all the information provided by its
officers and directors in their FINRA questionnaires to Representative Counsel specifically for use by Representative Counsel in connection
with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.20
<U>Foreign Corrupt Practices Act</U>. None of the Company and its Subsidiaries or, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or affiliate of the Company and its Subsidiaries or any other person acting on behalf of the Company and its Subsidiaries,
has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers
in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of
any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic
or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection
with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal or governmental
litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future,
might adversely affect the assets, business, operations or prospects of the Company. The Company has taken reasonable steps to ensure
that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt
Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.21
<U>Compliance with OFAC</U>. None of the Company and its Subsidiaries or, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company and its Subsidiaries or any other person acting on behalf of the Company and its Subsidiaries, is
currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;OFAC&rdquo;),
and the Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. sanctions administered by OFAC.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.22
<U>Money Laundering Laws</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;Money Laundering Laws&rdquo;); and
no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money Laundering Laws is
pending or, to the best knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.23
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to you or to Representative
Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.24
<U>Lock-Up Agreements. Schedule 3</U> hereto contains a complete and accurate list of the Company&rsquo;s officers, directors and each
owner of the Company&rsquo;s outstanding shares of Common Stock (or securities convertible or exercisable into shares of Common Stock)
(collectively, the &ldquo;Lock-Up Parties&rdquo;). The Company has caused each of the Lock-Up Parties, other than Paul H. Saunders, SC
Digital Technologies, LP and Roger Leger, to deliver to the Representative an executed Lock-Up Agreement, in the form attached hereto
as <U>Exhibit B</U> (the &ldquo;Lock-Up Agreement&rdquo;), prior to the execution of this Agreement. Notwithstanding anything to the
contrary set forth herein, the Company&rsquo;s outstanding shares of Common Stock (or securities convertible or exercisable into shares
of Common Stock) beneficially owned (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) by Paul H. Saunders, SC Digital Technologies,
LP and Roger Leger, are subject to the applicable Lock-Up Period and the Company has notified the Transfer Agent of such applicable Lock-Up
Period.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.25
<U>Subsidiaries</U>. All direct and indirect Subsidiaries of the Company are duly organized and in good standing under the laws of the
place of organization or incorporation, and each Subsidiary is in good standing in each jurisdiction in which its ownership or lease
of property or the conduct of business requires such qualification, except where the failure to qualify would not have a material adverse
effect on the assets, business or operations of the Company taken as a whole. The Company&rsquo;s ownership and control of each Subsidiary
is as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.26
<U>Related Party Transactions</U>. There are no business relationships or related party transactions involving the Company or any other
person required to be described in the Registration Statement, the Pricing Disclosure Package and the Prospectus that have not been described
as required.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.27
<U>Board of Directors</U>. The Board of Directors of the Company is comprised of the persons set forth under the heading of the Pricing
Prospectus and the Prospectus captioned &ldquo;Management.&rdquo; The qualifications of the persons serving as board members and the
overall composition of the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules
promulgated thereunder (the &ldquo;Sarbanes-Oxley Act&rdquo;) applicable to the Company and the listing rules of the Exchange. At least
one member of the Audit Committee of the Board of Directors of the Company qualifies as an &ldquo;audit committee financial expert,&rdquo;
as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at least a majority of the persons serving
on the Board of Directors qualify as &ldquo;independent,&rdquo; as defined under the listing rules of the Exchange.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.28
<U>Sarbanes-Oxley Compliance</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.28.1.
<U>Disclosure Controls</U>. The Company has developed and currently maintains disclosure controls and procedures that will comply with
Rule 13a-15 or 15d-15 under the Exchange Act Regulations, applicable to it, and except as described in the Registration Statement, the
Pricing Disclosure Package or Prospectus and such controls and procedures are effective as of the date hereof to ensure that all material
information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&rsquo;s
Exchange Act filings and other public disclosure documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.28.2.
<U>Compliance</U>. The Company is, or at the Applicable Time and on the Closing Date will be, in material compliance with the provisions
of the Sarbanes-Oxley Act applicable to it, as a Smaller Reporting Company, and has implemented or will implement such programs and has
taken reasonable steps to ensure the Company&rsquo;s future compliance (not later than the relevant statutory and regulatory deadlines
therefor) with all of the material provisions of the Sarbanes-Oxley Act (it being understood that this subsection shall not require the
Company to comply with Section 404 of the Sarbanes-Oxley Act as of an earlier date then it would otherwise be required to comply under
applicable law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.29
<U>Accounting Controls</U>. The Company and its Subsidiaries maintain systems of &ldquo;internal control over financial reporting&rdquo;
(as defined under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and
have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons
performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
the Company is not aware of any material weaknesses in its internal controls. The Company&rsquo;s auditors and the Audit Committee of
the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are known to the Company&rsquo;s management and that have adversely affected
or are reasonably likely to adversely affect the Company&rsquo; ability to record, process, summarize and report financial information;
and (ii) any fraud known to the Company&rsquo;s management, whether or not material, that involves management or other employees who
have a significant role in the Company&rsquo;s internal controls over financial reporting.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.30
<U>No Investment Company Status</U>. The Company is not and, after giving effect to the Offering and the application of the proceeds
thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be, required to register
as an &ldquo;investment company,&rdquo; as defined in the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.31
<U>No Labor Disputes</U>. No labor dispute with the employees of the Company or any of its Subsidiaries exists or, to the knowledge of
the Company, is imminent. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.32
<U>Intellectual Property Rights</U>. The Company and each of its Subsidiaries owns or possesses or has valid rights to use all patents,
patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses,
inventions, trade secrets and similar rights (&ldquo;Intellectual Property Rights&rdquo;) necessary for the conduct of the business of
the Company and its Subsidiaries as currently carried on and as described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus. To the knowledge of the Company, no action or use by the Company or any of its Subsidiaries necessary for the conduct
of its business as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to
any infringement of, or license or similar fees for, any Intellectual Property Rights of others. Neither the Company nor any of its Subsidiaries
has received any notice alleging any such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except
as would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of
the Company, there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned
by the Company; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging
the rights of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a
reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims in this Section 2.32,
reasonably be expected to result in a Material Adverse Change; (C) the Intellectual Property Rights owned by the Company and, to the
knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by a court of competent jurisdiction
invalid or unenforceable, in whole or in part, and there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit,
proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company is unaware
of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other
claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change; (D) there is no pending or, to the Company&rsquo;s
knowledge, threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise violates any
Intellectual Property Rights or other proprietary rights of others, the Company has not received any written notice of such claim and
the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or in the aggregate,
together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change; and (E) to the Company&rsquo;s
knowledge, no employee of the Company is in or has ever been in violation in any material respect of any term of any employment contract,
patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement
or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment
with the Company, or actions undertaken by the employee while employed with the Company and could reasonably be expected to result, individually
or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s knowledge, all material technical information developed by
and belonging to the Company which has not been patented or disclosed in a patent application has been kept confidential. The Company
is not a party to or bound by any options, licenses or agreements with respect to the Intellectual Property Rights of any other person
or entity that are required to be set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus and are
not described therein. The Registration Statement, the Pricing Disclosure Package and the Prospectus contain in all material respects
the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company has been obtained
or is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company&rsquo;s knowledge,
any of its officers, directors or employees, or otherwise in violation of the rights of any persons.. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.33
<U>Taxes</U>. Each of the Company and its Subsidiaries has filed all returns (as hereinafter defined) required to be filed with taxing
authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof, except where the failure to do so
would not reasonably be expected to result in a Material Adverse Change. Each of the Company and its Subsidiaries has paid all taxes
(as hereinafter defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed against the Company
or such respective Subsidiary. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the
Registration Statement are sufficient for all material accrued and unpaid taxes, whether or not disputed, and for all periods to and
including the dates of such consolidated financial statements. Except as disclosed in writing to the Underwriters or as would not reasonably
be expected to have a Material Adverse Change, (i) no issues have been raised (and are currently pending) by any taxing authority in
connection with any of the returns or taxes asserted as due from the Company or its Subsidiaries, and (ii) no waivers of statutes of
limitation with respect to the returns or collection of taxes have been given by or requested from the Company or its Subsidiaries. The
term &ldquo;taxes&rdquo; means all federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, ad
valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp,
occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges of any kind whatever, together
with any interest and any penalties, additions to tax or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means
all returns, declarations, reports, statements and other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.34
<U>ERISA Compliance</U>. Except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Change, the Company and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security Act of 1974,
as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;ERISA&rdquo;)) established or maintained
by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all material respects with ERISA. &ldquo;ERISA
Affiliate&rdquo; means, with respect to the Company, any member of any group of organizations described in Sections 414(b),(c),(m) or
(o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the &ldquo;Code&rdquo;)
of which the Company is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is reasonably expected to
occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of its ERISA Affiliates.
No &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of its ERISA Affiliates, if such &ldquo;employee
benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo; (as defined under ERISA). Neither
the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material liability under (i) Title IV of
ERISA with respect to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo; or (ii) Sections 412, 4971, 4975 or
4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of its ERISA Affiliates that
is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge of the Company, nothing has occurred,
whether by action or failure to act, which would reasonably be expected to cause the loss of such qualification.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.35
<U>Compliance with Laws</U>. The Company: (A) is and at all times has been in compliance in all material respects with all statutes,
rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing,
labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company
(&ldquo;Applicable Laws&rdquo;), except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Change; (B) has not received any warning letter, untitled letter or other correspondence or notice from any other governmental authority
alleging or asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits
and supplements or amendments thereto required by any such Applicable Laws (&ldquo;Authorizations&rdquo;), except as to noncompliance
that would not reasonably be expected to result in a Material Adverse Change; (C) possesses all material Authorizations and such Authorizations
are valid and in full force and effect and are not in material violation of any term of any such Authorizations; (D) has not received
written notice of any material claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from
any governmental authority or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations
and has no knowledge that any such governmental authority or third party is considering any such material claim, litigation, arbitration,
action, suit, investigation or proceeding; (E) has not received written notice that any governmental authority has taken, is taking or
intends to take material action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental
authority is considering such material action; (F) has filed, obtained, maintained or submitted all material reports, documents, forms,
notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations
and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete
and correct in all material respects on the date filed (or were corrected or supplemented by a subsequent submission); and (G) has not,
either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market
withdrawal or replacement, safety alert, post-sale warning, &ldquo;dear doctor&rdquo; letter, or other notice or action relating to the
alleged lack of safety or efficacy of any product or any alleged product defect or violation and, to the Company&rsquo;s knowledge, no
third party has initiated, conducted or intends to initiate any such notice or action, as would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.36
<U>Ineligible Issuer</U>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness
of the Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant
made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities and at the date
hereof, the Company was not and is not an &ldquo;ineligible issuer,&rdquo; as defined in Rule 405, without taking account of any determination
by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">2.37
<U>Real Property</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company
and its Subsidiaries have good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real
or personal property which are material to the business of the Company and its Subsidiaries taken as a whole, in each case free and clear
of all liens, encumbrances, security interests, claims and defects that do not, singly or in the aggregate, materially affect the value
of such property and do not interfere with the use made and proposed to be made of such property by the Company or its Subsidiaries;
and all of the leases and subleases material to the business of the Company and its subsidiaries, considered as one enterprise, and under
which the Company or any of its Subsidiaries holds properties described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, are in full force and effect, and neither the Company nor any Subsidiary has received any notice of any material
claim of any sort that has been asserted by anyone adverse to the rights of the Company or any Subsidiary under any of the leases or
subleases mentioned above, or affecting or questioning the rights of the Company or such Subsidiary to the continued possession of the
leased or subleased premises under any such lease or sublease.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.38
<U>Contracts Affecting Capital</U>. There are no transactions, arrangements or other relationships between and/or among the Company,
any of its affiliates (as such term is defined in Rule 405 of the Securities Act Regulations) and any unconsolidated entity, including,
but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially
affect the Company&rsquo;s or its Subsidiaries&rsquo; liquidity or the availability of or requirements for their capital resources required
to be described or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus which have
not been described or incorporated by reference as required.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.39
<U>Loans to Directors or Officers</U>. There are no outstanding loans, advances (except normal advances for business expenses in the
ordinary course of business) or guarantees or indebtedness by the Company or its Subsidiaries to or for the benefit of any of the officers
or directors of the Company, its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement,
the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.40
<U>Smaller Reporting Company</U>. As of the time of filing of the Registration Statement, the Company was a &ldquo;smaller reporting
company,&rdquo; as defined in Rule 12b-2 of the Exchange Act Regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.41
<U>Industry Data</U>. The statistical and market-related data included in each of the Registration Statement, the Pricing Disclosure
Package and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
accurate or represent the Company&rsquo;s good faith estimates that are made on the basis of data derived from such sources.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.42
<U>Forward Stock Split</U>. The Company has taken all necessary corporate action to effectuate a forward stock split of its shares of
Common Stock on the basis of one (1) such share for each 7.1 issued and outstanding share thereof (the &ldquo;Forward Stock Split&rdquo;),
such Forward Stock Split to be effective no later than the first trading day of the Firm Shares following the date hereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.43
<U>Emerging Growth Company</U>. From the time of the initial confidential submission of the Registration Statement to the Commission
(or, if earlier, the first date on which the Company engaged directly in or through any Person authorized to act on its behalf in any
Testing-the Waters Communication) through the date hereof, the Company has been and is an &ldquo;emerging growth company,&rdquo; as defined
in Section 2(a) of the Securities Act (an &ldquo;Emerging Growth Company&rdquo;). &ldquo;Testing-the-Waters Communication&rdquo; means
any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.44
<U>Testing-the-Waters Communications</U>. The Company has not (i) alone engaged in any Testing-the-Waters Communications, other than
Testing-the-Waters Communications with the written consent of the Representative and with entities that are qualified institutional buyers
within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501
under the Securities Act and (ii) authorized anyone other than the Representative to engage in Testing-the-Waters Communications. The
Company confirms that the Representative has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The
Company has not distributed any Written Testing-the-Waters Communications other than those listed on <U>Schedule 2-C</U> hereto. &ldquo;Written
Testing-the-Waters Communication&rdquo; means any Testing-the-Waters Communication that is a written communication within the meaning
of Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.45
<U>Electronic Road Show</U>. The Company has made available a Bona Fide Electronic Road Show in compliance with Rule 433(d)(8)(ii) of
the Securities Act Regulations such that no filing of any &ldquo;road show&rdquo; (as defined in Rule 433(h) of the Securities Act Regulations)
is required in connection with the Offering.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.46
<U>Margin Securities</U>. The Company owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of
Governors of the Federal Reserve System (the &ldquo;Federal Reserve Board&rdquo;), and none of the proceeds of Offering will be used,
directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness
which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of
Common Stock to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or X of the Federal Reserve Board.
</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.
<U>Covenants of the Company</U>. The Company covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.1
<U>Amendments to Registration Statement</U>. The Company shall deliver to the Representative, prior to filing, any amendment or supplement
to the Registration Statement or Prospectus proposed to be filed after the Effective Date and not file any such amendment or supplement
to which the Representative shall reasonably object in writing. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.2
<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.1.
<U>Compliance</U>. The Company, subject to Section 3.2.2, shall comply with the requirements of Rule 430A of the Securities Act Regulations,
and will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective amendment to the Registration
Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed; (ii) of the receipt of any comments
from the Commission; (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement
to the Prospectus or for additional information; (iv) of the issuance by the Commission of any stop order suspending the effectiveness
of the Registration Statement or any post-effective amendment or of any order preventing or suspending the use of any Preliminary Prospectus
or the Prospectus, or of the suspension of the qualification of the Public Securities and Representative&rsquo;s Securities for offering
or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant
to Section 8(d) or 8(e) of the Securities Act concerning the Registration Statement and (v) if the Company becomes the subject of a proceeding
under Section 8A of the Securities Act in connection with the Offering of the Public Securities and Representative&rsquo;s Securities.
The Company shall effect all filings required under Rule 424(b) of the Securities Act Regulations, in the manner and within the time
period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and shall take such steps as it deems necessary to ascertain promptly
whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that
it was not, it will promptly file such prospectus. The Company shall use its reasonable best efforts to prevent the issuance of any stop
order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.2.
<U>Continued Compliance</U>. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the
Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement
and in the Registration Statement, the Pricing Disclosure Package and the Prospectus. If at any time when a prospectus relating to the
Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (&ldquo;Rule 172&rdquo;), would
be) required by the Securities Act to be delivered in connection with sales of the Public Securities, any event shall occur or condition
shall exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i) amend the
Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) amend or supplement the
Pricing Disclosure Package or the Prospectus in order that the Pricing Disclosure Package or the Prospectus, as the case may be, will
not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein
not misleading in the light of the circumstances existing at the time it is delivered to a purchaser or (iii) amend the Registration
Statement or amend or supplement the Pricing Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements
of the Securities Act or the Securities Act Regulations, the Company will promptly (A) give the Representative notice of such event;
(B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement,
the Pricing Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed
filing or use, furnish the Representative with copies of any such amendment or supplement and (C) file with the Commission any such amendment
or supplement; provided that the Company shall not file or use any such amendment or supplement to which the Representative or counsel
for the Underwriters shall reasonably object. The Company will furnish to the Underwriters such number of copies of such amendment or
supplement as the Underwriters may reasonably request. The Company has given the Representative notice of any filings made pursuant to
the Exchange Act or the Exchange Act Regulations within 48 hours prior to the Applicable Time. The Company shall give the Representative
notice of its intention to make any such filing from the Applicable Time until the later of the Closing Date and the exercise in full
or expiration of the Over-allotment Option specified in Section 1.2 hereof and will furnish the Representative with copies of the related
document(s) a reasonable amount of time prior to such proposed filing, as the case may be, and will not file or use any such document
to which the Representative or counsel for the Underwriters shall reasonably object. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.3.
<U>Exchange Act Registration</U>. For a period of three (3) years after the date of this Agreement, the Company shall use its reasonable
best efforts to maintain the registration of the shares of Common Stock under the Exchange Act. The Company shall not deregister the
shares of Common Stock under the Exchange Act without the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.4.
<U>Free Writing Prospectuses</U>. The Company agrees that, unless it obtains the prior written consent of the Representative, it shall
not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission or
retained by the Company under Rule 433; provided that the Representative shall be deemed to have consented to each Issuer General Use
Free Writing Prospectus hereto and any &ldquo;road show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i)
that has been reviewed by the Representative. The Company represents that it has treated or agrees that it will treat each such free
writing prospectus consented to, or deemed consented to, by the Underwriters as an &ldquo;issuer free writing prospectus,&rdquo; as defined
in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely
filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing
Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would
conflict with the information contained in the Registration Statement or included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing at that subsequent time, not misleading, the Company will promptly notify the Underwriters and will promptly amend or supplement,
at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.5.
<U>Testing-the-Waters Communications</U>. If at any time following the distribution of any Written Testing-the-Waters Communication there
occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include
an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative
and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such
untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.3
<U>Delivery to the Underwriters of Registration Statements</U>. The Company has delivered or made available or shall deliver or make
available to the Representative and counsel for the Representative, without charge, signed copies of the Registration Statement as originally
filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts,
and will also deliver to the Underwriters, without charge, a conformed copy of the Registration Statement as originally filed and each
amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration Statement and each amendment thereto
furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to
EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.4
<U>Delivery to the Underwriters of Prospectuses</U>. The Company has delivered or made available or will deliver or make available to
each Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company
hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter,
without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule
172, would be) required to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented)
as such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will
be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation S-T.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.5
<U>Effectiveness and Events Requiring Notice to the Representative</U>. The Company shall use its reasonable best efforts to cause the
Registration Statement to remain effective with a current prospectus for at least nine (9) months after the Applicable Time, and shall
notify the Representative immediately and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any
amendment thereto; (ii) of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding
for that purpose; (iii) of the issuance by any state securities commission of any proceedings for the suspension of the qualification
of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that
purpose; (iv) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or
Prospectus; (v) of the receipt of any comments or request for any additional information from the Commission; and (vi) of the happening
of any event during the period described in this Section 3.5 that, in the judgment of the Company, makes any statement of a material
fact made in the Registration Statement, the Pricing Disclosure Package or the Prospectus untrue or that requires the making of any changes
in (a) the Registration Statement in order to make the statements therein not misleading, or (b) in the Pricing Disclosure Package or
the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading. If
the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company shall
make every reasonable effort to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.6
<U>Review of Financial Statements.</U> For a period of three (3) years after the date of this Agreement, the Company, at its expense,
shall use its reasonable best efforts to cause its regularly engaged independent registered public accounting firm to review (but not
audit) the Company&rsquo;s financial statements for each of the three fiscal quarters immediately preceding the announcement of any quarterly
financial information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.7
<U>Listing</U>. The Company shall use its reasonable best efforts to maintain the listing of the shares of Common Stock (including the
Public Securities) on the Exchange for at least three years from the date of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.8
<U>Financial Public Relations Firm</U>. As of the Effective Date, the Company shall continue to have retained a financial public relations
firm, which is currently Argot Partners.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.9
<U>Reports to the Representative</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.9.1.
<U>Periodic Reports, etc</U>. For a period of three (3) years after the date of this Agreement, the Company shall use its reasonable
best efforts to furnish or make available to the Representative copies of such financial statements and other periodic and special reports
as the Company from time to time furnishes generally to holders of any class of its securities and also promptly furnish or make available
to the Representative: (i) a copy of each periodic report the Company shall be required to file with the Commission under the Exchange
Act and the Exchange Act Regulations; (ii) a copy of every press release and every news item and article with respect to the Company
or its affairs which was released by the Company; (iii) a copy of each Form 8-K prepared and filed by the Company; (iv) five copies of
each registration statement filed by the Company under the Securities Act; and (v) such additional documents and information with respect
to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably request;
provided the Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably
acceptable to the Representative and Representative Counsel in connection with the Representative&rsquo;s receipt of such information.
Documents filed with the Commission pursuant to its EDGAR system and with respect to item (ii) disseminated widely to the public shall
be deemed to have been delivered to the Representative pursuant to this Section 3.9.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.9.2.
<U>Transfer Agent; Transfer Sheets</U>. For a period of three (3) years after the date of this Agreement, the Company shall retain a
transfer agent and registrar acceptable to the Representative (the &ldquo;Transfer Agent&rdquo;) and shall furnish to the Representative
at the Company&rsquo;s sole cost and expense such transfer sheets of the Company&rsquo;s securities as the Representative may reasonably
request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and DTC. VStock Transfer, LLC is acceptable
to the Representative to act as Transfer Agent for the shares of Common Stock. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.9.3.
<U>Trading Reports</U>. For a period of one (1) year after the date of this Agreement, the Company shall provide to the Representative,
at the Company&rsquo;s expense, such reports published by Exchange relating to price trading of the Public Securities, as the Representative
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.10
<U>Payment of Expenses</U></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.10.1.
<U>General Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date and the Option Closing
Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company
under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the
shares of Common Stock to be sold in the Offering (including the Option Shares) with the Commission; (b) all Public Filing System filing
fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating to the listing of such Public Securities
on the Exchange and such other stock exchanges as the Company and the Representative together determine, including any fees charged by
The Depository Trust Company (DTC) for new securities; (d) all fees, expenses and disbursements relating to background checks of the
Company&rsquo;s officers and directors in an amount not to exceed $15,000 in the aggregate; (e) all fees, expenses and disbursements
relating to the registration or qualification of the Public Securities under the &ldquo;blue sky&rdquo; securities laws of such states
and other jurisdictions as the Representative may reasonably designate; (f) all fees, expenses and disbursements relating to the registration,
qualification or exemption of the Public Securities under the securities laws of such foreign jurisdictions as the Representative may
reasonably designate; (g) the costs of all mailing and printing of the underwriting documents (including, without limitation, the Underwriting
Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters, Selected Dealers&rsquo; Agreement, Underwriters&rsquo;
Questionnaire and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and
as many preliminary and final Prospectuses as the Representative may reasonably deem necessary; (h) the costs and expenses of a public
relations firm; (i) the costs of preparing, printing and delivering certificates representing the Public Securities; (j) fees and expenses
of the transfer agent for the shares of Common Stock; (k) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities
from the Company to the Underwriters; (l) the costs associated with post-Closing advertising the Offering in the national editions of
the Wall Street Journal and New York Times; (m) the costs associated with one set of bound volumes of the public offering materials as
well as commemorative mementos and lucite tombstones, each of which the Company or its designee shall provide within a reasonable time
after the Closing Date in such quantities as the Representative may reasonably request, in an amount not to exceed $3,000; (n) the fees
and expenses of the Company&rsquo;s accountants; (o) the fees and expenses of the Company&rsquo;s legal counsel and other agents and
representatives; (p) fees and expenses of the Representative&rsquo;s legal counsel not to exceed $125,000; (q) the $29,500 cost associated
with the Underwriter&rsquo;s use of Ipreo&rsquo;s book-building, prospectus tracking and compliance software for the Offering; (r) $10,000
for data services and communications expenses; (s) up to $10,000 of ThinkEquity&rsquo;s actual accountable &ldquo;road show&rdquo; expenses;
and (t) up to $30,000 of ThinkEquity&rsquo;s market making and trading, and clearing firm settlement expenses for the Offering. The Representative
may deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or the Option Closing Date, if any, the
expenses set forth herein to be paid by the Company to the Underwriters. The Representative acknowledges having received prior to the
date of this Agreement an advance of $35,000 to be credited against the expenses in Section 3.10.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.10.2.
<U>Non-accountable Expenses</U>. The Company further agrees that, in addition to the expenses payable pursuant to Section 3.10.1, on
the Closing Date it shall pay to the Representative, by deduction from the net proceeds of the Offering contemplated herein, a non-accountable
expense allowance equal to one percent (1%) of the gross proceeds received by the Company from the sale of the Firm Shares (excluding
the Option Shares), less the Advance (as such term is defined in Section 8.3 hereof), provided, however, that in the event that the Offering
is terminated, the Company agrees to reimburse the Underwriters pursuant to Section 8.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.11
<U>Application of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent
with the application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure
Package and the Prospectus.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.12
<U>Delivery of Earnings Statements to Security Holders</U>. The Company shall make generally available to its security holders as soon
as practicable, but not later than the first day of the fifteenth (15<SUP>th</SUP>) full calendar month following the date of this Agreement,
an earnings statement (which need not be certified by independent registered public accounting firm unless required by the Securities
Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act)
covering a period of at least twelve (12) consecutive months beginning after the date of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.13
<U>Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent
of the Representative) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might
reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.14
<U>Internal Controls</U>. The Company shall maintain a system of internal accounting controls sufficient to provide reasonable assurances
that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorization; (ii) transactions are recorded
as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets;
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.15
<U>Accountants</U>. As of the date of this Agreement, the Company shall retain an independent registered public accounting firm reasonably
acceptable to the Representative, and the Company shall continue to retain a nationally recognized independent registered public accounting
firm for a period of at least three (3) years after the date of this Agreement. The Representative acknowledges that the Auditor is acceptable
to the Representative.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.16
<U>FINRA</U>. The Company shall advise the Representative (who shall make an appropriate filing with FINRA) if it is or becomes aware
that (i) any officer or director of the Company, (ii) any beneficial owner of 5% or more of any class of the Company&rsquo;s securities
or (iii) any beneficial owner of the Company&rsquo;s unregistered equity securities which were acquired during the 180 days immediately
preceding the filing of the Registration Statement is or becomes an affiliate or associated person of a FINRA member participating in
the Offering (as determined in accordance with the rules and regulations of FINRA).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.17
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely
contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary
capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other
transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.18
<U>Company Lock-Up Agreements</U>. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.18.1.
<U>Restriction on Sales of Capital Stock</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior
written consent of the Representative, it will not, for a period of 180 days after the date of this Agreement (the &ldquo;Lock-Up Period&rdquo;),
(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock
of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file
or caused to be filed any registration statement with the Commission (other than on a Form S-8, or successor form thereto) relating to
the offering of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares
of capital stock of the Company; (iii) complete any offering of debt securities of the Company, other than entering into a line of credit
with a traditional bank or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of capital stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv)
above is to be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
restrictions contained in this Section 3.18.1 shall not apply to (i) the shares of Common Stock to be sold hereunder, (ii) the issuance
by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security outstanding on
the date hereof, which is disclosed in the Registration Statement, Disclosure Package and Prospectus, provided that such options, warrants,
and securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities or to extend the term of such securities, or (iii) the issuance by the Company
of stock options or shares of capital stock of the Company under any equity compensation plan of the Company, provided that in each of
(ii) and (iii) above, the underlying shares shall be restricted from sale during the entire Lock-Up Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Notwithstanding
the foregoing, if (i) during the last 17 days of the Lock-Up Period, the Company issues an earnings release or material news or a material
event relating to the Company occurs, or (ii) prior to the expiration of the Lock-Up Period, the Company announces that it will release
earnings results or becomes aware that material news or a material event will occur during the 16-day period beginning on the last day
of the Lock-Up Period, the restrictions imposed by this Section 3.18.1 shall continue to apply until the expiration of the 18-day period
beginning on the issuance of the earnings release or the occurrence of such material news or material event, as applicable, unless the
Representative waives, in writing, such extension; provided, however, that this extension of the Lock-Up Period shall not apply to the
extent that FINRA has amended or repealed NASD Rule 2711(f)(4), or has otherwise provided written interpretive guidance regarding such
rule, in each case, so as to eliminate the prohibition of any broker, dealer, or member of a national securities association from publishing
or distributing any research report, with respect to the securities of an Emerging Growth Company prior to or after the expiration of
any agreement between the broker, dealer, or member of a national securities association and the Emerging Growth Company or its shareholders
that restricts or prohibits the sale of securities held by the Emerging Growth Company or its shareholders after the initial public offering
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.18.2.
<U>Restriction on Continuous Offerings</U>. Notwithstanding the restrictions contained in Section 3.18.1, the Company, on behalf of itself
and any successor entity, agrees that, without the prior written consent of the Representative, it will not, for a period of twelve (12)
months after the date of this Agreement, directly or indirectly in any &ldquo;at-the-market,&rdquo; continuous equity, equity lines,
or variable transaction, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock
of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.19
<U>Release of D&amp;O Lock-up Period</U>. If the Representative, in its sole discretion, agrees to release or waive the restrictions
set forth in the Lock-Up Agreements described in Section 2.24 hereof for an officer or director of the Company and provide the Company
with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the
Company agrees to announce the impending release or waiver by a press release substantially in the form of <U>Exhibit C</U> hereto through
a major news service at least two (2) Business Days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.20
<U>Blue Sky Qualifications</U>. The Company shall use its reasonable best efforts, in cooperation with the Underwriters, if necessary,
to qualify the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic
or foreign) as the Representative may designate and to maintain such qualifications in effect so long as required to complete the distribution
of the Public Securities; provided, however, that the Company shall not be obligated to file any general consent to service of process
or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject
itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.21
<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the
exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed
with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations. Additionally,
the Company shall report the use of proceeds from the issuance of the Public Securities as may be required under Rule 463 under the Securities
Act Regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.22
<U>Emerging Growth Company Status</U>. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth
Company at any time prior to the later of (i) completion of the distribution of the Public Securities within the meaning of the Securities
Act and (ii) fifteen (15) days following the completion of the Lock-Up Period.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.
<U>Conditions of Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Public Securities,
as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date
hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the
Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.1
<U>Regulatory Matters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1.1.
<U>Effectiveness of Registration Statement; Rule 430A Information</U>. The Registration Statement has become effective not later than
5:00 p.m., Eastern time, on the date of this Agreement or such later date and time as shall be consented to in writing by you, and, at
each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment thereto has been issued under the Securities Act, no order preventing or suspending the use of any Preliminary
Prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to
the Company&rsquo;s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the Commission
for additional information. The Prospectus containing the Rule 430A Information shall have been filed with the Commission in the manner
and within the time frame required by Rule 424(b) (without reliance on Rule 424(b)(8)) or a post-effective amendment providing such information
shall have been filed with, and declared effective by, the Commission in accordance with the requirements of Rule 430A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1.2.
<U>FINRA Clearance</U>. On or before the date of this Agreement, the Representative shall have received clearance from FINRA as to the
amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1.3.
<U>Exchange Stock Market Clearance</U>. On the Closing Date, the Company&rsquo;s shares of Common Stock, including the Firm Shares, shall
have been approved for listing on the Exchange, subject only to official notice of issuance. On the first Option Closing Date (if any),
the Company&rsquo;s shares of Common Stock, including the Option Shares, shall have been approved for listing on the Exchange, subject
only to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.2
<U>Company Counsel Matters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.1.
<U>Closing Date Opinion of Counsel</U>. On the Closing Date, the Representative shall have received the favorable opinion of Greenberg
Traurig, LLP, counsel to the Company, dated the Closing Date and addressed to the Representative, in form and substance reasonably satisfactory
to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.2.
<U>Opinion of Special Intellectual Property Counsel for the Company</U>. On the Closing Date, the Representative shall have received
the opinion of McCarter &amp; English, LLP, special intellectual property counsel for the Company, dated the Closing Date, addressed
to the Representative in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.3.
<U>Option Closing Date Opinions of Counsel</U>. On the Option Closing Date, if any, the Representative shall have received the favorable
opinions of each counsel listed in Sections 4.2.1 and 4.2.2, dated the Option Closing Date, addressed to the Representative and in form
and substance reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made by such counsels
in their respective opinions delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.4.
<U>Reliance</U>. In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other than the
laws of the United States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified
in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representative) of other
counsel reasonably acceptable to the Representative, familiar with the applicable laws; and (ii) as to matters of fact, to the extent
they deem proper, on certificates or other written statements of officers of the Company and officers of departments of various jurisdictions
having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements
or certificates shall be delivered to Representative Counsel if requested. The opinion of Greenberg Traurig, LLP and any opinion relied
upon by Greenberg Traurig, LLP shall include a statement to the effect that it may be relied upon by Representative Counsel in its opinion
delivered to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.3
<U>Comfort Letters</U>. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.3.1.
<U>Cold Comfort Letter</U>. At the time this Agreement is executed you shall have received a cold comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements and certain
financial information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus, addressed to the Representative
and in form and substance satisfactory in all respects to you and to the Auditor, dated as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.3.2.
<U>Bring-down Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received
from the Auditor a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms
the statements made in the letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be a date not
more than three (3) business days prior to the Closing Date or the Option Closing Date, as applicable. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.4
<U>Officers&rsquo; Certificates</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.4.1.
<U>Officers&rsquo; Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date and
any Option Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer, its President and its Chief Financial
Officer (on behalf of the Company and not in an individual capacity) stating that (i) such officers have carefully examined the Registration
Statement, the Pricing Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the Registration
Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is
other than the Closing Date) did not include any untrue statement of a material fact and did not omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading, and the Pricing Disclosure Package, as of the Applicable
Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), any Issuer Free Writing Prospectus
as of its date and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the Prospectus and
each amendment or supplement thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement
of a material fact and did not omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
in which they were made, not misleading, (ii) since the Effective Date, no event has occurred which should have been set forth in a supplement
or amendment to the Registration Statement, the Pricing Disclosure Package or the Prospectus, (iii) to their knowledge after reasonable
investigation, as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the representations and
warranties of the Company in this Agreement are true and correct in all material respects (except for those representations and warranties
that are qualified as to materiality, which shall be true and correct in all respects and except for those representations and warranties
which refer to facts existing at a specific date, which shall be true and correct as of such date) and the Company has complied with
all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any
Option Closing Date if such date is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most recent
audited financial statements included or incorporated by reference in the Pricing Disclosure Package, any material adverse change in
the financial position or results of operations of the Company, or any change or development that, singularly or in the aggregate, would
result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.4.2.
<U>Secretary&rsquo;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have
received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Date, as the case
may be, respectively, certifying: (i) that each of the Charter and Bylaws is true and complete, has not been modified and is in full
force and effect; (ii) that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering are in full force and
effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence between the Company or its counsel
and the Commission; and (iv) as to the incumbency of the officers of the Company. The documents referred to in such certificate shall
be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.5
<U>No Material Changes</U>. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been
no Material Adverse Change from the latest dates as of which such condition is set forth in the Registration Statement, the Pricing Disclosure
Package and the Prospectus; (ii) no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the
Company or any Insider before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable
decision, ruling or finding would reasonably be expected to materially adversely affect the business, operations, prospects or financial
condition or income of the Company, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus;
(iii) no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or to the Company&rsquo;s
knowledge threatened by the Commission; and (iv) the Registration Statement, the Pricing Disclosure Package and the Prospectus and any
amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the
Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of the Securities Act
and the Securities Act Regulations, and neither the Registration Statement, the Pricing Disclosure Package nor the Prospectus nor any
amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.6
<U>Delivery of Agreements</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6.1.
<U>Lock-Up Agreements</U>. On or before the date of this Agreement, the Company shall have delivered to the Representative executed copies
of the Lock-Up Agreements from each of the persons listed in <U>Schedule 3</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6.2.
<U>Representative&rsquo;s Warrant Agreement</U>. On the Closing Date, the Company shall have delivered to the Representative executed
copies of the Representative&rsquo;s Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.7
<U>Additional Documents</U>. At the Closing Date and at each Option Closing Date (if any) Representative Counsel shall have been furnished
with such documents and opinions as they may require for the purpose of enabling Representative Counsel to deliver an opinion to the
Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities and the
Representative&rsquo;s Securities as herein contemplated shall be satisfactory in form and substance to the Representative and Representative
Counsel. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.8
<U>Forward Stock Split</U>. Not later than the first trading day of the Firm Shares following the date hereof, the Forward Stock Split
shall be effective.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.1
<U>Indemnification of the Underwriters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.1.1.
<U>General</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter, its affiliates
and each of its and their respective directors, officers, members, employees, representatives, partners, shareholders, affiliates, counsel,
and agents and each person, if any, who controls any such Underwriter within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act (collectively the &ldquo;Underwriter Indemnified Parties,&rdquo; and each an &ldquo;Underwriter Indemnified Party&rdquo;),
against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses
reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever,
whether arising out of any action between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter
Indemnified Parties and any third party, or otherwise) to which they or any of them may become subject under the Securities Act, the
Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries (a &ldquo;Claim&rdquo;), (i) arising
out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (A) the Registration Statement,
the Pricing Disclosure Package, any Preliminary Prospectus, the Prospectus, or in any Issuer Free Writing Prospectus or in any Written
Testing-the-Waters Communication (as from time to time each may be amended and supplemented); (B) any materials or information provided
to investors by, or with the approval of, the Company in connection with the marketing of the Offering, including any &ldquo;road show&rdquo;
or investor presentations made to investors by the Company (whether in person or electronically); or (C) any application or other document
or written communication (in this Section 5, collectively called &ldquo;application&rdquo;) executed by the Company or based upon written
information furnished by the Company in any jurisdiction in order to qualify the Public Securities and Representative&rsquo;s Securities
under the securities laws thereof or filed with the Commission, any state securities commission or agency, the Exchange or any other
national securities exchange; or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, unless such statement or
omission was made in reliance upon, and in conformity with, the Underwriters&rsquo; Information or (ii) otherwise arising in connection
with or allegedly in connection with the Offering. The Company also agrees that it will reimburse each Underwriter Indemnified Party
for all reasonable and documented fees and expenses (including but not limited to any and all reasonable legal or other expenses reasonably
incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising
out of any action between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties
and any third party, or otherwise) (collectively, the &ldquo;Expenses&rdquo;), and further agrees wherever and whenever possible to advance
payment of Expenses as they are incurred by an Underwriter Indemnified Party in investigating, preparing, pursuing or defending any Claim.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.1.2.
<U>Procedure</U>. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against
the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution
of such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the
approval of such Underwriter Indemnified Party) and payment of actual expenses if an Underwriter Indemnified Party requests that the
Company do so. Such Underwriter Indemnified Party shall have the right to employ its or their own counsel in any such case, but the fees
and expenses of such counsel shall be at the expense of the Company, and shall be advanced by the Company. The Company shall not be liable
for any settlement of any action effected without its consent (which shall not be unreasonably withheld). In addition, the Company shall
not, without the prior written consent of the Underwriters, settle, compromise or consent to the entry of any judgment in or otherwise
seek to terminate any pending or threatened action in respect of which advancement, reimbursement, indemnification or contribution may
be sought hereunder (whether or not such Underwriter Indemnified Party is a party thereto) unless such settlement, compromise, consent
or termination (i) includes an unconditional release of each Underwriter Indemnified Party, acceptable to such Underwriter Indemnified
Party, from all liabilities, expenses and claims arising out of such action for which indemnification or contribution may be sought and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any Underwriter
Indemnified Party.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.2
<U>Indemnification of the Company</U>. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company,
its directors, its officers who signed the Registration Statement and persons who control the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the
foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue statements or omissions
made in the Registration Statement, any Preliminary Prospectus, the Pricing Disclosure Package or Prospectus or any amendment or supplement
thereto or in any application, in reliance upon, and in strict conformity with, the Underwriters&rsquo; Information. In case any action
shall be brought against the Company or any other person so indemnified based on any Preliminary Prospectus, the Registration Statement,
the Pricing Disclosure Package or Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity
may be sought against any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each
other person so indemnified shall have the rights and duties given to the several Underwriters by the provisions of Section 5.1.2. The
Company agrees promptly to notify the Representative of the commencement of any litigation or proceedings against the Company or any
of its officers, directors or any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, in connection with the issuance and sale of the Public Securities or in connection with the Registration
Statement, the Pricing Disclosure Package, the Prospectus, or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.3
<U>Contribution</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.3.1.
<U>Contribution Rights</U>. If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient
to hold harmless an indemnified party under Section 5.1 or 5.2 in respect of any loss, claim, damage or liability, or any action in respect
thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount
paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in
such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters,
on the other, from the Offering of the Public Securities, or (ii) if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also
the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that
resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations.
The relative benefits received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall
be deemed to be in the same proportion as the total net proceeds from the Offering of the Public Securities purchased under this Agreement
(before deducting expenses) received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand,
and the total underwriting discounts and commissions received by the Underwriters with respect to the shares of the Common Stock purchased
under this Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand. The relative fault shall be determined
by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access
to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would
not be just and equitable if contributions pursuant to this Section 5.3.1 were to be determined by pro rata allocation (even if the Underwriters
were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable considerations
referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action
in respect thereof, referred to above in this Section 5.3.1 shall be deemed to include, for purposes of this Section 5.3.1, any legal
or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 5.3.1 in no event shall an Underwriter be required to contribute any amount in excess
of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the Offering of
the Public Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue
or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.3.2.
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice
of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made
against another party (&ldquo;contributing party&rdquo;), notify the contributing party of the commencement thereof, but the failure
to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate therein
with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any
party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written consent
of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended to supersede, to the extent permitted
by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available. Each Underwriter&rsquo;s obligations
to contribute pursuant to this Section 5.3 are several and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.
<U>Default by an Underwriter</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">6.1
<U>Default Not Exceeding 10% of Firm Shares or Option Shares</U>. If any Underwriter or Underwriters shall default in its or their obligations
to purchase the Firm Shares or the Option Shares, if the Over-allotment Option is exercised hereunder, and if the number of the Firm
Shares or Option Shares with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Shares
or Option Shares that all Underwriters have agreed to purchase hereunder, then such Firm Shares or Option Shares to which the default
relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">6.2
<U>Default Exceeding 10% of Firm Shares or Option Shares</U>. In the event that the default addressed in Section 6.1 relates to more
than 10% of the Firm Shares or Option Shares, you may in your discretion arrange for yourself or for another party or parties to purchase
such Firm Shares or Option Shares to which such default relates on the terms contained herein. If, within one (1) Business Day after
such default relating to more than 10% of the Firm Shares or Option Shares, you do not arrange for the purchase of such Firm Shares or
Option Shares, then the Company shall be entitled to a further period of one (1) Business Day within which to procure another party or
parties satisfactory to you to purchase said Firm Shares or Option Shares on such terms. In the event that neither you nor the Company
arrange for the purchase of the Firm Shares or Option Shares to which a default relates as provided in this Section 6, this Agreement
will automatically be terminated by you or the Company without liability on the part of the Company (except as provided in Sections 3.9
and 5 hereof) or the several Underwriters (except as provided in Section 5 hereof); provided, however, that if such default occurs with
respect to the Option Shares, this Agreement will not terminate as to the Firm Shares; and provided, further, that nothing herein shall
relieve a defaulting Underwriter of its liability, if any, to the other Underwriters and to the Company for damages occasioned by its
default hereunder.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">6.3
<U>Postponement of Closing Date</U>. In the event that the Firm Shares or Option Shares to which the default relates are to be purchased
by the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, you or the Company shall have the
right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five (5) Business Days,
in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Pricing Disclosure Package or the
Prospectus or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the Registration Statement,
the Pricing Disclosure Package or the Prospectus that in the opinion of counsel for the Underwriter may thereby be made necessary. The
term &ldquo;Underwriter&rdquo; as used in this Agreement shall include any party substituted under this Section 6 with like effect as
if it had originally been a party to this Agreement with respect to such shares of Common Stock.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.
<U>Additional Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">7.1
<U>Board Composition and Board Designations</U>. The Company shall use its reasonable best efforts to ensure that: (i) the qualifications
of the persons serving as members of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act,
with the Exchange Act and with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the
event the Company seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii)
if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee financial
expert,&rdquo; as such term is defined under Regulation S-K and the listing rules of the Exchange.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">7.2
<U>Prohibition on Press Releases and Public Announcements</U>. The Company shall not issue press releases or engage in any other publicity,
without the Representative&rsquo;s prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1<SUP>st</SUP>)
Business Day following the forty-fifth (45<SUP>th</SUP>) day after the Closing Date, other than normal and customary releases issued
in the ordinary course of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">7.3
<U>Right of First Refusal</U>. Provided that the Firm Shares are sold in accordance with the terms of this Agreement, the Representative
shall have an irrevocable right of first refusal (the &ldquo;Right of First Refusal&rdquo;), for a period of fifteen (15) months after
the date the Offering is completed, to act as sole and exclusive investment banker, sole and exclusive book-runner, sole and exclusive
financial advisor, sole and exclusive underwriter and/or sole and exclusive placement agent, at the Representative&rsquo;s sole and exclusive
discretion, for each and every future public and private equity and debt offering, including all equity linked financings (each, a &ldquo;Subject
Transaction&rdquo;), during such fifteen (15) month period, of the Company, or any successor to or subsidiary of the Company, on terms
and conditions customary to the Representative for such Subject Transactions. For the avoidance of any doubt, the Company shall not retain,
engage or solicit any additional investment banker, book-runner, financial advisor, underwriter and/or placement agent in a Subject Transaction
without the express written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall notify the Representative of its intention to pursue a Subject Transaction, including the material terms thereof, by providing
written notice thereof by registered mail or overnight courier service addressed to the Representative. If the Representative fails to
exercise its Right of First Refusal with respect to any Subject Transaction within ten (10) Business Days after the mailing of such written
notice, then the Representative shall have no further claim or right with respect to the Subject Transaction. The Representative may
elect, in its sole and absolute discretion, not to exercise its Right of First Refusal with respect to any Subject Transaction; provided
that any such election by the Representative shall not adversely affect the Representative&rsquo;s Right of First Refusal with respect
to any other Subject Transaction during the fifteen (15) month period agreed to above.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.
<U>Effective Date of this Agreement and Termination Thereof</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.1
<U>Effective Date</U>. This Agreement shall become effective when both the Company and the Representative have executed the same and
delivered counterparts of such signatures to the other party.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.2
<U>Termination</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if
any domestic or international event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii) if trading on the New York Stock Exchange or the Nasdaq Stock Market
LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges
for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction;
or (iii) if the United States shall have become involved in a new war or an increase in major hostilities; or (iv) if a banking moratorium
has been declared by a New York State or federal authority; or (v) if a moratorium on foreign exchange trading has been declared which
materially adversely impacts the United States securities markets; or (vi) if the Company shall have sustained a material loss by fire,
flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have
been insured, will, in your opinion, make it inadvisable to proceed with the delivery of the Firm Shares or Option Shares; or (vii) if
the Company is in material breach of any of its representations, warranties or covenants hereunder; or (viii) if the Representative shall
have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such adverse
material change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed with the
offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the Public Securities;
or (ix) the Common Stock shall fail for any reason to open for trading on the Exchange by the end of regular trading hours on June 16,
2023.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.3
<U>Expenses</U>. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant
to Section 6.2 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified
herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters their actual
and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements
of Representative Counsel) up to $150,000, inclusive of the $35,000 advance for accountable expenses previously paid by the Company to
the Representative (the &ldquo;Advance&rdquo;) and upon demand the Company shall pay the full amount thereof to the Representative on
behalf of the Underwriters; provided, however, that such expense cap in no way limits or impairs the indemnification and contribution
provisions of this Agreement. Notwithstanding the foregoing, any advance received by the Representative will be reimbursed to the Company
to the extent not actually incurred in compliance with FINRA Rule 5110(g)(4)(A).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.4
<U>Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination
of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force
and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this Agreement
or any part hereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.5
<U>Representations, Warranties, Agreements to Survive</U>. All representations, warranties and agreements contained in this Agreement
or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless
of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter,
its officers or directors or any person controlling the Company or (ii) delivery of and payment for the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.1
<U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed
(registered or certified mail, return receipt requested), personally delivered or sent by electronic mail transmission and confirmed
and shall be deemed given when so delivered or emailed and confirmed or if mailed, two (2) days after such mailing</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Representative:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 41<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Head of Investment Banking</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
<U>notices@think-equity.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Venable
LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">151
W. 42nd Street, 49th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Mr. William N. Haddad</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: (212) 307-5598</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azitra,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21
Business Park Drive</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Branford,
CT 06405</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Francisco D. Salva</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greenberg
Traurig, LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18565
Jamboree Road, Suite 500</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Irvine,
CA 92612</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Daniel K. Donahue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: (949) 732-6501</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.2
<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.3
<U>Amendment</U>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.4
<U>Entire Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof. Notwithstanding
anything to the contrary set forth herein, it is understood and agreed by the parties hereto that all other terms and conditions of that
certain engagement letter between the Company and ThinkEquity LLC dated August 23, 2022, as amended, shall remain in full force and effect.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.5
<U>Binding Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters,
the Company and the controlling persons, directors and officers referred to in Section 5 hereof, and their respective successors, legal
representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim
under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &ldquo;successors and assigns&rdquo;
shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.6
<U>Governing Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in
the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in
Section 9.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. Each of the Company and the Underwriters agree that the prevailing party(ies) in any such action shall be entitled to recover
from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred
in connection with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of
its stockholders and affiliates) and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.</FONT></P>




<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.7
<U>Execution in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall
constitute valid and sufficient delivery thereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.8
<U>Waiver, etc</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not
be deemed or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision
hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZITRA,
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Francisco D. Salva</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francisco
    D. Salva</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed
                                            as of the date first written above mentioned, on behalf of itself and as Representative of
                                            the several Underwriters named on <U>Schedule 1</U> hereto:</FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THINKEQUITY
    LLC</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Eric Lord</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Lord</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
    of Investment Banking</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">[Signature
Page]</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt; font-variant: small-caps">AZITRA,
INC. &ndash; Underwriting Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Underwriter</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Number of <BR> Firm Shares to be <BR> Purchased</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Option Shares<BR> to be Purchased if the<BR> Over-Allotment Option is<BR> Fully Exercised</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">ThinkEquity LLC.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,500,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">225,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; font-weight: bold">TOTAL</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,500,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">225,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Sch. 1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Firm Shares: 1,500,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Option Shares: 225,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Share: $5.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Share: $0.375</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Non-accountable expense allowance per Share: $0.05</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Share (before expenses and non-accountable expense allowance): $4.625</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer
General Use Free Writing Prospectuses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free
Writing Prospectus dated June 5, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free
Writing Prospectus dated April 28, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free
Writing Prospectus dated April 11, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free
Writing Prospectus dated March 27, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Written
Testing-the-Waters Communications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Sch. 2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
3</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>List
of Lock-Up Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francisco
    D. Salva</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman
    Staskey</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travis
    Whitfill</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francisco
    D. Salva</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travis
    Whitfill</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    McClary, MD</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barbara
    Ryan</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Schroer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bios
    Partners</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Breakout
    Labs (Thiel)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Connecticut
    Innovations</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KdT
    Ventures</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    H. Saunders</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SC
    Digital Technologies, LP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simkins
    Equity Opportunity, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barkley
    Investments LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bryan
    White</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bayer
    HealthCare LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azim
    Munivar</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Glenn Louis Fletcher</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stella
    Robertson</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Svetlana
    Panicheva</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Circle
    K Invesco, LP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Andrews</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roger
    Leger</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeanne
    Bertonis</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Sampson</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Sch. 3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&rsquo;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER
THAN (I) THINKEQUITY LLC, OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER
OF THINKEQUITY LLC OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO DECEMBER 12, 2023. VOID AFTER 5:00 P.M., EASTERN TIME, JUNE 15, 2028.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AZITRA,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: 60,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Exercise Date: December 12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT TO PURCHASE COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, ThinkEquity LLC or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after December 12, 2023 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and, in accordance with FINRA Rule
5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Azitra, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 60,000 shares of Common Stock, par value $0.0001 per share, of the Company (the &ldquo;<U>Warrant Shares</U>&rdquo;), as subject
to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as
defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the effective date of the registration statement on Form S-1 (File No. 333-269876), including any related prospectus
or prospectuses, for the registration of the Company&rsquo;s common stock, par value $0.0001 per share and the Warrant Shares under the
Securities Act, that the Company has filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the New York Stock Exchange is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, or (c) in all other
cases, the fair market value of the Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly
executed facsimile copy (or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice
of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt
of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$6.25</B>, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier&rsquo;s
check, at the election of the Holder this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless
exercise&rdquo; in which the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading
    Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
    trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
    of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X) =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a &ldquo;cashless exercise,&rdquo; the parties acknowledge and agree that in accordance with Section
3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the
holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to
take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
its transfer agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as
defined below), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of
the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). If the Warrant Shares can be delivered via DWAC, the transfer
agent shall have received from the Company, at the expense of the Company, any legal opinions or other documentation required by it to
deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back up documentation from the Holder, including
with respect to affiliate status) and, if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer
agent shall have received from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide
a confirmation as to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless
exercise of this Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be
deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder
of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise
Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior
to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in
cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the
Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided</U>, <U>however</U>,
that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise notice concurrently
with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder&rsquo;s
right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such
restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise on
or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market
transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to
pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.
<U>Signature</U>. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder
in order to exercise this Purchase Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise
this Purchase Warrant. No additional legal opinion, other information or instructions shall be required of the Holder to exercise this
Purchase Warrant. The Company shall honor exercises of this Purchase Warrant and shall deliver Shares underlying this Purchase Warrant
in accordance with the terms, conditions and time periods set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates), would beneficially own in excess of the
Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially
owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
(i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in
the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company&rsquo;s
transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st
</SUP>day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any Subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other
than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable by holders of Common Stock as a result of such Fundamental
Transaction for each share of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear
upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect
therein shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice
provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant
shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call
transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately
following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the
transfer of any security:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
by operation of law or by reason of reorganization of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
to any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred remain
subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
if the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages
or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in the
fund; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a)
for the remainder of the time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant
full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5.</U>&nbsp;<U>Registration Rights.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.1.</U>&nbsp;<U>Demand
Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
Grant of Right. The Company, upon written demand (a &ldquo;Demand Notice&rdquo;) of the Holder(s) of at least 51% of the Warrants and/or
the underlying Warrant Shares (&ldquo;Majority Holders&rdquo;), agrees to register, on one occasion, all or any portion of the Warrant
Shares underlying the Warrants (collectively, the &ldquo;Registrable Securities&rdquo;). On such occasion, the Company will file a registration
statement with the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its
reasonable best efforts to have the registration statement declared effective promptly thereafter, subject to compliance with review
by the Commission; provided, however, that the Company shall not be required to comply with a Demand Notice if the Company has filed
a registration statement with respect to which the Holder is entitled to piggyback registration rights pursuant to Section 5.2 hereof
and either: (i) the Holder has elected to participate in the offering covered by such registration statement or (ii) if such registration
statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration statement
has been withdrawn or until thirty (30) days after such offering is consummated. The demand for registration may be made at any time
beginning on the Initial Exercise Date and expiring on the fifth anniversary of the Effective Date. The Company covenants and agrees
to give written notice of its receipt of any Demand Notice by any Holder(s) to all other registered Holders of the Warrants and/or the
Registrable Securities within ten (10) days after the date of the receipt of any such Demand Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 5.1.1,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. The Company agrees to use its reasonable best efforts to cause the filing
required herein to become effective promptly and to qualify or register the Registrable Securities in such States as are reasonably requested
by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities in a State
in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State or submit
to general service of process in such State, or (ii) the principal shareholders of the Company to be obligated to escrow their shares
of capital stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted under
Section 5.1.1 to remain effective for a period of at least twelve (12) consecutive months after the date that the Holders of the Registrable
Securities covered by such registration statement are first given the opportunity to sell all of such securities. The Holders shall only
use the prospectuses provided by the Company to sell the Warrant Shares covered by such registration statement, and will immediately
cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no longer be used due
to a material misstatement or omission. Notwithstanding the provisions of this Section 5.1.2, the Holder shall be entitled to a demand
registration under this Section 5.1.2 on only one (1) occasion and such demand registration right shall terminate on the fifth anniversary
of the date of the Underwriting Agreement (as defined below) in accordance with FINRA Rules 5110(g)(8)(B) and 5110(g)(8)(C).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.2</U>&nbsp;&nbsp;<U>&ldquo;Piggy-Back&rdquo;
Registration.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1
Grant of Right. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right, for
a period of no more than two (2) years from the Initial Exercise Date in accordance with FINRA Rule 5110(g)(8)(D), to include the Registrable
Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated
by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however, that if, solely
in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall,
in its reasonable discretion, impose a limitation on the number of Shares which may be included in the Registration Statement because,
in such underwriter(s)&rsquo; judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution,
then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable Securities
with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable
Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable
Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless
the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such
Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2
Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1 hereof,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish
the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to the proposed date
of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed
by the Company during the two (2) year period following the Initial Exercise Date until such time as all of the Registrable Securities
have been sold by the Holder. The holders of the Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for
herein by giving written notice within ten (10) days of the receipt of the Company&rsquo;s notice of its intention to file a registration
statement. Except as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration
under this Section 5.2.2; provided, however, that such registration rights shall terminate on the second anniversary of the Initial Exercise
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.3</U>&nbsp;&nbsp;<U>General Terms</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement
hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a)
of the Exchange Act against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses
reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under
the Securities Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the
same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the
Underwriting Agreement between the Underwriters and the Company, dated as of June 15, 2023. The Holder(s) of the Registrable Securities
to be sold pursuant to such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the
Company, against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably
incurred in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities
Act, the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns,
in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the provisions contained
in Section 5.2 of the Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2
Exercise of Warrants. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants prior
to or after the initial filing of any registration statement or the effectiveness thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.3
Documents Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each
underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel
to the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten public offering,
an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a &ldquo;cold comfort&rdquo; letter
dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, a letter
dated the date of the closing under the underwriting agreement) signed by the independent registered public accounting firm which has
issued a report on the Company&rsquo;s financial statements included in such registration statement, in each case covering substantially
the same matters with respect to such registration statement (and the prospectus included therein) and, in the case of such accountants&rsquo;
letter, with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer&rsquo;s
counsel and in accountants&rsquo; letters delivered to underwriters in underwritten public offerings of securities. The Company shall
also deliver promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to
the managing underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all
memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each Holder
and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the
registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation
shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and
independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.4
Underwriting Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by
any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably
satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such
managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily
contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating
to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties
and covenants of the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such
Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters except
as they may relate to such Holders, their Warrant Shares and their intended methods of distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.5
Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.6
Damages. Should the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the Company or the
Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available
to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened
breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity
of posting bond or other security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and
in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company
will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or
stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the underwriting agreement, dated June 15, 2023, by and between the Company and ThinkEquity LLC
as representatives of the underwriters set forth therein (the &ldquo;Underwriting Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows) </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>AZITRA,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:
AZITRA, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">_________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. If the Warrant is being exercised via cash exercise, the undersigned is an &ldquo;accredited investor&rdquo;
as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing warrant, execute</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
form and supply required information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Do
not use this form to exercise the warrant.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________
whose address is</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
______________, _______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement
or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper
evidence of authority to assign the foregoing Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
15, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 41<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on Schedule 1 to the Underwriting Agreement referenced below</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that ThinkEquity LLC (the &ldquo;Representative&rdquo;), proposes to enter into an Underwriting Agreement (the
&ldquo;Underwriting Agreement&rdquo;) with Azitra, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), providing for the initial
public offering (the &ldquo;Public Offering&rdquo;) of shares of common stock, par value $0.0001 per share, of the Company (the &ldquo;Common
Shares&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
induce the Representative to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without
the prior written consent of the Representative, the undersigned will not, during the period commencing on the date hereof and ending
[six (6) months]<SUP>1</SUP> [twelve (12) months]<SUP>2</SUP> days after the date of the Underwriting Agreement relating to the Public
Offering (the &ldquo;Lock-Up Period&rdquo;), (1) offer, issue, pledge, sell, encumber, contract to sell, grant, lend, or otherwise transfer
or dispose of, directly or indirectly, any Common Shares or any securities convertible into or exercisable or exchangeable for Common
Shares, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires
the power of disposition (collectively, the &ldquo;Lock-Up Securities&rdquo;); (2) enter into any swap or other arrangement that transfers
to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise; (3) make any demand for
or exercise any right with respect to the registration of any Lock-Up Securities; or (4) publicly disclose the intention to make any
offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities.
Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Securities without the prior
written consent of the Representative in connection with (a) transactions relating to Lock-Up Securities acquired in open market transactions
after the completion of the Public Offering; <U>provided</U> that no filing under Section 13 or Section 16(a) of the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or other public announcement shall be required or shall be voluntarily made
in connection with subsequent sales of Lock-Up Securities acquired in such open market transactions; (b) transfers of Lock-Up Securities
as a <I>bona fide</I> gift, by will or intestacy or to a family member or trust for the benefit of the undersigned or a family member
(for purposes of this lock-up agreement, &ldquo;family member&rdquo; means any relationship by blood, marriage or adoption, not more
remote than first cousin); (c) transfers of Lock-Up Securities to a charity or educational institution; (d) if the undersigned is a corporation,
partnership, limited liability company or other business entity, (i) any transfers of Lock-Up Securities to another corporation, partnership
or other business entity that controls, is controlled by or is under common control with the undersigned or (ii) distributions of Lock-Up
Securities to members, partners, stockholders, subsidiaries or affiliates (as defined in Rule 405 promulgated under the Securities Act
of 1933, as amended) of the undersigned; (e) if the undersigned is a trust, to a trustee or beneficiary of the trust; (f) to a nominee
or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (b), (c), (d) or (e) above; <U>provided
</U>that in the case of any transfer pursuant to the foregoing clauses (b), (c) (d), (e) or (f), (i) any such transfer shall not involve
a disposition for value, (ii) each transferee shall sign and deliver to the Representative a lock-up agreement substantially in the form
of this lock-up agreement and (iii) no filing under Section 13 or Section 16(a) of the Exchange Act or other public announcement shall
be required or shall be voluntarily made; (g) the receipt by the undersigned from the Company of Common Shares upon the vesting of restricted
stock awards or stock units or upon the exercise of options to purchase the Company&rsquo;s Common Shares issued under an equity incentive
plan of the Company or an employment arrangement described in the Pricing Prospectus (as defined in the Underwriting Agreement) (the
&ldquo;Plan Shares&rdquo;) or the transfer of Common Shares or any securities convertible into Common Shares to the Company upon a vesting
event of the Company&rsquo;s securities or upon the exercise of options to purchase the Company&rsquo;s securities, in each case on a
&ldquo;cashless&rdquo; or &ldquo;net exercise&rdquo; basis or to cover tax obligations of the undersigned in connection with such vesting
or exercise, but only to the extent such right expires during the Lock-up Period, provided that no filing under Section 13 or Section
16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made within [six (6) months] [twelve
(12) months] after the date of the Underwriting Agreement, and after such [six (6) months] [twelve (12) months], if the undersigned is
required to file a report under Section 13 or Section 16(a) of the Exchange Act reporting a reduction in beneficial ownership of Common
Shares during the Lock-Up Period, the undersigned shall include a statement in such schedule or report to the effect that the purpose
of such transfer was to cover tax withholding obligations of the undersigned in connection with such vesting or exercise and, provided
further, that the Plan Shares shall be subject to the terms of this lock-up agreement; (h) the establishment of a trading plan pursuant
to Rule 10b5-1 under the Exchange Act for the transfer of Lock-Up Securities, provided that (i) such plan does not provide for the transfer
of Lock-Up Securities during the Lock-Up Period and (ii) to the extent a public announcement or filing under the Exchange Act, if any,
is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan, such public
announcement or filing shall include a statement to the effect that no transfer of Lock-Up Securities may be made under such plan during
the Lock-Up Period; (i) the conversion of the outstanding preferred stock or convertible notes of the Company into Common Shares, provided
that such Common Shares remain subject to the terms of this agreement; (i) the transfer of Lock-Up Securities that occurs by operation
of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement, provided that the transferee agrees
to sign and deliver a lock-up agreement substantially in the form of this lock-up agreement for the balance of the Lock-Up Period, and
provided further, that any filing under Section 13 or Section 16(a) of the Exchange Act that is required to be made during the Lock-Up
Period as a result of such transfer shall include a statement that such transfer has occurred by operation of law; and (j) the transfer
of Lock-Up Securities pursuant to a bona fide third party tender offer, merger, consolidation or other similar transaction made to all
holders of the Common Shares involving a change of control (as defined below) of the Company after the closing of the Public Offering
and approved by the Company&rsquo;s board of directors; provided that in the event that the tender offer, merger, consolidation or other
such transaction is not completed, the Lock-Up Securities owned by the undersigned shall remain subject to the restrictions contained
in this lock-up agreement. For purposes of clause (j) above, &ldquo;change of control&rdquo; shall mean the consummation of any bona
fide third party tender offer, merger, amalgamation, consolidation or other similar transaction the result of which is that any &ldquo;person&rdquo;
(as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and
13d-5 of the Exchange Act) of a majority of total voting power of the voting stock of the Company. The undersigned also agrees and consents
to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar against the transfer of the undersigned&rsquo;s
Lock-Up Securities except in compliance with this lock-up agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Applicable to (i) the Company and any successor of the Company and (ii) the Company&rsquo;s stockholders of 0.5% or more of the
outstanding shares of common stock (or securities convertible into shares of common stock, including options and warrants).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>Applicable to directors and officers of the Company.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally
applicable to any issuer-directed or &ldquo;friends and family&rdquo; Securities that the undersigned may purchase in the Public Offering;
(ii) the Representative agrees that, at least three (3) business days before the effective date of any release or waiver of the foregoing
restrictions in connection with a transfer of Lock-Up Securities, the Representative will notify the Company of the impending release
or waiver; and (iii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver by press release
through a major news service at least two (2) business days before the effective date of the release or waiver. Any release or waiver
granted by the Representative hereunder to any such officer or director shall only be effective two (2) business days after the publication
date of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit
a transfer of Lock-Up Securities not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described
in this lock-up agreement to the extent and for the duration that such terms remain in effect at the time of such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation
of the Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the
undersigned&rsquo;s heirs, legal representatives, successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, if the Underwriting Agreement is not executed by April 30, 2023, or if the Underwriting Agreement (other
than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common
Shares to be sold thereunder, then this lock-up agreement shall be void and of no further force or effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only
be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Press Release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AZITRA,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Date]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azitra,
Inc. (the &ldquo;Company&rdquo;) announced today that ThinkEquity LLC, acting as representative for the underwriters in the Company&rsquo;s
recent public offering of _______ shares of the Company&rsquo;s common stock, is [waiving] [releasing] a lock-up restriction with respect
to _________ shares of the Company&rsquo;s common stock held by [certain officers or directors] [an officer or director] of the Company.
The [waiver] [release] will take effect on _________, 20___, and the shares may be sold on or after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is
prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration
under the Securities Act of 1933, as amended.</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Ex. C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF INCORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AZITRA,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azitra,
Inc., a Delaware corporation, does hereby certify as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
The name of the corporation is Azitra, Inc. (the &ldquo;<U>Corporation</U>&rdquo;), and the Corporation was originally incorporated pursuant
to the General Corporation Law of the State of Delaware (the &ldquo;<U>General Corporation Law</U>&rdquo;) on January 2, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
This Amended and Restated Certificate of Incorporation has been adopted in accordance with Sections 228, 242 and 245 of the General Corporation
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
The certificate of incorporation of the Corporation is hereby amended, restated and integrated to read in its entirety as set forth on
Exhibit A attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused the undersigned authorized officer of the Corporation to execute and acknowledge this Amended
and Restated Certificate of Incorporation this 21st day of June 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Francisco Salva</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francisco
Salva</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF INCORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AZITRA,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST.
The name of the corporation is Azitra, Inc. (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND.
The address of the Corporation&rsquo;s registered office in the State of Delaware is 251 Little Falls Drive, City of Wilmington, County
of New Castle, State of Delaware 19808. The name of its registered agent at such address is Corporation Service Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD.
The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation
Law of the State of Delaware (as the same exists or may hereafter be amended, the &ldquo;<U>General Corporation Law</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOURTH.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Capital Stock</U>. The total number of shares of all classes of capital stock which the Corporation shall have authority to issue
is 110,000,000 shares, divided into: (i) 100,000,000 shares, par value $0.0001 per share, of common stock (the &ldquo;<U>Common Stock</U>&rdquo;);
and (ii) 10,000,000 shares, par value $0.0001 per share, of preferred stock (the &ldquo;<U>Preferred Stock</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Common Stock</U>. The powers (including voting powers), if any, preferences and relative, participating, optional, special and other
rights, if any, and the qualifications, limitations and restrictions, if any, of the Common Stock are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Dividends</U>. Subject to applicable law and the rights, if any, of the holders of any series of Preferred Stock then outstanding,
dividends may be declared and paid on the Common Stock at such times and in such amounts as the Board of Directors of the Corporation
(the &ldquo;<U>Board of Directors</U>&rdquo;) in its discretion shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Voting Rights</U>. Except as otherwise provided by or pursuant to the provisions of this Amended and Restated Certificate of Incorporation
(including any certificate filed with the Secretary of State of the State of Delaware establishing a series of Preferred Stock) (as the
same may be amended or amended and restated, this &ldquo;<U>Certificate of Incorporation</U>&rdquo;) or by applicable law, each holder
of Common Stock, as such, shall be entitled to one (1) vote for each share of Common Stock held of record by such holder on all matters
on which stockholders generally are entitled to vote. The number of authorized shares of Common Stock may be increased or decreased (but
not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of all
of the then outstanding shares of capital stock of the Corporation entitled to vote irrespective of Section 242(b)(2) of the General
Corporation Law, without the separate vote of the holders of the Common Stock as a class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Liquidation Rights</U>. Subject to applicable law and the rights, if any, of the holders of any series of Preferred Stock then outstanding,
in the event of any liquidation, dissolution or winding up of the Corporation, the holders of the Common Stock shall be entitled to receive
the assets of the Corporation available for distribution to its stockholders ratably in proportion to the number of shares of Common
Stock held by them. A merger, conversion or consolidation of the Corporation with or into any other corporation or other entity, or a
sale or conveyance of all or any part of the assets of the Corporation (which shall not in fact result in the liquidation, dissolution
or winding up of the Corporation and the distribution of assets to its stockholders) shall not be deemed to be a liquidation, dissolution
or winding up of the Corporation within the meaning of this <U>Section 3</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>Preferred Stock</U>. The Board of Directors is hereby expressly authorized, by resolution or resolutions thereof, to provide from
time to time out of the unissued shares of Preferred Stock for one or more series of Preferred Stock, and, with respect to each such
series, to fix the number of shares constituting such series and the designation of such series, the powers (including voting powers),
if any, of the shares of such series and the preferences and relative, participating, optional, special or other rights, if any, and
the qualifications, limitations or restrictions, if any, of the shares of such series. The designations, powers (including voting powers),
preferences and relative, participating, optional, special and other rights, if any, of each series of Preferred Stock and the qualifications,
limitations or restrictions, if any, thereof, may differ from those of any and all other series of Preferred Stock at any time outstanding.
Except as may otherwise be provided by this Certificate of Incorporation or applicable law, no holder of any series of Preferred Stock
then outstanding, as such, shall be entitled to any voting powers in respect thereof. The number of authorized shares of Preferred Stock
may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of
a majority in voting power of all of the then outstanding shares of capital stock of the Corporation entitled to vote irrespective of
Section 242(b)(2) of the General Corporation Law, without the separate vote of the holders of the Preferred Stock as a class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIFTH.
<U>Board of Directors</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Management; Election of Directors</U>. The business and affairs of the Corporation shall be managed by or under the direction of the
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Removal of Directors</U>. Except for those directors, if any, elected by the holders of any series of Preferred Stock then outstanding
pursuant to any applicable provisions of this Certificate of Incorporation, any director or the entire Board of Directors may be removed
solely by the affirmative vote of the holders of at least sixty-six and two-thirds percent (66 <SUP>2</SUP>&frasl;<SUB>3</SUB>%) in voting
power of the then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting
together as a single class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Vacancies</U>. Subject to the rights, if any, of the holders of any series of Preferred Stock then outstanding, newly created directorships
resulting from an increase in the authorized number of directors or any vacancies on the Board of Directors resulting from the death,
resignation, disqualification, removal or other cause shall be filled solely and exclusively by a majority of the directors then in office,
although less than a quorum, or by the sole remaining director. Any director so elected shall hold office until the expiration of the
term of office of the director whom he or she has replaced and until his or her successor shall be elected and qualified, subject to
such director&rsquo;s earlier death, resignation, disqualification or removal. No decrease in the number of directors shall shorten the
term of any incumbent director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>No Written Ballot</U>. Unless and except to the extent that the bylaws of the Corporation shall so require, the election of directors
of the Corporation need not be by written ballot.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Amendment of Bylaws</U>. In furtherance and not in limitation of the powers conferred by the laws of the State of Delaware, the Board
of Directors is expressly authorized to make, alter, amend and repeal the bylaws of the Corporation. In addition to any affirmative vote
required by this Certificate of Incorporation, any bylaw that is to be made, altered, amended or repealed by the stockholders of the
Corporation shall receive the affirmative vote of the holders of at least sixty-six and two-thirds percent (66 <SUP>2</SUP>&frasl;<SUB>3</SUB>%)
in voting power of the outstanding shares of capital stock of the Corporation generally entitled to vote, voting together as a single
class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Special Meetings of Stockholders</U>. Except as otherwise provided by or pursuant to the provisions of this Certificate of Incorporation,
special meetings of stockholders for any purpose or purposes may be called at any time, but only by either the Chairperson of the Board
of Directors or the Board of Directors. Except as provided in the foregoing sentence, special meetings of stockholders may not be called
by another person or persons. Any meeting of stockholders may be canceled, postponed or rescheduled by action of the Board of Directors
or by the person calling such meeting (if other than the Board of Directors) at any time in advance of such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIXTH.
<U>Stockholder Action</U>. Except as otherwise provided by or pursuant to the provisions of this Certificate of Incorporation, including
the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, no action that
is required or permitted to be taken by the stockholders of the Corporation at any annual or special meeting of stockholders may be effected
by consent of stockholders in lieu of a meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEVENTH.
<U>Exculpation</U>. A director or officer of the Corporation shall not be liable to the Corporation or its stockholders for monetary
damages for breach of fiduciary duty as a director or officer, as applicable, except to the extent such exemption from liability or limitation
thereof is not permitted under the General Corporation Law. Any amendment, modification, repeal or elimination of the foregoing sentence
shall not adversely affect its application with respect to an act or omission by a director or officer of the Corporation occurring prior
to the time of such amendment, modification, repeal or elimination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIGHTH.
<U>Amendment</U>. The Corporation reserves the right at any time, and from time to time, to amend, alter, change or repeal any provision
contained in this Certificate of Incorporation, and other provisions authorized by the laws of the State of Delaware at the time in force
may be added or inserted, in the manner now or hereafter prescribed by applicable law; and all rights, preferences and privileges of
whatsoever nature conferred upon stockholders, directors, officers or any other persons whomsoever by and pursuant to this Certificate
of Incorporation are granted subject to the rights reserved in this Article EIGHTH.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NINTH.
<U>Forum for Adjudication of Disputes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Delaware Courts</U>. Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of
the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation,
(ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, stockholder or employee of the Corporation
to the Corporation or the Corporation&rsquo;s stockholders, (iii) any civil action to interpret, apply or enforce any provision of the
General Corporation Law, (iv) any claims, including claims in the right of the Corporation, as to which the General Corporation Law confers
jurisdiction upon the Court of Chancery of the State of Delaware or (v) any action asserting a claim governed by the internal affairs
doctrine; <U>provided</U>, <U>however</U>, in the event that the Court of Chancery of the State of Delaware lacks jurisdiction over such
action, the sole and exclusive forum for such action shall be another state or federal court located within the State of Delaware, in
all cases, subject to such court having personal jurisdiction over the indispensable parties named as defendants, except for, as to each
of (i) through (v) above, any claim as to which such court determines that there is an indispensable party not subject to the jurisdiction
of such court (and such indispensable party does not consent to the personal jurisdiction of such court within ten (10) days following
such determination). This Section 1 of Article NINTH shall not apply to claims or causes of action brought to enforce a duty or liability
created by the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), or the Securities Exchange Act of 1934,
as amended, or any other claim for which the federal courts have exclusive jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Federal Courts</U>. Unless the Corporation consents in writing to the selection of an alternative forum, the federal district courts
of the United States of America shall, to the fullest extent permitted by applicable law, be the sole and exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Application</U>. Failure to enforce the foregoing provisions of this Article NINTH would cause the Corporation irreparable harm and
the Corporation shall, to the fullest extent permitted by applicable law, be entitled to equitable relief, including injunctive relief
and specific performance, to enforce the foregoing provisions. Any person purchasing or otherwise acquiring any interest in shares of
capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article NINTH. This Article
NINTH shall not apply to any action asserting claims arising under the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>ex3-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND
AMENDED AND RESTATED</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BYLAWS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AZITRA,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meetings
of Stockholders</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.1 <U>Annual Meetings.</U> If required by applicable law, an annual meeting of stockholders shall be held for the election of directors
at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution of the Board
of Directors (the &ldquo;<U>Board of Directors</U>&rdquo;) of Azitra, Inc. (as such name may be changed in accordance with applicable
law from time to time, the &ldquo;<U>Corporation</U>&rdquo;) from time to time. Any annual meeting of stockholders may be canceled, postponed
or rescheduled by action of the Board of Directors or by the person calling such meeting (if other than the Board of Directors) at any
time in advance of such meeting. Any other proper business may be transacted at the annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.2 <U>Special Meetings</U>. Except as otherwise provided by or pursuant to the provisions of the Corporation&rsquo;s certificate of
incorporation (including any certificate filed with the Secretary of State of the State of Delaware establishing a series of preferred
stock of the Corporation) (as the same may be amended or amended and restated from time to time, the &ldquo;<U>Certificate of Incorporation</U>&rdquo;),
special meetings of stockholders for any purpose or purposes may be called at any time, but only by either the Chairperson of the Board
of Directors or the Board of Directors. Except as provided in the foregoing sentence, special meetings of stockholders may not be called
by any person or persons. Any special meeting of stockholders may be canceled, postponed or rescheduled by action of the Board of Directors
or by the person calling such meeting (if other than the Board of Directors) at any time in advance of such meeting. Business transacted
at any special meeting of stockholders shall be limited to the purposes stated in the notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.3 <U>Notice of Meetings</U>. Whenever stockholders are required or permitted to take any action at a meeting, a notice of the meeting
shall be given that shall state the place, if any, date and hour of the meeting, the means of remote communications, if any, by which
stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date for determining stockholders
entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the
meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. Unless otherwise provided by
applicable law, the Certificate of Incorporation or these Bylaws (as the same may be amended or amended and restated, these &ldquo;<U>Bylaws</U>&rdquo;),
the notice of any meeting shall be given not less than ten (10) nor more than sixty (60) days before the date of the meeting to each
stockholder entitled to vote at such meeting, as of the record date for determining the stockholders entitled to notice of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.4 <U>Adjournments</U>. Any meeting of stockholders, annual or special, may adjourn from time to time to reconvene at the same or some
other place, if any, and notice need not be given of any such adjourned meeting if the time and place, if any, thereof, and the means
of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person or by proxy and vote
at such adjourned meeting are (a) announced at the meeting at which the adjournment is taken, (b) displayed, during the time scheduled
for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means
of remote communication or (c) set forth in the notice of meeting given in accordance with <U>Section 1.3</U> of these Bylaws. At the
adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment
is for more than thirty (30) days, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at
the meeting. If after the adjournment a new record date for determining stockholders entitled to vote is fixed for the adjourned meeting,
the Board of Directors shall fix a new record date for notice of such adjourned meeting in accordance with <U>Section 1.8</U> of these
Bylaws, and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of
the record date fixed for notice of such adjourned meeting.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.5 <U>Quorum</U>. Except as otherwise provided by applicable law, the Certificate of Incorporation or these Bylaws, at each meeting
of stockholders the presence in person or by proxy of the holders of a majority in voting power of the outstanding shares of capital
stock of the Corporation entitled to vote at the meeting shall be necessary and sufficient to constitute a quorum. In the absence of
a quorum, the chairman of the meeting or the stockholders so present may, by a majority in voting power thereof, adjourn the meeting
from time to time in the manner provided in <U>Section 1.4</U> of these Bylaws until a quorum is present or represented. Shares of the
Corporation&rsquo;s capital stock shall neither be entitled to vote nor be counted for quorum purposes if such shares belong to (a) the
Corporation, (b) another corporation, if a majority of the shares entitled to vote in the election of directors of such other corporation
is held, directly or indirectly, by the Corporation or (c) any other entity, if a majority of the voting power of such other entity is
held, directly or indirectly, by the Corporation or if such other entity is otherwise controlled, directly or indirectly by the Corporation;
<U>provided</U>, <U>however</U>, that the foregoing shall not limit the right of the Corporation or any subsidiary of the Corporation
to vote stock, including but not limited to its own capital stock, held by it in a fiduciary capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.6 <U>Organization</U>. Meetings of stockholders shall be presided over by the Chairperson of the Board of Directors, if any, or in
his or her absence by a chairperson designated by the Board of Directors, or in the absence of such designation by a chairperson chosen
at the meeting. The Secretary of the Corporation (the &ldquo;<U>Secretary</U>&rdquo;) shall act as secretary of the meeting, but in his
or her absence the chairperson of the meeting may appoint any person to act as secretary of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.7 <U>Voting; Proxies</U>. Except as otherwise provided by or pursuant to the provisions of the Certificate of Incorporation, each stockholder
entitled to vote at any meeting of stockholders shall be entitled to one (1) vote for each share of capital stock of the Corporation
held by such stockholder which has voting power upon the matter in question. Each stockholder entitled to vote at a meeting of stockholders,
if any, may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon
after three (3) years from its date, unless the proxy provides for a longer period. A proxy shall be irrevocable if it states that it
is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A proxy
may be made irrevocable regardless of whether the interest with which it is coupled is an interest in the stock itself or an interest
in the Corporation generally. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person
or by delivering to the Secretary a revocation of the proxy or a new proxy bearing a later date. Voting at meetings of stockholders need
not be by written ballot. When a quorum is present at any meeting of stockholders, (a) for the election of directors, a plurality of
the votes cast shall be sufficient to elect directors and (b) all other elections, questions or business presented to the stockholders
at such meeting shall be decided by the affirmative vote of a majority of votes cast with respect to any such election, question or business
presented to the stockholders; provided, that, if any election, question or business contemplated by this sentence is one which, by express
provision of the Certificate of Incorporation, these Bylaws, the rules or regulations of any stock exchange applicable to the Corporation,
any regulation applicable to the Corporation or its securities or the laws of the State of Delaware, a vote of a different number or
voting by class or series is required, such express provision shall govern. For purposes of this <U>Section 1.7</U>, (i) a &ldquo;majority
of the votes cast&rdquo; means that the number of shares voted &ldquo;for&rdquo; any election, question or business, in each case, exceeds
the votes cast &ldquo;against&rdquo; such election, question or business, respectively, and (ii) &ldquo;votes cast&rdquo; shall not include
abstentions and broker non-votes.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.8 <U>Fixing Date for Determination of Stockholders of Record</U>. In order that the Corporation may determine the stockholders entitled
to notice of any meeting of stockholders or any adjournment thereof, or to consent to corporate action without a meeting, if any, or
entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect
of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record
date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors,
and which record date: (a) in the case of a determination of stockholders entitled to notice of any meeting of stockholders or any adjournment
thereof, shall, unless otherwise required by applicable law, not be more than sixty (60) nor less than ten (10) days before the date
of such meeting and, unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before
the date of the meeting shall be the date for determining the stockholders entitled to vote at such meeting, the record date for determining
the stockholders entitled to notice of such meeting shall also be the record date for determining the stockholders entitled to vote at
such meeting; (b) in the case of a determination of stockholders entitled to consent to corporate action without a meeting, shall not
be more than ten (10) days from the date upon which the resolution fixing the record date is adopted by the Board of Directors; and (c)
in the case of any other action, shall not be more than sixty (60) days prior to such other action. If no record date is fixed: (i) the
record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders shall be at the close of business
on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding
the day on which the meeting is held; (ii) the record date for determining stockholders entitled to consent to corporate action without
a meeting, if any, when no prior action of the Board of Directors is required by applicable law, shall be the first date on which a signed
consent setting forth the action taken or proposed to be taken is delivered to the Corporation in accordance with applicable law, or,
if prior action by the Board of Directors is required by applicable law, shall be at the close of business on the day on which the Board
of Directors adopts the resolution taking such prior action; and (iii) the record date for determining stockholders for any other purpose
shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. A determination
of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting;
<U>provided</U>, <U>however</U>, that the Board of Directors may fix a new record date for the determination of stockholders entitled
to vote at the adjourned meeting, and in such case shall also fix as the record date for determining the stockholders entitled to notice
of such adjourned meeting the same or an earlier date as that fixed for the determination of stockholders entitled to vote in accordance
with the foregoing provisions of this <U>Section 1.8</U> at the adjourned meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.9 <U>List of Stockholders Entitled to Vote</U>. The Corporation shall prepare, no later than the tenth (10<SUP>th</SUP>) day before
each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting; <U>provided</U>, <U>however</U>, if
the record date for determining the stockholders entitled to vote is less than ten (10) days before the meeting date, the list shall
reflect the stockholders entitled to vote as of the tenth (10th) day before the meeting date, arranged in alphabetical order, and showing
the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination
of any stockholder, for any purpose germane to the meeting for a period of ten (10) days ending on the day before the meeting date (a)
on a reasonably accessible electronic network; <U>provided</U> that the information required to gain access to such list is provided
with the notice of meeting or (b) during ordinary business hours at the principal place of business of the Corporation. Except as otherwise
provided by applicable law, the stock ledger shall be the only evidence as to who are the stockholders entitled to examine the list of
stockholders required by this <U>Section 1.9</U> or to vote in person or by proxy at any meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.10 <U>Action By Consent in Lieu of Meeting</U>. Unless otherwise restricted by the Certificate of Incorporation, any action that is
required or permitted to be taken by the stockholders of the Corporation at any annual or special meeting of stockholders may be effected
by consent of stockholders in lieu of a meeting of stockholders. When, as permitted by or pursuant to the provisions of the Certificate
of Incorporation, action required or permitted to be taken at any annual or special meeting of stockholders is taken without a meeting,
without prior notice and without a vote, a consent or consents, setting forth the action so taken, shall be signed by the holders of
outstanding capital stock of the Corporation having not less than the minimum number of votes that would be necessary to authorize or
take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the Corporation
in accordance with applicable law. When, as permitted by or pursuant to the provisions of the Certificate of Incorporation, action required
or permitted to be taken at any annual or special meeting of stockholders is taken without a meeting, without prior notice and without
a vote, prompt notice of the taking of the corporate action without a meeting by less than unanimous consent shall, to the extent required
by applicable law, be given to those stockholders who have not consented and who, if the action had been taken at a meeting, would have
been entitled to notice of the meeting if the record date for notice of such meeting had been the date that consents signed by a sufficient
number of holders to take the action were delivered to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.11 <U>Inspectors of Election</U>. The Corporation may, and shall if required by applicable law, in advance of any meeting of stockholders,
appoint one or more inspectors of election, who may be employees of the Corporation, to act at the meeting or any adjournment thereof
and to make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any inspector
who fails to act. In the event that no inspector so appointed or designated is able to act at a meeting of stockholders, the individual
presiding over the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge
of his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according
to the best of his or her ability. The inspector or inspectors so appointed or designated shall (a) ascertain the number of shares of
capital stock of the Corporation outstanding and the voting power of each such share, (b) determine the shares of capital stock of the
Corporation represented at the meeting and the validity of proxies and ballots, (c) count all votes and ballots, (d) determine and retain
for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors and (e) certify their
determination of the number of shares of capital stock of the Corporation represented at the meeting and such inspectors&rsquo; count
of all votes and ballots. Such certification and report shall specify such other information as may be required by applicable law. In
determining the validity and counting of proxies and ballots cast at any meeting of stockholders of the Corporation, the inspectors may
consider such information as is permitted by applicable law. No individual who is a candidate for an office at an election may serve
as an inspector at such election.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.12 <U>Conduct of Meetings</U>. The date and time of the opening and the closing of the polls for each election, question or business
upon which the stockholders will vote at a meeting shall be announced at the meeting by the individual presiding over the meeting. The
Board of Directors may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem
appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the individual presiding
over any meeting of stockholders shall have the right and authority to convene and to adjourn the meeting whether or not a quorum is
present, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such individual, are appropriate
for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed
by the individual presiding over the meeting of stockholders, may include, without limitation, the following: (a) the establishment of
an agenda or order of business for the meeting; (b) rules and procedures for maintaining order at the meeting and the safety of those
present; (c) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized
and constituted proxies or such other persons as the individual presiding over the meeting of stockholders shall determine; (d) restrictions
on entry to the meeting after the time fixed for the commencement thereof; and (e) limitations on the time allotted to, and the number
of, questions or comments by participants. The Board of Directors or, in addition to making any other determinations that may be appropriate
to the conduct of the meeting, the individual presiding over any meeting of stockholders, in each case, shall have the power and duty
to determine whether any election, question or business was or was not properly made, proposed or brought before the meeting and therefore
shall be disregarded and not be considered or transacted at the meeting, and, if the Board of Directors or the individual presiding over
the meeting, as the case may be, determines that such election, question or business was not properly made, proposed or brought before
the meeting and shall be disregarded and not be considered or transacted at the meeting, the individual presiding over the meeting shall
declare to the meeting that such election, question or business was not properly made, proposed or brought before the meeting and shall
be disregarded and not be considered or transacted at the meeting, and any such election, question or business shall not be considered
or transacted at the meeting. Unless and to the extent determined by the Board of Directors or the individual presiding over the meeting,
meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.13 <U>Notice of Stockholder Business and Nominations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Annual Meetings of Stockholders</U>. (i) Nominations of one or more individuals for election to the Board of Directors by the stockholders
generally entitled to vote (which, for the avoidance of doubt, shall exclude nominations of one or more individuals for election as Preferred
Directors (as defined below)) (each, a &ldquo;<U>Nomination</U>,&rdquo; and more than one, &ldquo;<U>Nominations</U>&rdquo;) and the
proposal of any question or business other than Nominations to be considered by the stockholders generally entitled to vote (which, for
the avoidance of doubt, shall exclude any question or business other than Nominations required by or pursuant to the provisions of the
Certificate of Incorporation with respect to the rights of the holders of any series of preferred stock of the Corporation then outstanding
to be voted on by the holders of any one or more such series, voting separately as a single class) (collectively, &ldquo;<U>Business</U>&rdquo;)
may be made at an annual meeting of stockholders only (A) pursuant to the Corporation&rsquo;s notice of meeting (or any supplement thereto);
<U>provided</U>, <U>however</U>, that reference in the Corporation&rsquo;s notice of meeting to the election of directors or the election
of members of the Board of Directors shall not include or be deemed to include Nominations, (B) by or at the direction of the Board of
Directors, or (C) by any stockholder of the Corporation who was a stockholder of record of the Corporation at the time the notice provided
for in this <U>Section 1.13</U> is delivered to the Secretary, who is entitled to vote at the meeting and who complies with the notice
procedures set forth in this <U>Section 1.13</U> and with the requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;), and the regulations promulgated thereunder (including Rule 14a-19 under the Exchange Act (&ldquo;<U>Rule 14a-19</U>&rdquo;)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
For Nominations or Business to be properly brought before an annual meeting by a stockholder pursuant to <U>Section 1.13(a)(i)(C)</U>,
the stockholder must have given timely notice thereof in writing to the Secretary and any proposed Business must constitute a proper
matter for stockholder action. To be timely, a stockholders&rsquo; notice shall be delivered to the Secretary at the principal executive
offices of the Corporation not later than the close of business on the ninetieth (90<SUP>th</SUP>) day nor earlier than the close of
business on the one hundred twentieth (120<SUP>th</SUP>) day prior to the first anniversary of the preceding year&rsquo;s annual meeting;
<U>provided</U>, <U>however</U>, that in the event that the date of the annual meeting is more than thirty (30) days before or more than
seventy (70) days after such anniversary date, notice by the stockholder must be so delivered not earlier than the close of business
on the one hundred twentieth (120<SUP>th</SUP>) day prior to such annual meeting and not later than the close of business on the later
of the ninetieth (90<SUP>th</SUP>) day prior to such annual meeting or the tenth (10<SUP>th</SUP>) day following the day on which public
announcement of the date of such meeting is first made by the Corporation. In no event shall the public announcement of an adjournment
or postponement of an annual meeting of stockholders of the Corporation commence a new time period (or extend any time period) for the
giving of a stockholders&rsquo; notice as described above. Such stockholders&rsquo; notice shall set forth: (A) as to each Nomination
to be made by such stockholder, (1) all information relating to the individual subject to such Nomination that would be required to be
disclosed in a proxy statement soliciting proxies for the election of such individual as a director in an election contest (even if an
election contest is not involved), or that is otherwise required to be disclosed, in each case, pursuant to and in accordance with Regulation
14A under the Exchange Act, without regard to the application of the Exchange Act to either the Nomination or the Corporation, and (2)
such individual&rsquo;s good faith written consent to being named as a nominee in a proxy statement relating to such annual meeting and
to serving as director if elected; (B) as to the Business proposed by such stockholder, a brief description of the Business, the text
of the proposed Business (including the text of any resolutions proposed for consideration and in the event that such Business includes
a proposal to amend these Bylaws, the language of the proposed amendment), the reasons for conducting such Business at the meeting and
any material interest in such Business of such stockholder and of the beneficial owner, if any, on whose behalf the proposal is made;
and (C) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the Nomination or Business is made
(1) the name and address of such stockholder, as they appear on the Corporation&rsquo;s books, and of such beneficial owner, (2) the
class, series and number of shares of capital stock of the Corporation which are owned beneficially and of record by such stockholder
and such beneficial owner, (3) a description of any direct or indirect compensatory, reimbursement, indemnification, payment or other
agreements, arrangements or understandings (whether oral or in writing) during the past three years, and any other material relationships,
in each case, between or among the stockholder giving the notice and the beneficial owner, if any, on whose behalf the Nomination or
Business is made, or any of their respective affiliates or associates or others acting in concert therewith, on the one hand, and each
proposed nominee or his or her respective affiliates and associates, on the other hand, including, without limitation, those with respect
to such Nomination or Business, (4) a representation that the stockholder is a holder of record of capital stock of the Corporation entitled
to vote at such meeting and such stockholder (or a qualified representative of such stockholder) intends to appear in person or by proxy
at the meeting to propose such Nomination or Business and (5) a representation that the stockholder or the beneficial owner, if any,
or any of their respective affiliates or associates or others acting in concert therewith, intends or is part of a group which intends
to (x) deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding capital
stock required to approve or adopt the Business or elect the nominee subject to the Nomination, (y) if applicable, solicit proxies in
support of any proposed director nominees other than the Corporation&rsquo;s director nominees in accordance with Rule 14a-19 and/or
(z) otherwise engage in a solicitation (within the meaning of Exchange Act Rule 14a-1(l)) with respect to such Nomination or Business,
as applicable, and if so, the name of each participant (as defined in Item 4 of Schedule 14A under the Exchange Act) in such solicitation;
<U>provided</U>, <U>however</U>, that if the Business is otherwise subject to Rule 14a-8 (or any successor thereto) promulgated under
the Exchange Act (&ldquo;<U>Rule 14a-8</U>&rdquo;), the foregoing notice requirements shall be deemed satisfied by a stockholder if the
stockholder has notified the Corporation of his, her or its intention to present such Business at an annual meeting of stockholders of
the Corporation in compliance with Rule 14a-8, and such Business has been included in a proxy statement that has been prepared by the
Corporation to solicit proxies for such annual meeting of stockholders. The Corporation may require any individual subject to such Nomination
to furnish such other information as it may reasonably require to determine the eligibility of such individual subject to such Nomination
to serve as a director of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Notwithstanding anything in the second sentence of <U>Section 1.13(a)(ii)</U> to the contrary, in the event that the number of directors
to be elected to the Board of Directors by the stockholders generally entitled to vote (which, for the avoidance of doubt, shall exclude
the Preferred Directors) at an annual meeting is increased and there is no public announcement by the Corporation naming the nominees
for election to the additional directorships at least one hundred (100) days prior to the first (1<SUP>st</SUP>) anniversary of the preceding
year&rsquo;s annual meeting, a stockholders&rsquo; notice required by this <U>Section 1.13</U> shall also be considered timely, but only
with respect to nominees for election to such additional directorships, if it shall be delivered to the Secretary at the principal executive
offices of the Corporation not later than the close of business on the tenth (10<SUP>th</SUP>) day following the day on which such public
announcement is first made by the Corporation.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Special Meetings of Stockholders.</U> Only such Business shall be conducted at a special meeting of stockholders of the Corporation
as shall have been brought before the meeting pursuant to the Corporation&rsquo;s notice of meeting (or any supplement thereto); <U>provided</U>,
<U>however</U>, that reference therein to the election of directors or the election of members of the Board of Directors shall not include
or be deemed to include Nominations. Nominations may be made at a special meeting of stockholders of the Corporation at which one or
more directors are to be elected by the stockholders generally entitled to vote (which, for the avoidance of doubt, shall exclude the
Preferred Directors) pursuant to the Corporation&rsquo;s notice of meeting (or any supplement thereto) as aforesaid (<U>provided</U>
that the Board of Directors has determined that directors shall be elected at such meeting) (i) by or at the direction of the Board of
Directors, or (ii) by any stockholder of the Corporation who is a stockholder of record at the time the notice provided for in this <U>Section
1.13</U> is delivered to the Secretary, who is entitled to vote at the meeting and upon such election and who complies with the notice
procedures set forth in this <U>Section 1.13</U> and with the requirements of the Exchange Act and the regulations promulgated thereunder
(including Rule 14a-19). In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more
directors to the Board of Directors by the stockholders generally entitled to vote (which, for the avoidance of doubt, shall exclude
the Preferred Directors), any such stockholder entitled to vote in such election may make Nominations of one or more individuals (as
the case may be) for election to such position(s) as specified in the Corporation&rsquo;s notice of meeting, if the stockholders&rsquo;
notice setting forth the information required by <U>Section 1.13(a)(ii), Section 1.13(c)(ii)</U> and <U>Section 1.13(c)(iii)</U> shall
be delivered to the Secretary at the principal executive offices of the Corporation not earlier than the close of business on the one
hundred twentieth (120<SUP>th</SUP>) day prior to such special meeting and not later than the close of business on the later of the ninetieth
(90<SUP>th</SUP>) day prior to such special meeting or the tenth (10<SUP>th</SUP>) day following the day on which public announcement
is first made of the date of such special meeting and of the nominee(s) proposed by the Board of Directors to be elected at such special
meeting. In no event shall the public announcement of an adjournment or postponement of a special meeting of stockholders of the Corporation
commence a new time period (or extend any time period) for the giving of a stockholders&rsquo; notice as described above.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>General.</U> (i) Only individuals subject to a Nomination made in compliance with the procedures set forth in this <U>Section 1.13
</U>shall be eligible for election at an annual or special meeting of stockholders of the Corporation, and only such Business shall be
conducted at an annual or special meeting of stockholders of the Corporation as shall have been brought before such meeting in accordance
with the procedures set forth in this <U>Section 1.13</U>. Except as otherwise provided by applicable law, the Board of Directors or
the individual presiding over the meeting shall have the power and duty to determine whether (A) a Nomination or any Business proposed
to be brought before the meeting was or was not made, proposed or brought, as the case may be, in accordance with the procedures set
forth in this <U>Section 1.13</U> and with the applicable requirements of the Exchange Act and the regulations promulgated thereunder
(including, without limitation, Rule 14a-19) and (B) any proposed Nomination or Business shall be disregarded or that such Nomination
or Business shall not be considered or transacted at the meeting. The number of nominees a stockholder may nominate for election at a
meeting of stockholders (or in the case of one or more stockholders giving the notice on behalf of a beneficial owner, the number of
nominees such stockholders may collectively nominate for election at the meeting on behalf of such beneficial owner) shall not exceed
the number of directors to be elected at such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any stockholder and, if applicable, any member of its group that intends to solicit proxies in support of a Nomination or Nominations
(a &ldquo;<U>Nominating Group</U>&rdquo;) who has delivered a notice of Nomination in accordance with <U>Section 1.13(a)</U> shall (A)
in accordance with Rule 14a-19, deliver a written notice to the Corporation, which notice shall be postmarked or transmitted electronically
to the Secretary at the principal offices of the Corporation no later than sixty (60) days prior to the first anniversary of the previous
year&rsquo;s annual meeting date, except that for a special meeting of stockholders, or if the Corporation did not hold an annual meeting
during the previous year, or if the date of the annual meeting has changed by more than thirty (30) days from the previous year, then
as of the later of sixty (60) days prior to the date of the meeting or the tenth (10<SUP>th)</SUP> day following the day on which public
announcement of the date of the meeting is first made by the Corporation, certifying to the Secretary that such stockholder or Nominating
Group has complied with all of the requirements of this <U>Section 1.13</U> and Rule 14a-19(a)(1) and that such stockholder or Nominating
Group will continue to comply with all applicable requirements of this Section 1.13 and Rule 14a-19 with respect to such Nomination (including,
for the avoidance of doubt, a statement that such stockholder or Nominating Group intends to solicit proxies in support of director nominees
other than the Corporation&rsquo;s nominees from the holders of shares representing at least 67% of the voting power of shares entitled
to vote on the election of directors), (B) no later than the day that is the later of thirty (30) days prior to the meeting date or ten
(10) days after the date that the Corporation files its definitive proxy statement, certify to the Secretary that such stockholder or
Nominating Group has filed a definitive proxy statement in accordance with Rule 14a-19(a)(2), and (C) no later than the day that is ten
(10) business days prior to the meeting or any adjournment thereof, certify to the Secretary that such stockholder or Nominating Group
has solicited proxies in support of director nominees other than the Corporation&rsquo;s nominees from the holders of shares representing
at least 67% of the voting power of shares entitled to vote on the election of directors.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To be eligible as a nominee for election as a director of the Corporation, the proposed nominee must deliver (in accordance with the
time periods prescribed for delivery of notice under <U>Section 1.13(c)(ii)</U>) to the Secretary at the principal executive offices
of the corporation a written and completed questionnaire (which questionnaire shall be provided by the Secretary upon written request)
and a written agreement, representing, warranting and covenanting (in the form provided by the Secretary upon written request) that such
proposed nominee (A) is not and will not become a party to (1) any agreement, arrangement or understanding with, and has not given any
commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act
or vote on any issue or question (a &ldquo;Voting Commitment&rdquo;) that has not been disclosed to the Corporation or (2) any Voting
Commitment that could limit or interfere with such proposed nominee&rsquo;s ability to comply, if elected as a director of the Corporation,
with such proposed nominee&rsquo;s fiduciary duties under applicable law, (B) is not, and will not become, a party to any agreement,
arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation,
reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Corporation, and
(C) would be in compliance with, if elected as a director of the Corporation, and will comply with applicable publicly disclosed corporate
governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation. Further,
the Board of Directors may request that any nominating stockholder or Nominating Group and/or proposed nominee furnish any additional
information as may be reasonably required or appropriate for the review and consideration by the Board of Directors, including, without
limitation, such information (x) as may reasonably be required by the Corporation to determine the qualifications of such proposed nominee
to serve as a director of the Corporation or the eligibility of such proposed nominee to serve as an independent director of the Corporation
in accordance with the Corporation&rsquo;s corporate governance guidelines (including, without limitation, any applicable stock exchange
rules or requirements) or (y) as could be material to a reasonable stockholder&rsquo;s understanding of the qualifications of such proposed
nominee to serve as a director of the Corporation or the independence, or lack thereof, of such proposed nominee, and such nominating
stockholder or Nominating Group and/or proposed nominee shall provide such additional information within ten (10) business days after
it has been requested by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any stockholder or Nominating Group that has delivered a notice of Nomination or Business in accordance with this <U>Section 1.13</U>
and, if applicable, the proposed nominee(s) for election as a director, shall update and supplement such notice in writing to the Corporation,
so that the information provided or required to be provided in such notice or accompany such notice pursuant to this <U>Section 1.13
</U>shall be true and correct in all respects and at all times through the date if the meeting or any adjournment thereof (and in any
event as of not later than the day that is eight (8) business days prior to the date of the meeting or any adjournment thereof), and
any such update shall be delivered to the Secretary at the principal offices of the Corporation within two (2) business days after the
occurrence of any material change to the information previously provided or required to be provided pursuant to this <U>Section 1.13</U>.
For the avoidance of doubt, the obligation to update and supplement as set forth in this paragraph shall not limit the Corporation&rsquo;s
rights with respect to any deficiencies in any notice provided by a stockholder or Nominating Group, extend any applicable deadlines
hereunder or enable or be deemed to permit a stockholder or Nominating Group who has previously submitted notice hereunder to amend or
update any previously delivered Nomination or Business or deliver any new Nomination or Business, including by changing or adding nominees,
proposals, matters and/or resolutions proposed to be brought before a meeting of the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
Notwithstanding the foregoing provisions of this <U>Section 1.13</U>, if the stockholder or Nominating Group (or a qualified representative
of the stockholder or Nominating Group) does not appear at the annual or special meeting of stockholders of the Corporation to present
a Nomination or Business, such Nomination or Business shall be disregarded and such Nomination or Business shall not be considered or
transacted at the meeting, notwithstanding that proxies in respect of such vote may have been received by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
Upon request by the Corporation, if any stockholder or Nominating Group delivers a notice of Nomination pursuant to Rule 14a-19(b), such
stockholder or Nominating Group shall deliver to the Corporation, no later than five (5) business days prior to the date of the meeting,
reasonable evidence that it has met the requirements of Rule 14a-19(a)(3). In the event that a stockholder or Nominating Group providing
notice of Nomination no longer intends to solicit proxies in accordance with Rule 14a-19, such stockholder or Nominating Group shall
provide notice to the Corporation of such intention as promptly as practicable. Any stockholder or Nominating Group directly or indirectly
soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use
by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
For purposes of this <U>Section 1.13</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
&ldquo;<U>public announcement</U>&rdquo; shall include disclosure in a press release reported by the Dow Jones News Service, Associated
Press or comparable national news service or in a document publicly filed by the Corporation with or publicly furnished by the Corporation
to the Securities and Exchange Commission pursuant to Section 13, 14 and 15(d) (or any successor thereto) of the Exchange Act; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
&ldquo;affiliates&rdquo; and &ldquo;associates&rdquo; shall have the respective meanings set forth in Rule 405 under the Securities Act
of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
In addition to the foregoing provisions of this <U>Section 1.13</U>, a stockholder shall also comply with all applicable requirements
of state and federal law, including the Exchange Act, the Certificate of Incorporation and these Bylaws, with respect to any nomination,
proposal or other matter set forth in this <U>Section 1.13</U>. Nothing in this <U>Section 1.13</U> shall be deemed to affect any (A)
rights or obligations, if any, of stockholders with respect to inclusion of proposals in the Corporation&rsquo;s proxy statement pursuant
to Rule 14a-8 (to the extent the Corporation or such proposals are subject to Rule 14a-8) or (B) rights, if any, of the holders of any
series of preferred stock of the Corporation then outstanding to elect directors pursuant to any applicable provisions of the Certificate
of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
of Directors</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.1 <U>Number; Qualifications</U>. Subject to applicable law and the rights, if any, of the holders of any series of preferred stock
of the Corporation then outstanding to elect directors pursuant to any applicable provisions of the Certificate of Incorporation (collectively,
the &ldquo;<U>Preferred Directors</U>&rdquo; and each, a &ldquo;<U>Preferred Director</U>&rdquo;), the Board of Directors shall consist
of one or more members, the number thereof to be determined from time to time by resolution of the Board of Directors. Directors need
not be stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.2 <U>Election of Directors</U>. Subject to the rights, if any, of the holders of any series of preferred stock of the Corporation to
elect one or more Preferred Directors pursuant to any applicable provisions of the Certificate of Incorporation, at each annual meeting
of stockholders of the Corporation, the stockholders shall elect directors, each of whom shall hold office for a term of one (1) year
or until such director&rsquo;s successor is duly elected and qualified, subject to such director&rsquo;s earlier death, resignation,
disqualification or removal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.3 <U>Resignation; Vacancies</U>. Any director may resign at any time upon notice to the Corporation. Subject to the rights, if any,
of the holders of any series of preferred stock of the Corporation then outstanding, newly created directorships resulting from an increase
in the authorized number of directors or any vacancies on the Board of Directors resulting from death, resignation, disqualification,
removal or other cause shall be filled solely and exclusively by a majority of the directors then in office, although less than a quorum,
or by the sole remaining director. Any director so elected shall hold office until the expiration of the term of office of the director
whom he or she has replaced and until his or her successor shall be elected and qualified, subject to such director&rsquo;s earlier death,
resignation, disqualification or removal. No decrease in the number of directors shall shorten the term of any incumbent director.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.4 <U>Regular Meetings</U>. Regular meetings of the Board of Directors may be held at such places within or without the State of Delaware
and at such times as the Board of Directors may from time to time determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.5 <U>Special Meetings</U>. Special meetings of the Board of Directors may be held at any time or place within or without the State
of Delaware whenever called by the Chairperson of the Board of Directors or by any two (2) members of the Board of Directors. Notice
of a special meeting of the Board of Directors shall be given by or at the direction of the person or persons calling the meeting; if
given by courier service or electronic transmission, at least twenty-four (24) hours before the special meeting, and if sent by mail,
at least four (4) days before the special meeting; and need not specify the purpose of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.6 <U>Telephonic Meetings Permitted</U>. Members of the Board of Directors, or any committee designated by the Board of Directors, may
participate in a meeting thereof by means of conference telephone or other communications equipment by means of which all individuals
participating in the meeting can hear each other, and participation in a meeting pursuant to this <U>Section 2.6</U> shall constitute
presence in person at such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.7 <U>Quorum; Vote Required for Action</U>. At all meetings of the Board of Directors the directors entitled to cast a majority of the
votes of the directors then in office shall constitute a quorum for the transaction of business, which in no case shall be less than
one third (1/3) of the votes of the total authorized directors. Except in cases in which the Certificate of Incorporation, these Bylaws
or applicable law otherwise provides, a majority of the votes entitled to be cast by the directors present at a meeting at which a quorum
is present shall be the act of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.8 <U>Organization</U>. Meetings of the Board of Directors shall be presided over by the Chairperson of the Board of Directors, if any,
or in his or her absence by a chairperson chosen at the meeting. The Secretary shall act as secretary of the meeting, but in his or her
absence the chairperson of the meeting may appoint any individual to act as secretary of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.9 <U>Action by Unanimous Consent of Directors</U>. Unless otherwise restricted by the Certificate of Incorporation or these Bylaws,
any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without
a meeting if all members of the Board of Directors or such committee, as the case may be, consent thereto in writing or by electronic
transmission. After action is taken, the consent or consents relating thereto shall be filed with the minutes of the proceedings of the
Board of Directors, or the committee thereof, in the same paper or electronic form as the minutes are maintained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committees</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.1 <U>Committees</U>. The Board of Directors may designate one or more committees, each committee to consist of one or more of the directors
of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace
any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of the committee, the
member or members thereof present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum,
may unanimously appoint another member of the Board of Directors to act at the meeting in place of any such absent or disqualified member.
Any such committee, to the extent permitted by applicable law and to the extent provided in the resolution of the Board of Directors
or these Bylaws, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business
and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.2 <U>Committee Rules</U>. Unless the Board of Directors otherwise provides, each committee designated by the Board of Directors may
make, alter and repeal rules for the conduct of its business. In the absence of such rules each committee shall conduct its business
in the same manner as the Board of Directors conducts its business pursuant to <U>Article II</U> of these Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officers</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.1 <U>Executive Officers; Election; Qualifications; Term of Office, Resignation; Removal; Vacancies</U>. The Board of Directors shall
elect a Chief Executive Officer and a Secretary, and it may, if it so determines, choose a Chairperson of the Board of Directors from
among its members. The Board of Directors may also choose a President, a Chief Financial Officer, one or more Vice Presidents, one or
more Assistant Secretaries, a Treasurer and one or more Assistant Treasurers and such other officers as it shall from time to time deem
necessary or desirable. Each such officer shall hold office until the first meeting of the Board of Directors after the annual meeting
of stockholders next succeeding his or her election, and until his or her successor is elected and qualified or until his or her earlier
death, resignation or removal. Any officer may resign at any time upon notice to the Corporation. The Board of Directors may remove any
officer with or without cause at any time, but such removal shall be without prejudice to the contractual rights of such officer, if
any, with the Corporation. Any number of offices may be held by the same person. Any vacancy occurring in any office of the Corporation
by death, resignation, removal or otherwise may be filled for the unexpired portion of the term by the Board of Directors at any regular
or special meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.2 <U>Powers and Duties of Executive Officers</U>. The officers of the Corporation shall have such powers and duties in the management
of the Corporation as may be prescribed in these Bylaws or a resolution by the Board of Directors and, to the extent not so provided,
as generally pertain to their respective offices, subject to the control of the Board of Directors. The Board of Directors may require
any officer, agent or employee to give security for the faithful performance of his or her duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.3 <U>Appointing Attorneys and Agents; Voting Securities of Other Entities</U>. Unless otherwise provided by resolution adopted by the
Board of Directors, the Chairperson of the Board of Directors or the Chief Executive Officer may from time to time appoint an attorney
or attorneys or agent or agents of the Corporation, for, in the name and on behalf of the Corporation, to cast the votes which the Corporation
may be entitled to cast as the holder of stock or other securities in any other corporation or other entity, any of whose stock or other
securities may be held by the Corporation, at meetings of the holders of the stock or other securities of such other corporation or other
entity, or to consent, in the name of the Corporation as such holder, to any action by such other corporation or other entity, and may
instruct the person or persons so appointed as to the manner of casting such votes or giving such consents, and may execute or cause
to be executed for, in the name and on behalf of the Corporation and under its corporate seal or otherwise, all such proxies or other
instruments as he or she may deem necessary or proper. Any of the rights set forth in this <U>Section 4.3</U> which may be delegated
to an attorney or agent may also be exercised directly by the Chairperson of the Board of Directors or the Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.1 <U>Certificates</U>. Every holder of capital stock of the Corporation represented by certificates shall be entitled to have a certificate
signed by, or in the name of, the Corporation by any two (2) authorized officers of the Corporation representing the number of shares
registered in certificate form. Each of the Chairperson of the Board of Directors, the Chief Executive Officer, the Chief Financial Officer
and the Secretary, in addition to any other officers of the Corporation authorized by the Board of Directors or these Bylaws, is hereby
authorized to sign certificates by, or in the name of, the Corporation. Any or all of the signatures on the certificate may be a facsimile.
In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall
have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued by the Corporation with
the same effect as if such person were such officer, transfer agent, or registrar at the date of issue. The Corporation shall not have
the power to issue a certificate in bearer form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.2 <U>Lost, Stolen or Destroyed Stock Certificates; Issuance of New Certificates or Uncertificated Shares</U>. The Corporation may issue
a new certificate of stock or uncertificated shares in the place of any certificate theretofore issued by it, alleged to have been lost,
stolen or destroyed, and the Corporation may require the owner of the lost, stolen or destroyed certificate, or such owner&rsquo;s legal
representative, to give the Corporation a bond sufficient to indemnify it against any claim that may be made against it on account of
the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.1 <U>Right to Indemnification</U>. The Corporation shall indemnify and hold harmless, to the fullest extent permitted by applicable
law, any individual (a &ldquo;<U>Covered Person</U>&rdquo;) who was or is made or is threatened to be made a party or is otherwise involved
in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &ldquo;<U>proceeding</U>&rdquo;), by reason
of the fact that he or she, or an individual for whom he or she is the legal representative, is or was a director or officer of the Corporation
or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee
or agent of another corporation or of a partnership, joint venture, trust, enterprise or nonprofit entity, including service with respect
to employee benefit plans, its participants or beneficiaries, against all liability and loss suffered and expenses (including attorneys&rsquo;
fees) reasonably incurred by such Covered Person. Notwithstanding the preceding sentence, except as otherwise provided in <U>Section
6.3</U>, the Corporation shall be required to indemnify a Covered Person in connection with a proceeding (or part thereof) commenced
by such Covered Person only if the commencement of such proceeding (or part thereof) by the Covered Person was authorized in the specific
case by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.2 <U>Prepayment of Expenses</U>. The Corporation shall to the fullest extent not prohibited by applicable law, pay the expenses (including
attorneys&rsquo; fees) incurred by a Covered Person in defending any proceeding in advance of its final disposition; <U>provided</U>,
<U>however</U>, that, to the extent required by applicable law, such payment of expenses in advance of the final disposition of the proceeding
shall be made only upon receipt of an undertaking by the Covered Person to repay all amounts advanced if it should be ultimately determined
that the Covered Person is not entitled to be indemnified under this <U>Article VI</U> or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.3 <U>Claims</U>. If a claim for indemnification (following the final disposition of such action, suit or proceeding) or advancement
of expenses under this <U>Article VI</U> is not paid in full within thirty (30) days after a written claim therefor by the Covered Person
has been received by the Corporation, the Covered Person may file suit to recover the unpaid amount of such claim and, if successful
in whole or in part, shall be entitled to be paid the expense (including attorneys&rsquo; fees) of prosecuting such claim. In any such
action the Corporation shall have the burden of proving that the Covered Person is not entitled to the requested indemnification or advancement
of expenses under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.4 <U>Nonexclusivity of Rights</U>. The rights conferred on any Covered Person by this <U>Article VI</U> shall not be exclusive of any
other rights which such Covered Person may have or hereafter acquire under any statute, provision of the Certificate of Incorporation,
these Bylaws, agreement, vote of stockholders or disinterested directors or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.5 <U>Other Sources</U>. The Corporation&rsquo;s obligation, if any, to indemnify or to advance expenses to any Covered Person who was
or is serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, enterprise
or nonprofit entity shall be reduced by any amount such Covered Person may collect as indemnification or advancement of expenses from
such other corporation, partnership, joint venture, trust, enterprise or non-profit entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.6 <U>Amendment, Repeal, Modification or Elimination</U>. Any amendment, repeal, modification or elimination of the Certificate of Incorporation
or these Bylaws shall not eliminate or impair any right to indemnification or advancement under the Certificate of Incorporation or these
Bylaws after the occurrence of the act or omission that is the subject of the action, suit or proceeding for which indemnification or
advancement of expenses is sought.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.7 <U>Other Indemnification and Prepayment of Expenses</U>. This <U>Article VI</U> shall not limit the right of the Corporation, to
the extent and in the manner permitted by applicable law, to indemnify and to advance expenses to persons other than Covered Persons
when and as authorized by appropriate corporate action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.8 <U>Certain Terms</U>. For purposes of this <U>Article VI</U>: (a) references to &ldquo;<U>the Corporation</U>&rdquo; shall include,
in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation
or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers and
employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or
was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, shall stand in the same position under this <U>Article VI</U> with respect to the resulting
or surviving corporation as such person would have with respect to such constituent corporation as if its separate existence had continued;
(b) references to &ldquo;<U>other enterprise</U>&rdquo; shall include employee benefit plans; (c) reference to &ldquo;<U>fines</U>&rdquo;
shall include any excise taxes assessed on a person with respect to any employee benefit plan; and (d) references to &ldquo;<U>serving
at the request of the Corporation or any of its consolidated subsidiaries</U>&rdquo; shall include any service as a director, officer,
employee or agent of the Corporation which imposes duties on, or involves services by, such director, officer, employee or agent with
respect to an employee benefit plan, its participants or beneficiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.1 <U>Fiscal Year</U>. The fiscal year of the Corporation shall be determined by resolution of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.2 <U>Seal</U>. The corporate seal of the Corporation shall have the name of the Corporation inscribed thereon and shall be in such
form as may be approved from time to time by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.3 <U>Manner of Notice</U>. Except as otherwise provided in these Bylaws or permitted by applicable law, notices to directors and stockholders
shall be in writing or electronic transmission and delivered by mail, courier service or electronic mail to the directors or stockholders
at their addresses appearing on the records of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.4 <U>Waiver of Notice of Meetings of Stockholders, Directors and Committees</U>. Any waiver of notice, given by the person entitled
to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting
shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at
the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the
business to be transacted at nor the purpose of any regular or special meeting of the stockholders, directors, or members of a committee
of directors need be specified in a waiver of notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.5 <U>Form of Records</U>. Any records administered by or on behalf of the Corporation in the regular course of its business, including
its stock ledger, books of account, and minute books, may be kept on, or by means of, or be in the form of, any information storage device,
method, or one or more electronic networks or databases (including one or more distributed electronic networks or databases); <U>provided
</U>that the records so kept can be converted into clearly legible paper form within a reasonable time, and, with respect to the stock
ledger, that the records so kept comply with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.6 <U>Amendment of Bylaws</U>. These Bylaws may be altered, amended or repealed, and new bylaws made, by the Board of Directors, but
the stockholders may make additional bylaws and may alter and repeal any bylaws whether adopted by them or otherwise. In addition to
any affirmative vote required by the Certificate of Incorporation, any bylaw that is to be made, altered, amended or repealed by the
stockholders of the Corporation shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66&#8532;%)
in voting power of the outstanding shares of capital stock of the Corporation entitled to vote, voting together as a single class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.7 <U>Forum for Adjudication of Disputes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Delaware Courts</U>. Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of
the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation,
(ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, stockholder or employee of the Corporation
to the Corporation or the Corporation&rsquo;s stockholders, (iii) any civil action to interpret, apply or enforce any provision of the
General Corporation Law of the State of Delaware (as the same exists or may hereafter be amended, the &ldquo;<U>General Corporation Law</U>&rdquo;),
(iv) any claims, including claims in the right of the Corporation, as to which the General Corporation Law confers jurisdiction upon
the Court of Chancery of the State of Delaware or (v) any action asserting a claim governed by the internal affairs doctrine; <U>provided</U>,
<U>however</U>, in the event that the Court of Chancery of the State of Delaware lacks jurisdiction over such action, the sole and exclusive
forum for such action shall be another state or federal court located within the State of Delaware, in all cases, subject to such court
having personal jurisdiction over the indispensable parties named as defendants, except for, as to each of (i) through (v) above, any
claim as to which such court determines that there is an indispensable party not subject to the jurisdiction of such court (and such
indispensable party does not consent to the personal jurisdiction of such court within ten (10) days following such determination). This
<U>Section 7.7(a)</U> shall not apply to claims or causes of action brought to enforce a duty or liability created by the Securities
Act or the Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Federal Courts</U>. Unless the Corporation consents in writing to the selection of an alternative forum, the federal district courts
of the United States of America shall, to the fullest extent permitted by applicable law, be the sole and exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Application</U>. Failure to enforce the foregoing provisions of this <U>Section 7.7</U> would cause the Corporation irreparable harm
and the Corporation shall, to the fullest extent permitted by applicable law, be entitled to equitable relief, including injunctive relief
and specific performance, to enforce the foregoing provisions. Any person purchasing or otherwise acquiring any interest in shares of
capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this <U>Section 7.7</U>. This <U>Section
7.7</U> shall not apply to any action asserting claims arising under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 124px; width: 250px"></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Azitra,
Inc. Announces Pricing of Initial Public Offering</B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BRANFORD,
Conn., June 15, 2023 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) (the &ldquo;Company&rdquo;), a biopharmaceutical company focused
on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today
announced the pricing of its initial public offering of 1,500,000 shares of common stock at a public offering price of $5.00 per share,
for aggregate gross proceeds of $7,500,000 prior to deducting underwriting discounts and other offering expenses. In addition, the Company
has granted the underwriters a 45-day option to purchase up to an additional 225,000 shares of common stock at the public offering price
less discounts, to cover over-allotments. The shares of common stock are expected to begin trading on the NYSE American under the ticker
symbol &ldquo;AZTR&rdquo; on June 16, 2023. The offering is expected to close on June 21, 2023, subject to satisfaction of customary
closing conditions.</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from the initial public offering for clinical trials and product development, research and development,
clinical manufacturing as well as for working capital and other general corporate purposes.</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
is acting as sole book-running manager for the offering. A registration statement on Form S-1 (File No. 333-269876) relating to the shares
being sold in this offering has been filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and became effective
on June 15, 2023. This offering is being made only by means of a prospectus. Electronic copies of the final prospectus, when available,
may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. The final prospectus will be filed with the
SEC and will be available on the SEC&rsquo;s website located at <U>http://www.sec.gov</U>.</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Azitra, Inc. </B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azitra,
Inc. is an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using
engineered proteins and topical live biotherapeutic products. The Company has built a proprietary platform that includes a microbial
library comprised of approximately 1,500 unique bacterial strains that can be screened for unique therapeutic characteristics. The platform
is augmented by an artificial intelligence and machine learning technology that analyzes, predicts and helps screen the Company&rsquo;s
library of strains for drug like molecules. The Company&rsquo;s initial focus is on the development of genetically engineered strains
of Staphylococcus epidermidis, or S. epidermidis, which the Company considers to be an optimal therapeutic candidate species for engineering
of dermatologic therapies. For more information, please visit <U>https://azitrainc.com/</U>.</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements </B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">press
release contains &ldquo;forward-looking statements&rdquo; that are subject to substantial risks and uncertainties. All statements, other
than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained
in this press release may be identified by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo; &ldquo;aim,&rdquo; &ldquo;should,&rdquo;
&ldquo;will&rdquo; &ldquo;would,&rdquo; or the negative of these words or other similar expressions, although not all forwardlooking
statements contain these words. Forward-looking statements are based on Azitra, Inc.&rsquo;s current expectations and are subject to
inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in
the section titled &ldquo;Risk Factors&rdquo; in the final prospectus related to the public offering filed with the SEC. Forward-looking
statements contained in this announcement are made as of this date, and Azitra, Inc. undertakes no duty to update such information except
as required under applicable law. CONTACT Norman Staskey Danforth Advisors nstaskey@danforthadvisors.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-2_001.jpg" ALT="" STYLE="height: 124px; width: 250px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Azitra,
Inc. Announces Closing of Initial Public Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">BRANFORD,
Conn., June 21, 2023 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) (the &ldquo;Company&rdquo;), a biopharmaceutical company focused
on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today
announced the closing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of $5.00 per
share, for gross proceeds of $7,500,000, before deducting underwriting discounts and offering expenses. In addition, the Company has
granted the underwriters a 45-day option to purchase up to an additional 225,000 shares of common stock to cover over-allotments at the
initial public offering price, less the underwriting discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company intends to use the net proceeds from the initial public offering for clinical trials and product development, research and development,
clinical manufacturing as well as for working capital and other general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ThinkEquity
acted as sole book-running manager for the offering. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
registration statement on Form S-1 (File No. 333-269876) relating to the shares of common stock being sold in this offering was filed
with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) and became effective on June 15, 2023. A final prospectus relating
to the offering was filed with the SEC and is available on the SEC&rsquo;s website at http://www.sec.gov. This offering is being made
only by means of a prospectus. Electronic copies of the final prospectus may be obtained from ThinkEquity, 17 State Street, 41st Floor,
New York, New York 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Azitra, Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azitra,
Inc. is an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using
engineered proteins and topical live biotherapeutic products. The Company has built a proprietary platform that includes a microbial
library comprised of approximately 1,500 unique bacterial strains that can be screened for unique therapeutic characteristics. The platform
is augmented by an artificial intelligence and machine learning technology that analyzes, predicts and helps screen the Company&rsquo;s
library of strains for drug like molecules. The Company&rsquo;s initial focus is on the development of genetically engineered strains
of Staphylococcus epidermidis, or S. epidermidis, which the Company considers to be an optimal therapeutic candidate species for engineering
of dermatologic therapies. For more information, please visit <U>https://azitrainc.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">This
press release contains &ldquo;forward-looking statements&rdquo; that are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo; &ldquo;aim,&rdquo; &ldquo;should,&rdquo;
&ldquo;will&rdquo; &ldquo;would,&rdquo; or the negative of these words or other similar expressions, although not all forward-looking
statements contain these words. Forward-looking statements are based on the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company&rsquo;s
current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult <FONT STYLE="background-color: white">to
predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.
These and other risks and uncertainties are described more fully in the section titled &ldquo;<I>Risk Factors</I>&rdquo; in the final
prospectus related to the public offering filed with the SEC. Forward-looking statements contained in this announcement are made as of
this date, and </FONT>the Company <FONT STYLE="background-color: white">undertakes no duty to update such information except as required
under applicable law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>CONTACT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Norman
Staskey</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>staskey@azitrainc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">SOURCE
Azitra, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '. Z,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **Y[QCXRTSP/HT>J:JER]O).L %N@9MQ#$<$CC"FN&_X:
M)\&?\^VK_P#@.G_Q= 'K5%>2_P##1/@S_GVU?_P'3_XNC_AHGP9_S[:O_P"
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M_"">,/\ H5-<_P#!=-_\37V_10!\0?\ "">,/^A4US_P73?_ !-'_"">,/\
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MH ^YJ*^&?^$N\2_]##JW_@;)_P#%4?\ "7>)?^AAU;_P-D_^*H ^YJ*^&?\
MA+O$O_0PZM_X&R?_ !5'_"7>)?\ H8=6_P# V3_XJ@#[FHKX9_X2[Q+_ -##
MJW_@;)_\51_PEWB7_H8=6_\  V3_ .*H ^YJ*^&?^$N\2_\ 0PZM_P"!LG_Q
M5'_"7>)?^AAU;_P-D_\ BJ /N:BOG;]GS6]6U3Q=J<6H:I>W<:V!94N+AY #
MYB<@$GFOHF@ HKRSX^ZC>Z9X M9["\N+28ZC&ID@E:-B/+DXR#TX'Y5\V?\
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M?!U?7_P2_P"20Z%_V\?^E$E 'H%%%1SSPVMO)<7$J0PQ*7DDD8*J*!DDD\
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M0>C#K_C^->+@=,1453X_Z_X'R/:QVM"#I_!_7_!^9>HHHKVCQ0HHHH ****
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M]?M*)5>\D2-UZ&-#L3_QU5KFZ^B?^&:;'_H9KG_P$7_XJC_AFBQ_Z&:Y_P#
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MG!+AR<=1M]*]@K%\(:>VD^#-$T]T"26]C#'( ,?.$&[]<UM4 %%%% !1110
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MX_ZZM_.H* "I;7_C[A_ZZ+_.HJEM?^/N'_KHO\Z /OJBBB@ HHHH ^%/$O\
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M@ HHHH \C_:+_P"2=6G_ &$X_P#T7+7RY7U'^T7_ ,DZM/\ L)Q_^BY:^7*
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M)+,K*.2I))! )!/<'Y?&** /O/3=7TW6(#/IFH6E["#@R6TRR*#Z94GFKE?
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MQ?KDVKZO/YEQ)\JJO"1(.B(.RC)_,DY))./13G1XV"NK*2 V&&.",@_B"#0
MVBBB@"2WF-O<Q3K]Z-PX^H.:^^Z^ *^_4=9(UD1@R, 5([@T .HHHH ****
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MO7>4 ? !ZFBOK_\ X4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#Y
MHKZ__P"%)?#S_H7O_)VX_P#CE'_"DOAY_P!"]_Y.W'_QR@#Y HKZ_P#^%)?#
MS_H7O_)VX_\ CE'_  I+X>?]"]_Y.W'_ ,<H ^0**^O_ /A27P\_Z%[_ ,G;
MC_XY1_PI+X>?]"]_Y.W'_P <H ^0**^O_P#A27P\_P"A>_\ )VX_^.4?\*2^
M'G_0O?\ D[<?_'* /D"BOK__ (4E\//^A>_\G;C_ ..4?\*2^'G_ $+W_D[<
M?_'* /D"OM_P)_R3SPU_V"K7_P!%+7/_ /"DOAY_T+W_ ).W'_QRNXL+&WTS
M3K:PLX_+M;6)(84W$[44 *,GDX '6@#RO]HO_DG5I_V$X_\ T7+7RY7W1XC\
M+Z/XMTY-/URS^U6J2B98_-=,. 0#E2#T8_G7+?\ "DOAY_T+W_D[<?\ QR@#
MY HKZ_\ ^%)?#S_H7O\ R=N/_CE'_"DOAY_T+W_D[<?_ !R@#RO]FS_D:M9_
MZ\A_Z&*^E*YKPUX \,>$+J:ZT+3/LDTR>7(WGRR97.<8=B.M=+0 4444 <YX
MW\&V'CGPY+I-\S1-GS+>X49:&0 X;'<<D$=P3R#@CY*\8> /$'@F\,6JV;&V
M) CO806@DSG #8X;@_*<'C.,8-?;%-DC2:)XI45XW!5D89# ]01WH ^ J*^Q
MM5^#W@35Y7EET"&WE9=H:S=H ON$4A,_A7,O^SEX/8DKJ&MKGH!/%@?^0Z /
ME^BOIG_AF[PSN_Y#&K8]-T?_ ,14J_LX>$0/FU/6R?::(?\ M.@#PKX:_P#)
M2_#G_7_%_P"A5]K5YMX=^"'A+PWK%MJD#ZC<W-LXDB-S.N%8=#A%7/XUZ30!
M\*>)?^1JUC_K^F_]#-9=?8ES\&_ -Y=S74^@[YIG:21OMDXRQ.2<!\=347_"
MDOAY_P!"]_Y.W'_QR@#Y H'45]?_ /"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_
M ,G;C_XY0!Z!1110 4444 %%%% '"?$OX9V'C_2PRE+76;=2+6[(X(Z^7)CD
MH3^*DY'<-\I>(_#&L>$]4;3M:LI+:<#*D\I(O]Y6'##Z=#P<$$5]T52U71]-
MURQ:RU6QM[RV;GRYXPP!P1D9Z'D\CD4 ?!M%?3VN_L[>&;]GDT>^O-*D8C:A
M/GQ*.^ Q#<^[UQ>H?LV^(([C;IVMZ9<08^_<"2%L_P"ZJN/UH \5HKV#_AG'
MQA_T$M#_ ._\W_QJKVF_LUZU*S?VIK]A; ?=-K$\^?KNV8_6@#Q&I[2SNM0N
MX[6RMIKFYD.$AA0N['T ')KZ7T7]G7PQ9&*35;Z^U*13ED!$,3_@N6'X/7I6
M@^%M"\,6WD:+I=M9*5"LT:?.X'3<Y^9NIZDT >,_#GX"R074.K>,DC/EDM'I
M:L'!(/!E8$@COM&0>,GJIX7XZZ=-8?%2^ED5%BO(()X I_@$8CZ=OFC:OK>N
M:\2_#_POXONX;K7=*6[GA3RTD\Z2,A<YP=C#(R3U]3ZT ?$M%?7_ /PI+X>?
M]"]_Y.W'_P <H_X4E\//^A>_\G;C_P".4 ?(%?:WPWU2/6/AOX?NXV9O]"2%
MRW4O&/+;_P >4UD?\*2^'G_0O?\ D[<?_'*ZGPYX8T?PGIK:?HEH;6U:4RF,
MRO)\Q !.7)(X XZ4 :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1XBTTZAIQ:-2T\/S
M(!U([C_/H*XR)]0M0R0M<PC/*H67G\*]*HKS\1@56G[12LST,/C71AR.-T><
M_;-6_P"?F]_[^/1]LU;_ )^;W_OX]>C45A_9LO\ GX_Z^9O_ &E'_GVOZ^1Y
MS]LU;_GYO?\ OX]'VS5O^?F]_P"_CUZ-11_9LO\ GX_Z^8?VE'_GVOZ^1YS]
MLU;_ )^;W_OX]'VS5O\ GYO?^_CUZ-11_9LO^?C_ *^8?VE'_GVOZ^1YS]LU
M;_GYO?\ OX])]LU;_GYO?^_CUZ/11_9LO^?C_KYA_:4?^?:_KY'#^'-*DN-1
M6XFB988?FRP(#-V']?P]Z[BBBN[#8>-"'*M3AQ.(E7GS/0****Z3F"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex99-2_001.jpg
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '. Z,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **Y[QCXRTSP/HT>J:JER]O).L %N@9MQ#$<$CC"FN&_X:
M)\&?\^VK_P#@.G_Q= 'K5%>2_P##1/@S_GVU?_P'3_XNC_AHGP9_S[:O_P"
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M_"">,/\ H5-<_P#!=-_\37V_10!\0?\ "">,/^A4US_P73?_ !-'_"">,/\
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MH ^YJ*^&?^$N\2_]##JW_@;)_P#%4?\ "7>)?^AAU;_P-D_^*H ^YJ*^&?\
MA+O$O_0PZM_X&R?_ !5'_"7>)?\ H8=6_P# V3_XJ@#[FHKX9_X2[Q+_ -##
MJW_@;)_\51_PEWB7_H8=6_\  V3_ .*H ^YJ*^&?^$N\2_\ 0PZM_P"!LG_Q
M5'_"7>)?^AAU;_P-D_\ BJ /N:BOG;]GS6]6U3Q=J<6H:I>W<:V!94N+AY #
MYB<@$GFOHF@ HKRSX^ZC>Z9X M9["\N+28ZC&ID@E:-B/+DXR#TX'Y5\V?\
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M?!U?7_P2_P"20Z%_V\?^E$E 'H%%%1SSPVMO)<7$J0PQ*7DDD8*J*!DDD\
M=Z )**\3\:?M":?ILLEEX6M4U&X1MIO+C(MQC'W0"&?^(9RHX!&X5XEX@^(7
MBOQ.'35=;NI('&UK>-O*B(SG!1< _4@F@#[ U+Q;X<T>>2#4M>TVTGC&YH9K
MI%D QG[I.?TKFI?C5\/H693XA5F']RUG8'\0F*^/J* /K9OCMX!!P-3N&]Q:
M2?X5+'\<?A\_WM:DC_WK.;^BFOD2B@#[,L/BUX#U*39!XEM$/K<!X!^<@45T
MVFZQIFLPO+I>HV=]&AVL]K.LH4^A*DXKX-I\,TMO,DT$CQ2QL&1T8JRD="".
MAH ^_**^1_#'QM\8>'I$2YO/[7LP?FAOB6?&03B3[V<9 R6 ST-?0G@3XFZ#
MX\@9+-VMM1C4&6RG(#CCDH?XUSD9'(XR!D4 =I1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 =!DUYWJUZVJZLSQ@LI(CB4#DCM^9Y
M_&NI\3ZA]DTTP(?WEQE/HO\ %_A^-8WA33OM%XUY(O[N#A<]W/\ @/Z5X^.D
MZU6.&C\_Z]#V,%%4:4L1+Y?UZG4Z98KI^GQ6XQN49<CNQZG_ #VJW117K1BH
MQ45LCR92<I.3W844451(4444 %%%% !1110 5QWBW3_)N4O4'R3?*_LPZ?F/
MY5V-5M0LTO[&6V?'SKP?0]C^=<N*H>VI./7IZG3A:_L:JETZ^AE>%M0^U:>;
M9VS+!P,]T[?ET_*MZO.M-NY-)U97D!78QCE7VZ$?AU_"O1%8,H92"I&01T-8
MY?7]I2Y7O'0WS"A[.KS+:6HM%%%>@>>%%%% !1110 4444 %%%% !1110 44
M44 %%%0WEW!864]Y=2B*WMXVEED;HB*,DGZ &@#C?B9\1;7X?Z&LJQK<:K=;
MEL[=L[<CJ[X_A&1P.2< 8Y(^1M7UC4=>U2;4M4NY+J[F;<\DA_0#H .P' [5
MH^,_%5YXR\4WFLW98"5ML$);(AB'W4'T'7&,DD]ZP* "BBB@ HKU'P/\#]=\
M66,.IWMPFDZ;,N^%Y(R\LJ]F"9&%/8DCC! ((->J67[._@VVD5Y[C5;O P4D
MG55)]?E0']: /EJBOJR\_9^\$70Q"NHVG/6"YS_Z&K5R7B7]F]4MWG\,ZO(\
MBKD6M^!ESWQ(H 'L"OU(H \ HJWJ>F7NC:E<:=J-M);7=N^R6*08*G^H[@C@
M@Y%5* "NZ^&GQ)OO .L .9+C1KA_]+M >G;S$SP'''IN P<<$<+10!]\VMU!
M?6<%W:RK+;SQK+%(IR'5AD$>Q!J:O)/V>]>;4O <VERR!I=,N2B+W$3_ #+G
M_@7F#Z 5ZW0!XM^TE_R*.D?]?Y_]%M7S37TM^TE_R*.D?]?Y_P#1;5\TT %%
M%% !1110 4444 %%%% !1110![/^S=_R.FJ_]@\_^C$KZ8KYG_9N_P"1TU7_
M +!Y_P#1B5],4 >1_M%_\DZM/^PG'_Z+EKY<KZC_ &B_^2=6G_83C_\ 1<M?
M+E !1110![7^S9_R-6L_]>0_]#%>@_M!?\DR/_7[%_[-7GW[-G_(U:S_ ->0
M_P#0Q7K?Q8\*ZEXQ\%G2M*$1N?M,<N)7VC:,YY_&@#XYHKU+_AG_ ,<?\\]/
M_P# G_ZU'_#/_CC_ )YZ?_X$_P#UJ /+:*=(C12O&WWE)4_44V@ HHIR(9)%
M1>K$ 4 -HKU+_AG_ ,<?\\]/_P# G_ZU'_#/_CC_ )YZ?_X$_P#UJ .6^&O_
M "4OPY_U_P 7\Z^UJ^;O!OP4\7Z'XST?5+R.R%M:W22R%+C)V@\X&*^D: /A
M3Q+_ ,C5K'_7]-_Z&:RZU/$O_(U:Q_U_3?\ H9K+H *[OX,_\E:T'_?E_P#1
M+UPE=+X U^W\+^-+'6[E=T=HDSA.?G;R7"KD XRQ SCC.30![K\;/BC-X<A_
MX1O0KD1ZI.F;JXC;Y[6,]%7'W78<YZJ,$<D$?,M6M3U&ZU?5+K4;Z4RW5U*T
MLKD8RS')X[#V[55H **** "OK_X)?\DAT+_MX_\ 2B2OD"OK_P""7_)(="_[
M>/\ THDH [NZNH+*TFN[F58K>!&DED<X5% R23Z "ODKXF_%74?'%]+96CR6
MN@QOB*W!P9L'AY/4]PO0<=3S7=_M$>,V7[+X0LY<*RBYOMK=>?W<9P?;>01_
M<(KY_H **** "BM_PGX,USQKJ1LM%M?,*;3-,YVQ0J3@%F_/@9)P< XKW#2/
MV;='CMO^)UKE]/<'!_T-4B1>.1\P8MSWX^E 'SA17UB/@)X$$ C^R7A<?\M3
M=-N/]/TK'OOV;_#,MM(+'5]5M[@_<>9HY47GNH52?^^A0!\S45V7CSX::YX!
MN(VO@EQI\[E8+V'.QCSA6!^ZV.<=#S@G!QQM !4]E>W.G7L-Y93R07,+AXY8
MVPRL.X-044 ?87PJ^(*>//#C-.-FK66V.\4+A6)SMD7MAL'CL0>V">]KX\^#
MFO/H/Q-TH[F$-\_V&55&=PDP%'M\^P_A7V'0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!YWJUX^K:LSQ@LI(CA4#DC/'YGG\:[G3+%=.
ML(K=<$J,N1W8]3_GM7$Z[8'3=4<1@K$Y\R(CC'M^!_I79Z1?C4=.CGR-_P!V
M0>C#K_C^->+@=,1453X_Z_X'R/:QVM"#I_!_7_!^9>HHHKVCQ0HHHH ****
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M]?M*)5>\D2-UZ&-#L3_QU5KFZ^B?^&:;'_H9KG_P$7_XJC_AFBQ_Z&:Y_P#
M1?\ XJ@#YVHKZ)_X9HL?^AFN?_ 1?_BJL6/[.&F6NH6UQ-KTUQ%%*KO"]JH$
MB@@E3\W0]* /1?AYX3B\&>"['2Q&%NB@FO&R#NG8#=R.H'W1[**ZFBB@ HHH
MH R/%.@6_BCPQJ.BW. EW"45R,['ZH^,C.U@#CVKX7K[XO;RWTZPN+VZD$5M
M;Q-+*YZ*BC)/X &O@>@ HHHH U/#-TUAXJT>\0 M!?0R@'U5P?Z5]UU\&:3_
M ,AFQ_Z^(_\ T(5]YT %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 9'B/3_MVF,R#,T.77U([C_/H*Y[POJ'V74/LSG]U<<#V;M^?3\J[B
MO/M<L#INJ,(\K&_[R(CM[?@?Z5X^.@Z52.)ATW_K\#U\#)5:<L//KM_7XGH-
M%4=(OQJ.FQ3DCS/NR =F'7_'\:O5ZT)J<5*.S/*G%PDXO=!1115$A1110 44
M44 %%%% !5/5+Y=.TZ6X.-P&$![L>G^/T!JY7%>*M0^TWPM(VS'!]['=^_Y=
M/SKDQE?V-)RZ]#KPE#VU51Z=3%@AFOKQ(E)>65^IR>3U)_G7I5K;QVEK';Q#
M"1KM'O[_ %KF?".G?ZR_D7_8BR/S/]/SKJZY<MH<E/VDMY?E_P $Z<RK\\_9
MQVC^84445ZIY84444 %%%% !1110!QGBS3_(NUO8Q\DW#^S#_$?R-:WA?4/M
M6G?9W.9+?"_5>W^'X"M/4;)-0L);9L?,/E)[-V-<)I=V^DZLKR J%8QRK[=#
M^77\*\6K_LN*53[,M_Z_'[SV:7^U85T_M1V_K\/N/1:*0$, 000>012U[1XP
M4444 %%%% !117G/BGXU^$/#3O;Q73:K>+D>58X95..-TA.WKP<$D>E 'HU%
M?,VL_M&^([OS$TG2[#3XW3:&D+3R(W]X'Y5_ J?QKB-2^*7CG5F5KGQ-?H5&
M!]E<6X/U$87/XT ?:!( R3@5B7'C+PO9SO!<^)-'@F0X:.6^B5E/N"V17Q#=
M7ES?3F>[N9KB9NLDSEV/XFH: /L2_P#C)X!T^22-]?CFD3^&WADE#?1E4J?S
MK@O$'[25JL)C\.:+-),1Q-J!"JAS_<0DL,9_B6OGBB@#3U_Q#JOB?59-3UB\
M>ZNG 7<V %4=%4#A1UX'J3WK,HHH **** /??V9O]9XG^EK_ .U:^@J^??V9
MO]9XG^EK_P"U:^@J "BBB@ HHIKNL:,[L%102S,< #U- $5Y>6^GV4UY=S)#
M;0(9)9'. J@9)-?(WQ1^)5WX]UCRH6>'1+5S]EM^F\]/-?U8CH/X0<#J2=?X
MO?%:7Q=>2:)I$K1Z# _S,#@WC@_>/^P#]U>_WCS@+Y30 4444 %%%?0GP1^%
MB1QP>+M>MLRG$FG6\@X0=1,1Z_W?3[W7:0 ;GP8^%H\,VB>(=:M\:S.G[B*0
M<VD9'IV<CKW ..,M7K]%% !1110!Y'^T7_R3JT_["<?_ *+EKY<KZC_:+_Y)
MU:?]A./_ -%RU\N4 %%%% 'M?[-G_(U:S_UY#_T,5]*5\U_LV?\ (U:S_P!>
M0_\ 0Q7TI0 4444 ? ][_P ?UQ_UU;^=05/>_P#']<?]=6_G4% !4MK_ ,?<
M/_71?YU%4MK_ ,?</_71?YT ??5%%% !1110!\*>)?\ D:M8_P"OZ;_T,UEU
MJ>)?^1JUC_K^F_\ 0S670 4444 ?3_[/7AF/3O!DVOR*C7.J2L$8')6&,E0.
MG!+AR<=1M]*]@K%\(:>VD^#-$T]T"26]C#'( ,?.$&[]<UM4 %%%% !1110
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MX_ZZM_.H* "I;7_C[A_ZZ+_.HJEM?^/N'_KHO\Z /OJBBB@ HHHH ^%/$O\
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M@ HHHH \C_:+_P"2=6G_ &$X_P#T7+7RY7U'^T7_ ,DZM/\ L)Q_^BY:^7*
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M)+,K*.2I))! )!/<'Y?&** /O/3=7TW6(#/IFH6E["#@R6TRR*#Z94GFKE?
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MQ?KDVKZO/YEQ)\JJO"1(.B(.RC)_,DY))./13G1XV"NK*2 V&&.",@_B"#0
MVBBB@"2WF-O<Q3K]Z-PX^H.:^^Z^ *^_4=9(UD1@R, 5([@T .HHHH ****
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MO7>4 ? !ZFBOK_\ X4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>aztr-20230615.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKCibP9z5Z8uekhvWBwbZnafy8rVipVRC9YfsymYScL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:AZTR="http://azitrainc.com/20230615" elementFormDefault="qualified" targetNamespace="http://azitrainc.com/20230615">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://azitrainc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="aztr-20230615_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="aztr-20230615_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>aztr-20230615_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>aztr-20230615_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://azitrainc.com/role/Cover" xlink:href="aztr-20230615.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://azitrainc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140009485082688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 15,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AZITRA,
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001701478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4478536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">21
    Business Park Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Branford<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">646-6446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock: Par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AZTR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aztr-20230615.xsd" xlink:type="simple"/>
    <context id="From2023-06-15to2023-06-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701478</identifier>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-15to2023-06-15">0001701478</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-15to2023-06-15">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-06-15to2023-06-15">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2023-06-15to2023-06-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-15to2023-06-15">2023-06-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-15to2023-06-15">AZITRA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-15to2023-06-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-15to2023-06-15">001-41705</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-15to2023-06-15">46-4478536</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-15to2023-06-15">21     Business Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-15to2023-06-15">Branford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-15to2023-06-15">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-15to2023-06-15">06405</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-15to2023-06-15">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-15to2023-06-15">646-6446</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-15to2023-06-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-15to2023-06-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-15to2023-06-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-15to2023-06-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-15to2023-06-15">Common     Stock: Par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-15to2023-06-15">AZTR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-15to2023-06-15">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-15to2023-06-15">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-06-15to2023-06-15">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "G@-56JL0B%C,!   B @
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( *> U59ED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "G@-56)!Z;HJT   #X 0
M&@              @ 'Y$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "G@-5699!YDAD!  #/ P  $P              @ '>$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   H%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://azitrainc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>aztr-20230615.xsd</File>
    <File>aztr-20230615_lab.xml</File>
    <File>aztr-20230615_pre.xml</File>
    <File>ex1-1.htm</File>
    <File>ex3-1.htm</File>
    <File>ex3-2.htm</File>
    <File>ex99-1.htm</File>
    <File>ex99-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aztr-20230615_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aztr-20230615_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aztr-20230615.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "AZTR",
   "nsuri": "http://azitrainc.com/20230615",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-06-15to2023-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://azitrainc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-06-15to2023-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://azitrainc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001493152-23-021998-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-021998-xbrl.zip
M4$L#!!0    ( *> U5;GIKR1*@,  *X+   1    87IT<BTR,#(S,#8Q-2YX
M<V2U5=MRVC 0?6YG^@^JW^4+#"D02"8EDPY3TF8@(9>7CK!ET$267$GFDJ^O
MY MW"-#63]+N.6=WI5VY<3F-*!AC(0EG3<NS70M@YO. L&'3>NC!JUZKW;;
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MI4NS=7,4$".]9Z32DU\_C3QP(8&$OZ&R,?):A,=8**([=&FNL]2),O2[I3#
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M,SF#"F/P5?#.(,>W%P8T0+O)T!$1$'H#;$(W'(I(5(1^0&4P:D1[.C_+#ED
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M3L'[7"95=)'D,*2_/CB$.Q]%2[#IZ/9MRQJO>H=7Z2/^V.UR7Q3E5]HPN&/
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MS %N@:.A=%X#N@QLEJBY+,'8P_<&@U&C"2S,9%VC XH3*SO"P)/1)>&)8
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M0)ET"BT1S@*3RW8F67&!N!D8S)Y74 @S616DD#B6 3]>]$\+ _4&,[).D^H
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M*DL#&Y?*VNFUKOW8*8-T0U4,?4=+HCU2$C^N=2=113A";'NOY;'NIZ8T-J;
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MOB_*XH#U)Q<5M+ZJJ8^DDJ,$W_4]CP/C1+\$UFG&J4QD1"D2)J4L]262N/A
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MW33%9Q;S[*(H.__P6ZF&!G_HC(AX7Z(:J*3S$>-E"'5$_%$*.-I44TJ;#]6
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M9I+;)\A SK N3#4PH57_:,)EH<N?O7]Z&/V30RGZ=1R]>O64JEW=F@_8(]K
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MF&<^_X27U)XX.#RM>2/E9KI8;KL(0[-%4P]&NNT<\?7T3O*,H4L8,G%%N1:
M#OY583$>*ZU+PL]\('S/:$4M'R.M*,!XO/0W<^EX9#0J;I:?\2V_^[".WJVJ
MBW1=^R8E2R3YK#+6[O!+=V%T"JKPK%7^^XXJHD"DGZ5)#I_(IK *W%X@7X]'
M_X->'PRU2+**]<F;\I+KQD[!<ZF*=+T?#]5_QT&AHF21<E/V%0=%7ZS]I%:Z
M\<1FE-Y:<+& +RWD_ ?F'<*';"?.H+L=102\[G/[N@,MS#V/2!)U+Z-$(7[A
M">6T C'A[ R];B<AIEX!_PRJN1TGFIY('9F'A_R^WST=7*U&*_2X.7H%-_NP
M+\> O["8?8.@[R99+*,F^8C;6DT,,%0H<+E:RM'BKL(-9TX>6]! 6KZG7@^>
MG@?KW#HOJ;N8FBW)C+S1VAW5>G2*+N;>6/#V4\X_<98+O_D7RMB[!N2ZB?Y/
MN:KP1[AT: K^NZP^L"$(@UEL&@P&?.J4;/X)'2X79;Y:^!R4I"I<48Q62>"=
MQJ/+%.6< ??IHJQ$"DG02WZ3^6H*JP+KM)C "RE(F8H]Z*EV7;]QSB*RADK3
M5DQ)R/L"?F!,>L'&<9&JP+[$5MB"[0?1VSJH&YF8[O"9>8)')BQOP<N+HLNG
MC]U3?;$N@95BRV*XO/27=W9DW]4YG,RYHX#PIQWMBYKU2!7,#I^R[-E;_?R8
M P]J&PS'CV3Z_^'Q__7X^_@1F! <?'="QM7$[2WBGB&ES2]A *7[<%*6'PXF
MJRR?B8*Q[;RF'U37:/YQBC;PO+E$-GQ5"[J+8'S5/HSV 0Z6R\]F29-$V%P\
MF_:9YBX4B:L&MO)JB=.6.^!8WX,(?GC^GU76V#?:K'#WR8M%N6P35*KYXN[.
MLK+7N$><;'P$N(\?TD:+A,B$K:2.A^:0IZ2/&:@,&[J1XB_WLMM+PZY;.R"*
M&V&&+>H;C[4LTD;+U^J.A:^:LY7L%C4:.F<Z@L#;BUK.'EJT;M"HF1!X<AY)
M#1/[/.3_M?+X/8JX;XKPDCX4Y66>SM S.$\N< BN\YME>!^/^J/>I!%F%^I%
M_O6$;6<>V;1"/8VPA3,DIY5.:=XA-4E:\KCO>F#A'H5/)$W[NBP.K"*PD;0P
M7#)?5:*Y#;\QGC@"-?&!#Q$?W6LV\Q_*$^RQ0JKD@G-06Q)A0&:@L_E$-WY0
MM[EQ[P=MJ+3@+X%5"5; ;6<TBLM+VC<I>D54)U=06 9CZM'>T=]<32AXNG7M
MG^PV:&O3NW%2H:Y<BPA?B76 __I1'!->EC 2@NRP-1L$I[*C]Y3O 6, W+UF
MKM2IK@'HX8GT/=B/'1]R'(&61_A4'#$O;KM%9+!VXQ'<FL,,"9&!! $*%T"#
M)5V0J]G1;;U"X >V4RQW/S0-6_Z(5(YP$&A,X37LV3>R<X9*/9",>=W=X6X_
MN3UN=UY&4IUH<U@$-&#%%#;.:+,\6UYR4[;M QO3A'>BV$F_L2&HPU9KZ9/J
MK\>C#5WL[K7$[#8-;IKCD'L*LUT)M8^N34Q'U"HZ_NOH[PP?'MI,A SV>.,
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M3WYEHVJE1A4KHI<#^[O@8PV3'QCR0 ,(MXNE3W &)IE_'14V'GF&&8F5=%$
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M%+XK2J21U!B8D283#!N(>\ZP&JQF6U^%+A33^!)+*682<O1P8J;571>'OFM
M9AQTD=QT*/P2BB 0 UN"3Z*<&4$.:I0KCC:,:0>N'E9B&>XF=(NH(NZLM0,=
M!\]*+-<G\^EA_)&6ALGP#5,!YYPP82CT'%+USH6"]G>FO!VG033>73&.@198
MWH9&MX7TL,$X5VW!0E4'W/S-G$F7$W->5#4%LO  )QA,PBJ&MJBRB583 [+)
M=5)U'VTE.<2BMJXR<HQ )Q/LRP*JC2M5M'NW'<$"9JJ$>J;3 MASRJW8TJ:/
MC[4\$2E90;O-BH7IIQ>C+L1B\U+YG#EQ?7:&S/DD;JCTJ/,0O(\5W2\ZX@,9
M\2$]?Q-3?A2S1&]*8LHGV%JHAKO:E @U_*F[C2NCW-FTDWUW>(4@\:8M,C;#
M;IR'#K_-C[&:V"K9&=3@A)/RL6-386M4'A#V#/I!N%&28#7.&2J*"_%J14@;
M[/EH-38S?,:>F@(]-)$["9TZ0MV@8T5USF/^)8>^#<.)A*5A=,5LV:8)S/Z]
M*I*2J-]?"S=SD\_-MA4O4WUW9%X-=BB'W7$8?H<K';<2HIC23<N_XLY:Z^[Y
M>BFYY?N$-*?;@B+HWR#(',Z<R>=2I^RPJ-A7@WK&_EFY)7_IP,1P:, %M-B@
MOL*27 F4@CZ,]-<U[+F$_X.O;73BXP^R/=_>)VWYKK W(]^(@KOXH(8/P:[R
M]0J3/ERC,575H'43U%[V>WG1=3E;Y@3D8Z"&237S \) Q*1DS)X8>JAY&KSP
M-W-A^KWNW+CH+ABP-GBHEIF8B<I3$1/->7(IAHEVC @K3BTM!:77$E0MH#S/
M$F2PB&J7T4GLH>,<PV:F=KU@UO:<$/HE#6*:3H@ &0U:<F/'1LW$T8B5J.E1
M/)EGN2P+A@K/2-M<2E@$S-1E[L"B)V#,\V/*Y4R&/<UX!LR!Z8 .1]2K)QT+
M18J:B@A'Y-W%_](T:&IRBK%C$\:&N[.25VEHT&ZUF+'S\%XUF<_D=\O"&IC$
MC]27CX7!Y6L)MOD*2I4VFA,Z)=)VPW\6M?NI#95TRU79[UFWVA&K!H])P-UU
M:ZNB>$/D/9! 0N4'?2J-^C@-RY+02W:\%C[E>*L'M*A!T*^=[J/?:UGOEFUP
M6$/9C]2Q$<:ETXF730@Y19HOL#=_]XO9#<S33%S%+]Z6O,FNDZNO>D4H+MR4
M:X9N4:OX\3/71?1BML3!\[MBMA1:ZPZKR5F[3F!MDV:[*3#ANPTPX;:!"2\>
M.C#A"9Z2I[4$S[=?D*OPFG'ZY)/:'DL;O,)3B;"]4+Q"L]'6%W!KM> 9&H4@
M08C-H+RYRJ;1.M=I_$6.H^NR@FM1H75GZS@Q5(@1$"2 >^8TL=I$/Q[%+%%>
M3=],5XQ,6/$39[2LV%R/4.M+)!;]UH631;SNB#:R^/BOC^?;WY&4VN8:T6L-
MZ'JU+TUZDKHS\&;)1SN*\!HDFXHEDTXCG+TT@64* FKA*F<95E+32WZ=H8<0
M3E:JG\=P$/=O:1T"'!DY/VZ%K!(G^IW6.)AFD!<IEEPJ',(E2C?\L,TD-G4-
MU!QVK.F3Z7(VS68SX]G:W]OL<<PD[YE3=L,!%%Q"+W0#7FL><JCSSW(!YYLR
M6],&Q?2!Z^Z'PK&#L#&Z41M^ZQ1GJ(;(UA+C!P4Z+34\W>0$81V0;.2F1F^C
MPKYGQM6BO,0H,_-5GBQF66T:4CL4W7SPB/"Q+BD2@_4D*O\. V7D-R$A<Y(!
M87PCM[Q/Z8-'#EGVQCVY.W,/IW6=^6_=S0*$D]UGB^\8WCK/3>/*Z_BHCV4%
M-NH(A&"W30K:VLYLHA=/PQO<MRTJ?N(VL7PQG=A&0;[-YZ0.1RG<0;X+:%ML
M9R)C#!,Y+PAK6\YGB!,AX]R1-JY_P#K/&>;QI-)<HQ19;2P]GVE).Y*CT2HP
MD#B:I_,1_0?:>,4JQ14I/?L,DZA)6>?T+6))QM'1O^P0#"UBS(/!/+"B0G%<
M'#:QP*?+\X(LR[*859;BQ)EC1_,QK4W=W6]/D*$Y+M_I]_9V]$M>*\(!QOD5
MR$0?_WDV00O8?;TY\V#U?H#IHZW_YY*^YA1-Y-?YZ4I^A\S3FIC7VA,T,<#=
M@O6#=1QEC+T=SY)LCGBMN69',0\.JPO+EM15@:V-D?5'B:FQU20U+\GFF23+
MO>>G9YS,YXR]/*M">)G)M2-2B  _E (UJ&F$(8 LP/Y+LGZ23@5PX,X$AFU
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MO8'0'X"8+[FSJ,;AA]U+T\94QHLNJS$N"$9#6SMMNG?!REJV*9[K4A>8*NW
M7T25)WD! P5L[IP7/&@55"[2LP=A3D$>K,4SRV0AC#X%Q"U-F805)\UYO>"(
M.NU5.5^#X_'HC@D#SODC?)Y$%6^(B79.:3OXL4DKW^\)\I&(#5G_6/ ?Q;:R
M5KAJ\\"P]5 [B<"%CQJC:A)9%T,/QXFFJA)(LGTW5WKCF5E2\+8N#$DW@X2)
M:;Z!B#2S#>"%+6><XTH6;<A<S9(J16.-0V)&\613+_]4>0@"WRY">XOQG*P)
M[+[C4L)YCT!])>Z=-,#YZ%WECK+?X^=08I.;#^24,*6(-@4@\2+B<O>A0\?(
M,CD'H2HF0A6K+Z,IFS095HOCSA7:/))3LAT*%S6_O:W82.*U9A,F:K%@6HV[
MP'[!=][@"J&N!8T[Q!V:7.>AR4I;XQQ(U=>2+(QI364Y*T,:X_V<(_:$ *4<
M;"<$U,,.=IAQ+3$W#T'8! NZV5+,B0IV\%U1XZ]-@^AFC+5E(:CUB'1M$,B)
MC]\8^82'CN'*D7#:<N07_8U/L>RD?#!:68#SEU\"K;5=X27@7)D2U6_<F3A&
MO&:= 8KWP+(FD)3&ZZB=A:(0F*;"79,%QNV-\Z.F."ML;F;1J</7*VRL5]<P
M_-DRF]4$D9B6R1+)@G*"B/OL$M&@-<1LP\>[NX/IL#W,/+2G@K3++-AQ2LY3
MAM^$O"G2?2GTVW:$-/]UP]S0R3R*6>[;!JI>6"' ^GUBD9QFTQJ/SF!W?\A]
M.[7A"IST1:W7EN!ABL!2HS87;->[Z1Z294P&(9)[3>IG'4\R7Z#T6JPXX#R.
M0.JG(>BD>>L0*SW=\ICK=4LT)8]&3QX(>MT^3&,(%L?N)+6:7VM-;)F+SZ#8
M&*U"UE157/%$JJ_ HXN)TQ0OR]J><'/I:J*R)L -9_X*-S/+HZM-8Y%PS9BU
MAO2^GPWV<(S-G6F'A:XTAL(%<&;K:*ID;;8N7LD8B?+J9*%NJZ-)$W2E*K1K
M=O=)=..U2QIH4#*#Q]G"])'*M%P&'\);9)^@M1&\H"VOJ#(XPM1R1*8,/L>!
MP32V?+^)+90-Q&@3?2--/^/W/4$O3"]Q/4--'*)8:M86<38O47"B7N#=[Z(H
MS]=ZF8=C#!",%I7;7$>V<;TG.=95T <]L+/VI)"DYM)-BA_@#9I.G(;,OY'K
M9.).Y"!2L(DBJPIP]0:PMA(X"@N!G1(NC<TVD4FF^J\ Z^E,37[?\EOG]]!,
M->WO09N>YJ6_/A7[;&>3BKWM5.S+AYZ*?9P'X;'R'+W8%E)B#O4UB@0WG$]/
M*J'\0CB?5!Z0<>[H-[53=G?^A.:,2RT'%[/P9O(?O/HH-PH!7_2BEVS73>0]
M61X4O037MP;"R3((WD_A$W<,L08BWX-:W\+ 84V6F'PIPU!*6HZSRFU4*!A'
M_F&.?:-*ETJOW^N8<".:XS34T=EI?-K$+#F4T^BXIPOL#\&9+L5C_-=S/\M9
M %(D/X<"Q&S#Z_(YTZ7$, USW7YZ]"XZ(0RB\HQ,S,4F="38GA?YEGP=1<<;
M79:["273R]0A:Z)86LW9.^M^/>FCN=%.H)WV/.WT)9J)CQR'C$WW/#VHR60"
MWZSX:*I; #K1S3#-"PI08*C .:[KWAQ'JV))X0=X*OQG28'C,N5$$7+IGC'S
M+WY6I3-F(R' AQ>C*$U*RCG2@G:XWAENU4J2!,04C^L):F[D>!IK, %3-X/=
M8?1*>DU%KY,5A\%D%-ZCI:_@G&GL;[I<$PK_>,M#*0'59.KJ^D\R;63U4:3E
MW.1?:Y0X,00,X,!FG'!JG:PLA&A$[CB%F.%PIS@V@5OE407#+W!NKD:FN,S:
MW2M$3=,&M4FP-CO"1VO7(IENO[=N :_:"2LX24-JDLH"4<*@P8NXD="GR%*R
M!(\OJ9G5B!H8:R4D71LX?G_X)MIAPWDBK=2"..@$.K =R]RAR:BJZ-GV2\[I
M[PO][5!?UPKT7_\X^Y ?S<=Q=%Y<,H$)IV6G_HFCIN*5]%T.$T"AW'KA8Q/K
M=&I'3>,L9PN9G<^.1\1:QH-"BJ=2*($$]Z'A4[/'P7VMK(I.'M,T<"T<_("?
MG,X-F;]N#TJ@9JI@)1(,/?'&P].Q.1XOTN:ZWUSW>MTSYO=#4=4+D!4-I[H,
M_>MN]1O;M5:Y&>B#@\"YVK#E!'_SM^Q6=]SE""30 'W<I@/]FB4XKQI,7<BZ
M\+>#IL9MW0S(IG!IH/BVBPUQE)35\3JFQKJ:HDD^V/?O0H0W>LT$N!<ELC@1
M6Q%';RNR>RAO,%IIELEI4O?[&DKR2O5[K;2%/C.><%GR;4A_:*DA,Z6KR 5G
M*[;\JCG#[/_%-7D^#$ON"H%B2?\&A_5";VY7):]=5*D_PZNBA:#5T+A6T;)R
M+F][V;# F?)SD]6DY@;( .+#]LRMSZ[P+/NLI/'P#I 1O#U ?!%5DX$*DKL?
M.;<ZLZ6M>$6+DW,Q<IM;XLG$*K_;#CN\'!:@J9)KMD][+,NPL0Q $CA,R2WM
M47W#+6=PE_S7URFR!G ,D:V$T\:EBCAUSJN;*W&$#;)!?14E=Z9-<]+>J*--
M^VTA)94B$PL;4P*"*BTO**];*<&XNBH\-/C':U.%JY=0P8P*1)6BL_%^A1]H
M"3\E39-RE,!MO/7^MUFZHL2IDYCW^0ERA]@4>[?AZ,KES,*.6RE+HW6,I;$B
MP0D0P=7?2AS:[ZDIYJQXFGZF%25+!E>]"7&3MG*TCPI+M..":\M\JKXD_!O_
M+(#?%?Q\SO<Z%D_0Y6.+'[BG.&QU3<X];XTNP,$2M J3OM9UFJ[9,-E\,=T,
M!WI"#QB;!SC=MA%;6=:Q<_,:AQZCT6!-4L2%[U3;RS@ZV?J'$8^UN[:Y!)^\
M0MQ3GKKS;)0I!.8#1C-!HH@ZB56-'+J#/ ?S<NSVG6RJ1W()L-J=6*TKY6 B
M(SO-S]":]6SM!3T;(P2LB!2GTL'0W$K#%8N7(H$X!0[7T?X/.SO18GN^'4='
M<(33,B=V<5/$P)V0!KM_/?GUP]^J^J]_P?\%%>#%[_Q.2*CD5UN([#N/!L_W
MZ9?UN?R2FBDQQB_TKV(7+\9;P A@D K8UW)E5XH[UY.G1$J^G###QYA"O4$$
MRZS,2,:\.=<W1:3L;A IMXQ(>;;ST!$I7_&4V)$^O>/ZG83K/BII_!O2R!_3
MZ;+21D$?-)#>&J0C\!W656<,J"PG1/YB+%=.475T0@[;*CIA,RS@*<OTHN :
MV%('R%=&R0.,!O@4,>;:YV"QSMX=14]RT.%S6)WS2A-C%%\4\*PM\\@JMN?3
M&L/TS,Y'AF$Q4VZP\0QN :H!PGH:BHN O?^92)2:WQH5Q>>M<IGG[9_W>\8>
M10+)K"K:'[-T@DSPR5^P0JOYK05H2.%=.^,ZQ+47?=MP; J45U,Z"DTP^ CW
MXW19H]O%%H4D-;(+7$:J[&*@\20=X2:U=.N G9?OS3)8LHE:X\B6-,!7P9!U
MKZ5Y5;]W6B9YQ0!=N].396E*X9N[;"*HC3+F4C'B&)0K2J$1P!!:-LF2<M7\
M1<[RS2DJIX66M2K:>XJ:*CKMPN7,H]K&[HZ,,KDH,CY/6C54+$>M7<094X]I
M8+#CQ,YC.4#CCJ.A-@;3(IZ>++;(78N0!1)%&J!M0KYA"8X5&:8=5*[^0GU=
M!.]7IZM\2+?*'_YVZC*D&;'K)D7#> &7YPIDB%#<:;N0A+32ILZ8+Q!;=K*2
M5"FUF% AXGH<4TA!M7$8ZJ<&Y?,DX[X9H*5RNB30DL^0QPZ#/DA59C DK<?5
M4)6$IQ@>C.$1C!8P.(WFW'X1-0+DN(HM"V&J0$AI[00)',>[P6E)P3ZI$M/#
MAQ?#P5$$PW9NV;PP* JN/H)EXJNVK>"Q9;3L@@8O(,9BZH<4*TK07"?)"/X3
M(?WN94)9\B*ZQ56T"7["_=2V^H?&A>L\:I5;JTY!]6'!!.:2.#.RYK:\QF )
M$VG][K:=EWN+/>..:\M!"%*Y\?;=*IJ'HQ+O6<3_>TY\'&DG9DGRAG8PG8E3
MAU'[E%78)CGRI/RP[R4YXHN+QOA:,KW2H-$T^J:.0V#$V49H'@E%H.1(]YO.
M<(2F0L88(C2?I#/X"MZ;5!V7EICPM9T).$&S%#B&11(MKD,Z_K@W<2/'(,<<
MTW8TF@U4=YLA*$8&(F/A<J&JY%L<(\@2AY8;U8_S$J/8%%TR])?FR&LQ9H@)
M!J U.\;)+B;W(.-P3+P9Z&N=4U\[-C_A]@=#I5PN:NE]IG!@!7T0RD\BQ=E\
MGDZ(B$M<8?L4<I[Q,7%TQEV8W?P<M[.L]#F_YM0*C@ JU8\>K5B9<.,)_B+N
MX+^*\K-0#[D)0?HXJ2;)?^3#7^@=_=[;MX?NTA.JHUI6"RX4+4IWZM*4CB8.
M>Y+-EW/^QF_TG[ )V%:0P"XRL/#)T^PW_;W\B, \%?<:<1[@K$;X#,-\ 1;;
MF^-W'P^$<H9A3 X'D\-K8>RL,[+Z67Z6X(66&&" 9^-@W0:6W!(4UMGRMWG;
MX(^*E"]XT<7L@N$X293#7EPFI31Z &>FI-X7&7:-^#?\\;P 0>0.%;*E%T.N
M^T<7'(<S+\JDA@$NY_T>RB!-?I*"8:Z]X-P-%\S8-)UPX:M.CA^NS[;/C+C3
M!?74-1E:W;;FZPAHAPSA1ABL/9S!Y3+FUI/A(C5D6H9C5[4%(@?B)P!VAU\*
MF7EPTE/8^AC$959@S"89C[,)A:_.X;AFXR2'$Y_"W7/^GV7RF9V>*7Q:@7%<
M2Q!$ZMJ363*7'AMSU,%9L:SH]--4;?_"PNFF0H.P(T7"->1,(GS!)%;R!E\E
MQ-RF,\. "(5/M/Y=JL=M;%2N6A-76@=^U'44Y>:N9%:QE,G"8=2>^ZI+@\20
MA:#(0=5?$JQ.:;C'"LJQ4%[S0KMU;0H<1=4>B>02X\'61Z4@JK9KU:XK=J@B
M4H([5/7GQ-&XYI[\IZHM7L</Y*=8876>I\J6I=%]=%)9(&.K3V>: A%-E]W4
M^:)$?VW<M:T(+='P)O&?2[@LW.U6/G1"K\ Q'4OA/YTS@@JV4=,IS' MS;IJ
MMM^&1E$:LCHA4\4 2<"HBK'/19I[REUN'7/-R)#2G.+I)8$@[+?/,5V*O_G[
M,D^CW1<QMK??>[:Q$6^:']W;Y$=O.S^ZN\F/;O*CU_)G.#^J;7K9F0EY[T!M
M<I&.>,2LN14I[Z<]I4!)KSJIZK*U6BUJ/C;T)Q1#M#6.>QP"-*V_O5J*EJ"!
M,/*,X>I'-D#,R 1:W^OG;-F(R.7"6UBZK]G^Y%1Z@#PR2M3+=[W/UZ)98(??
MNEG;)^7CEN!.?NI=>#45'7,/2&GJS"0^S)^ZK+>*Z=8";K:T=MD19_I<&HN3
M:J.MP@Z.] 69%L7-)TN.5RNGY,!/3YB>WN#6F5Y^C"H-K*1#+@D81LL%CN"/
MN_L[\<[.CN0[*H<3ZH_/]O$3;1;(>^-,STP(J4C1>IVMF/HRX$JMA;4Y&(B;
M*S_@5VC*E&:"_9= #.?M?4$77+T GBT6!<Z5M)-VNSW'B8D_V[$NW,KN"CR.
MTDN;K7&R$,;(RT3\4:X7@;%E+! - GG)Q3ID3RVDE.9L-(^SP,RXF5<LN5/>
MDI H.)BR<G&9#H]A01T=8,Z"$O<2Y1E(FEWJ3B+H!*',+)2"_=Z/2Q"#_=W=
MG<'9</!\.#@8;JRI)Q]Q>][6$[#SHK*7DSD4+51B+ETU:GC-F=GFHZ+[G6:@
M JD/?ST)'>O@:LI<IE/G:N)KHJ-EERBE$K151@R)I);(;Y*.NE+,9/KBRMTG
MV-?+9.4RN,5!:K#PNYQBF,7VY,0QKB*%,W3@FYB%5<JPQ />G-4G?U;W&6T7
M!F,^F6!,;$6($BPGR_(";A8^S@<D\MV!'+*'[,_7'&L23[QFT",CG<$%"J:#
M9U"F7RU'TIO"6';<>3#V3V*Q(-+NBU2[#]IS&3G'$JESRLE,Z9NI[03U+S<L
MU$5NHA[%^MZWD;"T'L#09QE/!,/),P)'$#*IBET&8>F3-U.%Z+8Z9,I.NPIE
M5^L][RGN2FFPWHWVN"W,-633"--LM,.3P0:\9&S +UDU!C%-\A1L^4W"OUW>
M[[Y/];<3^I>2]7]'@*W**OFQVVVR<AG ++^)^N#&=A+_G(E:K'-E'&SDP!$2
M?&L6C1A'AD[]P(',84J KP;!SV&C@WI9YH8[&Y-R*5;^#6-1B9PL->@!4L),
MR$]V55G A!B+1QZX9NO$6YMFY1Q'X0U->B5P@U=".%2%_XJ41^\_A:Z$J4P,
M[,C+(AKL>0S@9.X)@$[E\-9P3M?4Y ].LK^&EK[-T1Y/C;OM^^D_/)09/*SU
M/CW/\L]'!.$GF,%#&??N=])B.#JIP3X&S_.Y7Y$8O9D51?E0I@/?[/<0)!!'
M[_Z%:9*=YP]EZ >UH,5_Z/=^3A-**Q[;6H57#)1X*+,YVL(;Y@>ZXAF37?V_
M&%+_O,5U+MMPS>.=_U#F\["T$3.V86N&Q2H:")>B"05AU0GSXDCMP!"\[<V]
M<">C_6=*-!UX)WQX*&/>W0?3_--V]'POG]AKX25&XA_T7?#LQ4,9.MP%> W\
M4F([G]DL2^;1N^WHYV0R228/90YODM^P2]KV#^!_[(('\FSGNZW]_9??/Y3Q
M?PE:Y=D&K7+;:)6]AXY6N=\"?6]'ZSBP$E[>6"AW<]?\;U:72=SO'>?C.PW"
MWN:@]W8=HIP/2?DY>EU2JNAA#/]5F2#0%7LV'YY&.R^>[^P_E*&[;NJ;$BOE
MJW$1O=Z.3I+91?)09O&PCNC&G;LOH_T)G*%\E)9GQ+ZQ++.S.'I(GMWW^R_V
M^[V_)W,P$M,4?I5,X-O+#&1G?V?GH4SC&.DJL3#F\"!ZN?=B=^^A#-Q5GJ^3
M'*S'Z!_;T>LB3\Z7#^;R<AR[E\]?#J/OGNUMO=C?V7THX]^ <?[V4DI5,<Z,
M'$.V3O5<_M)HK$)D5Z;F!ADMI&L[4W_G%RF(L[#U4%]X_$<<@- <!!K!6:GS
MB,,P87IH2\7J FE]E%E6*KH<X%G9UG'=@EN?]!9OI!RDG L8#I0*OY53 )F
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M[("5$ZK)%A@SV:(E%R.U=$,S377\?IZ&!Q,>/$O/$FH[YHX5_HZ_$=QYA<Q
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M8Y?85\L*]%A5H9WAWO.1%=I)L@)#;IPNV# [2>HE&$^KF/\%LJ#_C5^\/,]
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MEUE/RETA&<5O\##TZ>MB._H$*AX!)9=%--@;NA=Q@->%]9 ,F44T@VK'/:E
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MFEH /^WG=#F;B99#&P:ML9;9^>/O]SHF,"5AS<?('4>"=,F'T<#FO=,H4Q&
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MPS9;UF2A"N5Q2=28PGX"X!?FUJ ZX_R631Z4AEF]?7<*IJ_*"V66\QX<M^?
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M!B1\QY K%\U9Q*)>61<Q#3XG6&<J7FQC=:/8P33B2#DK9B([K 6T QPI;-9
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M50FT_#IT#L*FT\N#R@Y86%G,TG%:&W*'-*>G!]T/]R$4'*&9YG:(?LF? [Q
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ML16?=GMFOAF[>7>;^7^K_MNE]#8EV+BW/V+(0ZH_$'9<*5HCCCL&8-0F =W
M9@]M$S;=X[3S@'&H+2V:S. U^HP]3!0/!^G4 8M%\KEEE@FP,U6?E97!HC,0
M=O)(4T7+30SRY1!>?\IM"=SWEV5N@84!&1(,.B[BV/Y(<H\GM/=PA/G/"X?
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M8CG.T@G"T,.JP0?<Y[SE?WLC_V9&A< 6)C<_8:9DXD8.D< &V:*62?!?WST
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MC-X=%' Q3B.C4UHBN<LX@\&8%7'<'B9T)^IJGU>=OL'^4/+[ EU9-U#R2@0
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M#))@:3$.=Y-FW=Z"JU *9<^/+3T^$^S2 6ZS\S@+JAS JE!E)-0 O$1$Y>U
MM %&\2:PUMFNOS #M[SF]N: 75#20K_'B6RP=L ^8W/?3UB2FW]>IS0=7%O8
M3+>-!ZPS'<'\3<6[TC]@]+ [;36 %#9POU19<W?A-^MRW\_CM-\:IPV0^!/<
M!UJC(S!-<6*<]Z<H=,&7,%3<NG$0"LT3. ^3$>E.0SY9$IEI+*!]325VXBYD
M>EGG1/'^2*!G-C48\$P3*V67I'QI9O%90NB=@1"U= UMA?:(\&! U(Y8+U7(
M:Z@^B&"R);X\9>R08Y.>?AQ9UF?)2!%=<TU<7L[("$*ETDQ53091/.1_PXW
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MF)4^%O9R;\BQG0,W1A>2._831]X,AZUZAI!3>29_K=*B/VUE>)BNU[ZD2NK
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M^ZTIR&><)-PYNCCY"__VU,Z'SL>SP_\'4$L#!!0    ( *> U5:/.A)='$H
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ML4X07-1 [P3U=.A=569I9B@W+$-#AHZ"7"3&Q,]8D]4("R1Z1507_=RJHQ7
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MX*V3!-DY2'EM5H#4ZM$'"N3Q%@[+K-5)3?1HWCM?M6T]A^8IP;UOB&8LBNO
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M.\7%+\J"RWW9]'?^+782UXVM)/$3/<4(@66CI\ER5C10%9+TUHM-@5*BBKH
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M\'S.S1T>?OWX\:Z.;>$K.H?E:,Y^?*(29>7+R@7%76K,M5U/H9&FJN4=F'E
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M)>/<^N18 S=9&7E<["A,O7PG:5HP<=+46_%]V6K2V 2@Z.ZQ.GXWEZ+X^J.
MKU,>6FB@C]FK$6=JCZ,?$@[B:! VJ$^9!Q,I H=%TN.RSPMG*5);7WP=F^U8
MXA[R4"DCPV_WYN3<WS24'L=!N,CNA%VL<#*CZY<AVF",(/R#'A&T88"CH [Y
MRW=RE1PS^ M=BVMJ:FP6419PSUX=9 ;_D:K_K_=7_[Q+!_(31:Z..75_]DUW
M4N,)6P,O7/L@>T)GB<W)Z6?:G25O!9;XDX!' _3P:T8]#F#$(TJ]E!3CW)4L
M>;8LS"(93(<5*!_?$$ ,=CWD!B\%^K<\F V6/E_6-=7Z.@R5A!HS*%>K&I74
MKK7:]TYCA"L V._\S&$@:@TDZ_B^P/8)B+^1=:2!V?(K1G'=:ZW](PA1_.MY
MBQ842B"[[(+#G&\12;II9%?T@/X5]TSKBT.RXE[+ :- +&P4,X8+-+ ?E4'T
M+ 5P&E("&J[8]@)%,0\J![0+YRL-*O>BM7R+OGU9417<#L;VDGM:Q\UL,>YT
M'R 8"T3'H,")RWW2HS+X=SH9@K<#J"^:*G9+;HB5WT%P]!G#Q0+L5VS]'0O9
M8Y2X^B!'^5B/$DBY\__;E\"V_&V3JQEA=TTLT8>G8"LU+((33PD(1SEXL7XB
MO!4>YFQK76L0HL649RL+ON.W&%,/&TG%K<5LS-S.1NP8JK\7P]7W0?2DYLH<
M!$!OE=)-17AT+'A=-P-0^KC:*UO=,/*7[,0>ZNXOI!W>C:4H\4=&T\_>2G_.
M';WJB!!2@LPQT8A)K=P"C.GV@TN[L(&5'\TJ]ZV45 M!?M79'03<T_Z+'62*
M30U"/PA!0&OG#DFI__&%J; V34G=Q3 &)R\5C:ZQ)-<Y2)MP?*,NQYG\'OY&
M?@9VQSD^ YO$WB&S6I?UEAV,B,!%?,&&/"KV#B\R8$6+38ESIWKW8D4J3LYG
M<(^OY)ZPXJ-C6/%VPXJ/CF'%HTP)9 JE5)ZSPQRUEW.X-4UEMBP$SI&=M6?2
M_5(7H4.3BG3T%PA9+,P8O$;WJ5"\/\OKM??0Q:$:UTK3X(?C!ED\F\A'"4 M
MXD4S?-/M /Y@^3G](^[%7F#_')LKA_HAFSH@#4&Z+N)5$01/ZY&?"FVJ5461
MJD,@+GL(;1'JA<TUM>CTUI^4U4<%M1Y F?B7W) S%;45 TZMZ0V(!;_<B!&]
M^%FO7D0?:MPK$3$^6Z>YCTX7#'"9+]="%^A0> 1Q'85&YJFDKBZ&@X_M^:[:
MIIS]QT75=@TZ=+MH1DY;6QKC/I^V;3G[>#'! $Z2FES:A@1$<J MN%]:6%2J
MHS;S#3>-)^N)*L(AA?#O\^M3H]B>2$?H3/ ]%3D.HXR1E"(NMJ(<U2_WA\*;
MP?7D8;$^\95#H6:5! 8ZEJ0SC35".;3%MMO.TG[ L,BG[>,]W,?(7'#Y6#I4
M=X7]#78N$-XJ"GSEOE#[=9/"=G";>ZRMW0W7IW.D'_WH'WCJ;Y"KW\F9WT?=
M[G,!SW@TL^AH+\ :V2K589ZM"\R,&2U7X;H2L<(V5R.J4@5*16&<@7X0] ?8
M!'H_E<K=2E:G@T_VLFY5TLXN=X:;J$V$]3X]F&>#?<X:<U&T'744PF0?!?5&
M&UR\Q7;HP_(B=@@#_<>!@YWQ$9W.A2#)K4L >\UMU[K5]HP[50:8D**E)FPS
MT&34  BY1C=P<,J'G9I(\X;4!*OID7]ST_BB(WK/18!GR2*;MP40O'E 59 )
M?!XX5@A4OC!*(^>3;++&M9L3$JL;46'=H'X6OFNP5.(@#W= JC;,0T0\QT(8
M%L(?NI3#&:7AE"2MF94X-3;L>=&V&RSBP1$A:A%/OQDK6,]5$\GQ;*0N<4OY
MU:2',75>F>9:T[-IY9+B0!-@;]?0.T@XK R[D3F0$!4UQG=Z.U>@FIEAM(<N
MT[W@I_=3-) K^8>Z!<( J5T:,ER>8RI,O052)$FN$V':L^1EBQ@3Z>@$W]1_
MQ;=_J10IP!#$<+T;6A,6TCW1#^:L5##6/$RY<>;A)AR3F;AE0P$X3X_0<>H(
MW4!_MXJ.[!=SH604<8(2MX%Z>,D^Y'8?4E>*M3][BS+#O]57E4<7TF!)9"P]
MP]3EW="[KFP/FC$ERBC=!3!U+N0!VP=MB@*F"VX3*L7&<[.JL%("MNJ\R- N
MXQTJLV*54!\OX3NK+#?ND0)+2E+?K0U!^?BZVPV#9;&D6W1N51N7K.O0D<$Y
M2OMY13;<Q+=_WB/'?&0?M[.40XH</CXZVF_7T?[X+^9HOP9!^JG='?O0^Q2.
M:3D?>.HO19X)I.M.KN$.;_^]$,).\?V"?2*OT=.,RM* N&+:JFUY9O4JU D)
M/ 9JRJJD&B6V6<\&U"70I79G>DPGU$NG5XG@1!>Y?U9SM_.?R;S3!>[)V+W*
M2.,N6E;A^)_=DJJ'5LY<9?6.R@9MY1D?ERNJR[J\1)>YQ(<R0:*UFZ(3![T@
MUGQ6SAPF6Z;)O"FP1P_\*\OA'V13,M("7027L /4(P=;V.I%^1'#BOT4&<2N
MM0Y:LLCFTG'6A1&D[I/>L04;^KK(9L%A,=*CD[X:S;@*W+O,E_^LG6<E"M7"
M8,K5$ET(A[ZCOT.5UK@X"^?N<*OB>'#*?R#U5KR%D7!D\D*R;&QB4S],M9#C
M!IL"2\>FR6\4X<0&OIL&#8EF@]8),8EU@V1 >585G,P"3MT&N'R7)ULJ3G<T
MHB"+@[?,@.#P73#&J"52U_HZ517W3.)'YH4%A5J;!"Y568#^5"(J!B\5&AED
MS1#M<Y78M:FP'L^)GY.+SXK9-)TLC&E/$]?YF.N/4@5>&]4+[Q.5Z!LT>5]C
M_V]9-;8"1K2PX;) 632B#1?'1Z:0MT@#KCC(:F9\>8C 3,MZLR._9%U5$O'B
M=EWJ.E(?0=QCFVUW2HDF..&<L(61%8-IA]OBT_B,M'9T5MG.\9UG*AB3;I)W
M'-H\%JK3AW4@R(GW<?4:OH?FW1\A)!EH"/PSVUHB>2$W<9>(C$M!]!\"=2V+
M61%->DR!V+8"]1O<=JP;&5[WA&^[ON*Q&Y2;A>&[C<)-43<YV"^M1P+YU0)E
M&:9SKNNVX,0 EE9TS>E.PYG^\MVROL)"HO:29UT?H^CN=V2-?,G\?KJUAO-A
M"'IO/L,:)].)8RJL >#U)E<V,K%B+5*"P_I=]CLN/'Z)805TSMP1<(7.G]9.
M*+?9"LMZ@U /DV!I\!4H&>56-<1!3U'6Q08'28BGWZMJ9ED?XM=M@TN.\MO$
MM5\E<4UA#X[LXB-;BI9[%&=$]Z*PAY>HB+"_<4$Z8:!E)R>+NBSK*RMXH_3.
MR=:C.BFU*Q0R=:AD=Z=V4I40Y3HK2&8AM[+5A+&"(.@B)X\_D^JTG.614;$C
M+'1N?:A Y M?:#ZD>HP<28R)+N-E-+23QNX+ =4H7H4+IJLYIT)MC/FG*?,=
M=5O$,R+ -,>$$&,#:R*]'K3CTC9*1HF>QL.U"-O&H14/WJ5P"0>F-/^ZI8BG
MPROA;"@UUKJ$@8'/;<^#,>AY1TGC36YL@\Q+)HV#F8I2KDD1"<EM/Z6$S/K(
M:CZRI2A60^7L7]65;1\A)0K(H%>ZB4#)N((O%61CBNR1$EW+*)/PH4\"C$FO
M"HEU  F1^25?82Q:3.O&^TP4SGA^(^QDSK$CH;V*&[UN,"SD.G,Y&W%7Z5$*
MT:B ?G;1&*+QE-"$+I+FP)=4M +QB W?E*!#R%'4?JQ+4?1/U?49>/VFWC3S
M$87<111]OV+?ABZP/AE#:S50QQ<%>M*W^-CWQ!5  _=&0:7[V+VQSY>1['%E
MI-?S8=!L^DX,;73GF[GHY.CF8O$Y=ENE7R5!+':*D4"'YX3<.'[XFJL1C\PG
MP6J.-_(C6\IU&L@].<96;S>V^N086SU>UIN)3VI#<0[\.V<UZ355_$F3'^L\
M8/0O2HIPJ KZ)#K<>XV\M^J]9_Q[AVAP@T)=2N^T0[']M@(#C77%QL:N]L@G
M:P,?6,]X.I$9^,(&G-)NE&>**L>#IBC%?=E$DYB+3:[UCXZ8[A*WX:+^_26
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M*L1U:3:P7%A2""(QDOI*M*W(T&XU#^$!#(P+7]!M_DU8'0ZF&"-MPA\(S$;
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M*_O?[Y^;]%)9?,N,7D;[#U!+ P04    " "G@-56/,]QMD4*  "5+@  "@
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M-C$U7VQA8BYX;6Q02P$"% ,4    " "G@-56'@*)7%@'  #75P  %0
M        @ &*#@  87IT<BTR,#(S,#8Q-5]P<F4N>&UL4$L! A0#%     @
MIX#55A%JJWE5&0$ !6H'  D              ( !%18  &5X,2TQ+FAT;5!+
M 0(4 Q0    ( *> U59P'/G@.!4  )"#   )              "  9$O 0!E
M>#,M,2YH=&U02P$"% ,4    " "G@-56CSH271Q*   WL@$ "0
M    @ 'P1 $ 97@S+3(N:'1M4$L! A0#%     @ IX#55H"F .I'"@  DR8
M  H              ( !,X\! &5X.3DM,2YH=&U02P$"% ,4    " "G@-56
M/,]QMD4*  "5+@  "@              @ &BF0$ 97@Y.2TR+FAT;5!+ 0(4
M Q0    ( *> U59>P<#T)QH  '[$   +              "  0^D 0!F;W)M
=."UK+FAT;5!+!08     "0 ) !,"  !?O@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
